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Abstract

Alcohol is a neuroactive molecule that is able to exert variable and often detrimental
effects on the developing brain, resulting in a broad range of physiological,
behavioural, and cognitive phenotypes that characterize ‘fetal alcohol spectrum
disorders’ (FASD). Factors affecting the manifestation of these phenotypes include
alcohol dosage, timing of exposure, and pattern of maternal alcohol consumption;
however, the biological processes that are vulnerable to ethanol at any given
neurodevelopmental stage are unclear, as is how their disruption results in the
emergence of specific pathological phenotypes later in life.
The research included in this thesis utilizes a C57BL/6J (B6) mouse model to examine
the changes to gene expression and behaviour following a binge-like exposure to
ethanol during synaptogenesis, a period of neurodevelopment characterized by the
rapid formation and pruning of synaptic connectivity that correlates to brain
development during the human third trimester. B6 pups were treated with a high
dose (5 g/kg over 2 hours) of ethanol at postnatal day 4 (P4), P7, or on both days
(P4+7). Mice were evaluated using a battery of behavioural tests designed to assess
FASD-relevant phenotypes, and showed delayed achievement of neuromuscular
coordination, hyperactivity, increased anxiety-related traits, and impaired spatial
learning and memory.
Gene expression analysis identified 315 transcripts that were altered acutely (4
hours) following ethanol exposure. Up-regulated transcripts were associated with
cellular stress response, including both pro- and anti-apoptotic molecules, as well as
maintenance of cell structural integrity. Down-regulated transcripts were associated
with energetically costly processes such as ribosome biogenesis and cell cycle
progression. Genes critical to synapse formation were also affected, as well as genes
important for the appropriate development of the hypothalamic-pituitary-adrenal
axis.
ii

Additionally, gene expression changes within the adult brain of mice treated with
ethanol at P4+7 were examined to evaluate

the long-term effects of

neurodevelopmental alcohol exposure. Array analysis identified 376 altered mRNA
transcripts with roles in synaptic function, plasticity, and stability, as well as
epigenetic processes such as folate metabolism and chromatin remodeling.
MicroRNA analyses identified changes in the levels of 33 microRNA species,
suggesting that that long-term changes to gene expression following may be
maintained (at least in part) via epigenetic mechanisms.
Taken together, these analyses illustrate the sensitivity of synaptogenesis to ethanol
exposure, leading to a ‘molecular footprint’ of gene expression changes that persists
into adulthood and may contribute to the emergence of long-term behavioural and
cognitive phenotypes associated with FASD.

Keywords
fetal alcohol spectrum disorder, brain, development, gene expression, ethanol,
mouse model, microarray, behaviour
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Chapter 1. Introduction

Chapter 1
I NTRODUCTION

1.1

Fetal alcohol exposure and the developmental origins of
health and disease

Development is guided by the interaction between the code inherited as one’s
genomic DNA and the dynamic systems that regulate its control. The development of
the mammalian brain is acutely sensitive to this interplay: dependent on precise
spatial and temporal gene regulation but highly responsive to the developmental
environment, including the decisions a woman may make regarding her own health
and her child’s while pregnant.
Neurodevelopmental gene expression can be affected by maternal stress, diet, and
the consumption of drugs or alcohol. How the prenatal environment influences the
emergence of later-life physiological or psychological disorders forms the basis of the
“developmental origins of health and disease” hypothesis (BARKER 2004, GILLMAN
2005), which has been applied to psychopathologies such as autism, schizophrenia,
attention-deficit hyperactivity disorder, and anxiety and mood diso rders (SCHLOTZ
and PHILLIPS 2009, BALE et al. 2010, DUFOUR-RAINFRAY et al. 2011, KIRAN KUMAR et al.
2013, UHER 2014). Few disorders, however, have such a clear developmental etiology
1
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as fetal alcohol spectrum disorders (FASD). Caused by prenatal alcohol exposure,
FASD is one of the most prevalent examples of how disrupting the developmental
environment can lead to a broad range of negative later-life physiological,
behavioural, and cognitive outcomes.

1.2

Fetal alcohol spectrum disorders

Fetal alcohol spectrum disorders (FASD) is a non-diagnostic umbrella term that
encompasses the physiological, neurological, behavioural, and cognitive features
displayed by individuals exposed to alcohol by maternal consumption during
pregnancy. Historically, very little attention was given to the relationship between
alcohol and birth defects and much medical literature condoned moderate alcohol use
during pregnancy until as recently as the middle of the 20 th century (ABEL 2012). In
1968, French researchers described delayed growth and distinctive physiological
characteristics in children of alcoholic mothers (LEMOINE et al. 1968), suggesting that
prenatal alcohol exposure was harmful to the development of a fetus. This study
remained largely ignored until 1973 when Jones and Smith reported similar findings
(JONES et al. 1973), describing an array of physiological and intellectual abnormalities
among children they defined as having ‘fetal alcohol syndrome’.
It is remarkable that such a common substance, consumed for centuries, was so
recently acknowledged as a health hazard and a cause of detrimental effects on a
developing child. However, since the publication of these seminal studies, the effects
of prenatal alcohol exposure have received increasing attention.

Even so, the

recognition of fetal alcohol-related disorders remains complicated, with variable
diagnostic criteria and significant phenotypic heterogeneity. Recently, the term
“neurodevelopmental disorder-prenatal alcohol exposed” achieved a code under the
category “otherwise specified neurodevelopmental disorder” within the most recent
American Psychiatric Association’s Diagnostic and Statistical Manual (DSM-5) as a
condition requiring further study (AMERICAN PSYCHIATRIC ASSOCIATION 2013). Some
2
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classification terms have, however, been established within Canada and the United
States to define the differences in the severity of physiological and behavioural
features that are nonetheless consistent with prenatal alcohol exposure (BERTRAND et
al. 2005, CHUDLEY et al. 2005) .
At its most severe, individuals exposed to heavy alcohol exposure during early
gestation display prenatal and postnatal growth deficiencies, distinctive craniofacial
features, physiological and central nervous system abnormalities, and significant
cognitive impairment that define Fetal Alcohol Syndrome (FAS) (ASTLEY et al. 1999,
ARCHIBALD et al. 2001, BERTRAND et al. 2005, LIPINSKI et al. 2012). More commonly,
prenatal alcohol exposure results in less severe clinical phenotypes that include
partial fetal alcohol syndrome (PFAS), in which individuals may present partial
physiological features of FAS while remaining severely cognitively impaired. Other
categories include static encephalopathy/alcohol exposed (SE/AE), meaning
permanent or unchanging neurological damage that may or may not present
physiologically

as

well

as

neurobehaviourally,

and

neurodevelopmental

disorder/alcohol exposed (ND/AE) that may present solely as cognitive and
behavioural changes in the absence of gross physiological abnormalities (ASTLEY and
CLARREN 2000). Importantly, the latter categories most likely comprise the majority
of FASD cases, making identification and diagnosis extremely difficult. Further, there
is no necessary correlation between detectable neurophysiological abnormalities and
severity of cognitive impairment (MATTSON et al. 1998).

1.2.1 Behavioural and cognitive phenotypes associated with FASD
Part of the difficulty with diagnosing FASD in the absence of confirmed prenatal
alcohol exposure relates to the phenotypic heterogeneity associated with FASD. Also,
the physical, cognitive, and behavioural impairments associated with prenatal
alcohol exposure (PAE) may not be clearly “normal” or “abnormal”; indeed,
individuals with PAE fall within a broad continuum that ranges from a normal
spectrum of behaviours to distinctively impaired (MATTSON and RILEY 1998, ASTLEY et
3
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al. 2009, KODITUWAKKU 2009). Many of these behaviours are also not specific to
prenatal alcohol exposure and may manifest differently across the life of an affected
individual.
The vulnerability of the developing brain to ethanol translates to risk for a broad
range of later-life outcomes. Infants and young children with PAE often show
impaired motor coordination, balance, and reflex responses that may persist into
adulthood (COLES et al. 1985, CONNOR et al. 2006, LUCAS et al. 2014). Also, children with
FAS and FASD typically have lower IQs than non-exposed children though there is
considerable variability, with most individuals with (non-severe) prenatal alcohol
exposure falling within a normal IQ range (MATTSON and RILEY 1998). Regardless,
children with FASD exhibit increased rates of learning disabilities and, as a result,
poor academic achievement (HOWELL et al. 2006). This may be due to impaired verbal
and non-verbal learning, as well as deficits in verbal information encoding and
visuospatial processing (MATTSON et al. 1996, ROEBUCK-SPENCER and MATTSON 2004,
WILLFORD et al. 2004).

Poor academic performance may also be attributable to

inattention and activity levels (GREEN et al. 2009, ALVIK et al. 2013); indeed, attentiondeficit/hyperactivity disorders (ADHD) is the most common psychiatric comorbidity
of children with FASD, with three to nine times higher prevalence than the general
population (BHATARA et al. 2006, HERMAN et al. 2008). Further compounding these
disadvantages are associations with PAE and disruptive, impulsive, and delinquent
behaviour, impaired social and adaptive functioning, and tendency to engage in
dangerous or risk-taking behaviour (RASMUSSEN 2005, RASMUSSEN and WYPER 2007,
JIRIKOWIC et al. 2008a, CROCKER et al. 2009, WARE et al. 2014). Additionally, recent
associations have been made between prenatal alcohol exposure and circadian
dysfunction, impacting adaptive function, mood, concentration and cognitive function
(EARNEST et al. 2001, WENGEL et al. 2011, CHEN et al. 2012). Many of these phenotypes
persist into adulthood and result in secondary psychiatric and psychosocial
manifestations such as increased risk for depression, anxiety and oppositional
defiance-related disorders, as well as an increased risk for alcohol and drug abu se,
impairments in moral and social development, and failure to learn from experience
4
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(STREISSGUTH and O'MALLEY 2000, STEINHAUSEN et al. 2003, BHATARA et al. 2006, NICCOLS
2007).

This often leads to increased difficulty with the legal system, either as

offenders or victims, and an increased prevalence within the correctional system
(FAST and CONRY 2004, STREISSGUTH et al. 2004). Comprehensive medical and social
programs are imperative to identify and improve the prognosis of individuals born
with FASD; however, we still have little understanding of how alcohol exposure
during neurodevelopment, including factors such as timing, dose, and pattern of
exposure, induces such a broad and variable range of neurobehavioural phenotypes.

1.2.2 Epidemiology of fetal alcohol spectrum disorders
Given the inconsistencies with diagnostic criteria, variability of phenotypic
presentation, and unlikelihood of accurately ascertaining the nature of gestational
alcohol exposure, there are large discrepancies in estimates of FASD incidence and
prevalence. It is, however, recognized that maternal alcohol consumption during
pregnancy is the most common preventable cause of neurodevelopmental disabilities
in Western cultures. The estimated prevalence of FAS is between 0.5 and 3 per 1,000
births; however, the estimated incidence of conditions falling within the FASD
spectrum in Canada is approximately 9 in 1000 births (PUBLIC HEALTH AGENCY OF
CANADA 2003).

More recent studies have suggested that the prevalence is

underestimated and may be as high as 2-5% (MAY et al. 2009, MAY et al. 2011). These
numbers are considerably concentrated within low socio -economic communities, in
children within the child care system, the Canadian correctional system, and in
certain remote, rural or indigenous populations, where estimates of FAS and FASD
rise to approximately 6.0% and 16.9%, respectively (WILLIAMS et al. 1999, MASOTTI et
al. 2006, LANGE et al. 2013, POPOVA et al. 2015). In a comprehensive analysis by Stade
et al. (2009) using a conservative estimate of 3 per 1000 births and including
individuals from 0-53 years of age, the annual estimated cost in 2007 for health care,
educational and social services, and other indirect costs associated with FASD was
$5.3 billion (95% confidence interval: $4.12 - $6.4 billion) at the population level
5
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(STADE et al. 2009). These numbers indicate that FASD is a pressing concern
economically, medically, and sociologically, and research into the biological etiology
of these disorders may aid in developing better diagnostic tools and improve the
ultimate quality of life for individuals prenatally exposed to alcohol.

1.2.3 Maternal drinking patterns and associations with FASD
The number of individuals diagnosed with prenatal alcohol exposure-related
disabilities has increased significantly over the last few decades. Part of this increase
is due to improvements in social and medical awareness of these disorders (CHUDLEY
et al. 2005, GOH et al. 2008, ASTLEY 2013). Regardless of this, in North America as
many as 30% of women continue to drink during pregnancy, with approximately 5%
engaging in “binge” drinking (ETHEN et al. 2009). This may occur for varied reasons:
naïveté of potential consequences, addiction, or unawareness of pregnancy. Further,
changes in social attitudes and drinking patterns among women of childbearing age
also may contribute to these growing numbers.
Binge drinking is defined as the consumption of alcohol that raises one’s blood alcohol
concentration (BAC) to approximately 0.08% or above (NATIONAL INSTITUTE OF
ALCOHOL ABUSE AND ALCOHOLISM 2004).

For an average woman, this equates to

approximately 4 standard drinks in two hours or less. According to a recent study
conducted by the United States Center for Disease Control, binge drinking prevalence,
frequency, and intensity was found to be highest in women aged 18-24 years of age
(CENTER FOR DISEASE CONTROL 2012). This is troubling, given that binge drinking in the
months prior to pregnancy considerably elevates the risk of drinking (and binge
drinking) during pregnancy (ETHEN et al. 2009). Generally, mothers of individuals
that fall with the SE/AE and ND/AE categories engage in drinking during the first
trimester, but cut down substantially upon recognition of the pregnancy; however,
when they do drink, they are likely to do so in a binge-type fashion. This is important
given that a binge pattern of drinking, even infrequently, results in higher and
prolonged BACs, which are strongly correlated with increased neurological and
6
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cognitive damage, regardless of the trimester in which the binge episode occurred
(MAY et al. 2013).

1.2.4 Effect of prenatal alcohol exposure on brain structure
Ethanol is a small molecule that easily crosses the placental and blood-brain barrier
(IDANPAAN-HEIKKILA et al. 1972). One to two hours after maternal alcohol ingestion,
blood alcohol levels of the fetus reaches an approximately equivalent level as
maternal BAC; however, ethanol elimination by the fetus does not occur at the same
level of metabolic efficiency, resulting in prolonged exposure time and reliance on
maternal ethanol metabolism to eliminate alcohol from the bloodstream and the
amniotic fluid (BURD et al. 2012). There is a dose-response relationship between
maternal BAC levels, the duration of a high BAC, and the severity of neurological
damage in the developing fetus (MAIER and WEST 2001). Consequently, binge drinking
is more detrimental to the developing brain than drinking patterns that produce low
or moderate BACs (MAIER and WEST 2001).
Much of the neuropathological data regarding how ethanol physiologically impacts
the developing brain in humans has been obtained using neuroimaging techniques.
Studies involving FAS and FASD patients have shown a wide array of morphological
changes and a general reduction in brain volume. There seem to be few areas (if any)
that are not susceptible to ethanol-induced damage, depending on timing of exposure.
Fairly consistently, magnetic resonance imaging studies have found abnormal
cortical thickness and diminution of white matter, the corpus callosum, the prefrontal
cortex, the cerebellum, and the hippocampus (ARCHIBALD et al. 2001, BOOKSTEIN et al.
2002, SOWELL et al. 2002, RILEY et al. 2004, CORTESE et al. 2006). Given the critical roles
in learning, memory, sensory information processing, and cognitive function played
by these brain regions, these results are consistent with the kinds of deficits seen in
FASD.

At the same time, many individuals that have abnormalities in brain

functioning show no gross anatomical abnormalities upon brain imaging (MATTSON
and RILEY 1998, SPADONI et al. 2007). Further, alcohol-exposed children both with and
7
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without physiological abnormalities are similarly impaired on tests of language,
memory, fine-motor speed, and visual-motor integration, suggesting that the degree
of behavioural and cognitive deficits may be independent of physical features
(MATTSON et al. 1998). These findings suggest that reduced brain volume in particular
regions cannot account for all the neurological phenotypes associated with FASD.

1.3 Animal models in FASD research
Understanding the biological mechanisms through which alcohol affects the
developing brain and leads to behavioural and cognitive abnormalities is a complex
and difficult challenge. The problem lies in the variability of phenotypes associated
with FASD: there is no checklist of behaviours that can confirm prenatal alcohol
exposure. Rarely, if ever, do researchers have information regarding the exact timing,
dosage, or pattern of maternal alcohol consumption, nor can they determine the
impact of potentially deleterious socioeconomic factors that may exacerbate FASDassociated traits. In order to better understand how prenatal alcohol exposure may
result in FASD in human populations requires the development and use of effective
animal models. Animal models are crucial to elucidating the biological mechanisms
that initiate or underlie human psychiatric disorders in ways not possible in humans;
additionally, these results can be effectively translated to improve human phenotypes
(BALE et al. 2010, NESTLER and HYMAN 2010a).

Animal models also allow for the

control of genetic and environmental factors that confound the manifestation of FASD
in humans, such as ethanol dosage, timing of exposure, pattern of exposure (acute or
chronic), maternal nutrition, comorbid drug exposure, and genetic background.
Creating a model for FASD in animals seems straight-forward given that these
disorders have a very discrete etiology: prenatal alcohol exposure. However, to
effectively model a human disorder, the model must provide a conserved biological
basis that can replicate similar anatomical, molecular, and phenotypic features of the
disorder.

8
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1.3.1 A multi-species approach to understanding FASD
Animal models have played a critical role in FASD research since the late 1970s to
establish that alcohol was indeed a teratogen and prenatal exposure was able to cause
adverse physiological and behavioural effects (BOND and DI GIUSTO 1976, CHERNOFF
1977, HENDERSON and SCHENKER 1977, RANDALL and TAYLOR 1979). Also, these early
studies determined that there was a relationship between dose of ethanol (ie,
maternal BAC levels) and severity of offspring abnormalities (CHERNOFF 1977,
RANDALL and TAYLOR 1979). In an important study conducted by Sulik et al. (1981), it
was demonstrated that the distinctive facial features of FAS could be replicated in
mice and that the appearance of these craniofacial abnormalities were dependent on
the timing of exposure (SULIK et al. 1981). This study demonstrated that there were
critical windows of vulnerability for certain physiological and neurological
abnormalities. Since these pivotal studies, many different animal models have been
developed and utilized over the last few decades, each lending itself more
appropriately to certain research goals depending on the nature and complexity of
the question. Fundamental biological questions regarding the effect of ethanol on
evolutionarily-conserved developmental mechanisms have been addressed using
organisms such as Caenorhabditis elegans, Drosophila, and zebrafish (DAVIS et al.
2008, MCCLURE et al. 2011, COLE et al. 2012). By far the most common model, however,
are rodent species such as mice, rats, and guinea pigs. While each model may mimic
one or several features of FASD, certainly none are entirely comprehensive. However,
together they effectively contribute to our understanding of genetic and cellular
mechanisms involved in prenatal alcohol exposure and how those mechanisms may
lead to physiological changes, neuro-functional alterations, and behavioural and
cognitive impairments in humans with FASD.

9
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1.3.2 Modeling FASD in mice
Mouse models are extremely useful for evaluating the genetic and cellular impact of
alcohol in vivo in a complex neurological system. In general, mice are often used for
health-related research due to their short generation time, their ease of care, and
basic genetic, developmental and physiological similarity to humans.

There is

considerable literature describing their physiology, behaviour, susceptibility to
ethanol teratology, and developmental timeline with relation to the human timeline .
They are also particularly amenable to genomic studies given the availability of tools
such as DNA sequence and gene expression data (including spatial and temp oral
expression of genes during development), well-established behavioural assays, and
availability of arrays and transgenic tools.
Mouse models, and in particular the C57BL/6 (B6) inbred strain, have been widely
used in FASD research since the demonstration that they could be used to recapitulate
strikingly similar physiological and craniofacial abnormalities to those observed in
humans with FAS (SULIK et al. 1981). Since then, numerous mouse models have been
developed using various ethanol dosages, treatments at different developmental
stages, and multiple methods of ethanol administration. These models are used to
examine the behavioural, physiological, cellular, and genetic consequences of ethanol
exposure.
Mouse models of FASD generally fall within one of two categories: chronic moderate
exposure throughout gestation or punctuated acute treatments at specific
neurodevelopmental stages. The former often utilizes inbred strains with a high
ethanol preference, such as B6, to model voluntary maternal ethanol consumption
throughout gestation (ALLAN et al. 2003, BOEHM et al. 2008, KLEIBER et al. 2011, BRADY
et al. 2012). Pregnant B6 females continue to consume approximately 70% of their
total liquid intake in the form of a 10% ethanol solution when given a choice between
the ethanol solution and water, exposing the developing fetus to low-to-moderate
levels of ethanol (BACs reach approximately 80 – 200 mg/dl) throughout gestation.
The resulting offspring show subtle but consistent behavioural phenotypes relevant
10
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to FASD, such as delays in the development of neuromuscular reflexes and
coordination, increases in novelty-induced anxiety, decreased sensitivity to ethanol
during adolescence, and deficits in spatial learning and hippocampal-dependent
learning tasks (BOEHM et al. 2008, KLEIBER et al. 2011, BRADY et al. 2012). Models using
voluntary consumption throughout gestation have face validity in that they likely
represent a common pattern of alcohol consumption in humans that choose to drink
while pregnant; however, they can make it difficult to ascertain the effects of ethanol
on processes that occur at specific neurodevelopmental stages. To address this, other
models use an exposure paradigm where a punctuated high-dose or “binge”-like
treatment is administered at a specific developmental time, either through oral
intubation, injection, or inhalation (PARSON and SOJITRA 1995, IKONOMIDOU et al. 2000,
HEATON et al. 2002b, BAKE et al. 2012, LIPINSKI et al. 2012, WAGNER et al. 2014). These
“binge” paradigms results in higher BACs, usually above 200 mg/dl, and as is the case
in humans, more severe neurological damage. In B6 mice, the threshold of 200 mg/dl
is sufficient to induce significant apoptotic neurodegeneration in the developing
brain, with the severity of damage proportional to the length of time BACs remain
above this level (IKONOMIDOU et al. 2000). These binge models are also useful in
making associations between the timing of exposure and specific physiological and
behavioural phenotypes, as ethanol can be administered both during specific
pregnancy trimester-equivalents, and in specific dosages (GOODLETT and JOHNSON
1997, MAIER et al. 1997, WOZNIAK et al. 2004, HUNT et al. 2009, LIPINSKI et al. 2012,
MANTHA et al. 2013). The variability of these studies, however, in terms of the dosage
administered and timing of exposure, make comparisons between different models
difficult.

A consistent ethanol administration

paradigm across different

developmental stages (and trimester-equivalents) would be useful to assess windows
of vulnerability of developing brain regions, behavioural changes associated with
these windows, and the effect of alcohol on molecular processes that may underlie
these changes. Our laboratory has developed a treatment paradigm in B6 mice that
represents a binge-like exposure, with a consistent dose, which we have administered
via subcutaneous injection during the first, second, or third human trimester
equivalent (KLEIBER et al. 2013, MANTHA et al. 2013). The results presented in this
11
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thesis examine the effects of ethanol on developing brain during the third trimesterequivalent, an exceptionally sensitive period to the teratogenic effects of alcohol.
However, results from multiple studies support that there is no safe time during
pregnancy in which it is safe to consume alcohol and not risk the proper
neurodevelopment of the fetus.

1.4 Biological mechanisms implicated in the
neurodevelopmental effects of alcohol
Alcohol’s adverse effects are likely due to a combination of direct and indirect
interactions with biological processes occurring in the developing brain at the time
of exposure. Part of the difficulty in assessing the etiology of FASD is the pleiotropic
nature of ethanol’s actions within the brain, as well as our incomplete understanding
of the exact cellular and molecular processes involved in brain development. There
are a number of studies, however, that have implicated specific biological
mechanisms that consistently seem to be adversely affected by ethanol, all of which
likely contribute to the heterogeneous physiological and behavioural phenotypes
associated with prenatal alcohol exposure. Some of these processes are discussed
below.

1.4.1 Alcohol metabolism
Genes involved in the metabolism of alcohol and its metabolic intermediates possess
polymorphisms in human populations that affect gene functioning, making them
natural targets for research examining susceptibility to the effects of alcohol (GOEDDE
et al. 1983, CRABBE et al. 1999). The primary pathway for the metabolism of alcohol
involves alcohol dehydrogenase (ADH), which converts alcohol into the toxic
intermediate metabolite acetaldehyde, which is then metabolized by acetaldehyde
dehydrogenase (ALDH) into acetate (ZAKHARI 2006). Both ethanol and acetaldehyde
12
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easily cross the placental barrier and are readily accessible by the developing fetus
very shortly after maternal consumption (BLAKLEY and SCOTT 1984). Studies have
examined the association of different alleles of enzymes within the alcohol
metabolism pathway, such as those within the alcohol dehydrogenase ADH1B gene,
with the severity or frequency of FAS and FASD in various populations (STOLER et al.
2002, JACOBSON et al. 2006, GREEN and STOLER 2007). Inefficient ADH proteins limit
the conversion of ethanol to the toxic metabolite acetaldehyde prolonging higher
BACs; similarly, inefficient ALDH isozymes result in longer exposure to acetaldehyde.
Further, ethanol may competitively inhibit the role of ADH in the catalyzation of
retinol to retinoic acid, a potent mediator of embryogenesis and cellular
differentiation, leading to retinoic acid deficiency (CHAMBON 1996, DUESTER 1996,
ZACHMAN and GRUMMER 1998). While these studies point to genes that may mitigate
the severity of ethanol neurotoxicity between individuals (WARREN and LI 2005), they
do not explain the mechanisms that trigger ethanol’s neurotoxic effects. More
important, polymorphisms in genes related to alcohol metabolism are not sufficient
to explain the full range of alcohol’s effects on the developing brain.

1.4.2 Oxidative stress
Numerous studies have demonstrated that prenatal alcoho l exposure results in
increased reactive oxygen species (ROS) and oxidative stress in multiple brain
regions (RAMACHANDRAN et al. 2001, RAMACHANDRAN et al. 2003, GREEN et al. 2006, CHU
et al. 2007, HILL et al. 2014). This increase in ROS can cause damage to cell
membranes, DNA, and proteins, and trigger the release of apoptosis-inducing factors
from the mitochondria (REGO and OLIVEIRA 2003). Changes in ROS levels can also
affect mitochondrial function, leading to altered intracellular and extracellular
calcium concentrations.

Given the need to tightly regulate calcium-mediated

neuronal signaling when establishing appropriate synaptic connections, altered
calcium concentrations could be detrimental during synaptogenesis.
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The developing brain is vulnerable to ethanol-induced ROS damage for multiple
reasons, including a high oxygen metabolic rate, the high concentration of fatty acids
that can be used as substrates for ROS, and the relatively low concentration of
endogenous antioxidant enzymes as compared to the adult brain (FLOYD and CARNEY
1992, HALLIWELL 1992, HENDERSON et al. 1999, SOKOLOFF 1999). Indeed, there is
substantial evidence that supplementation with exogenous antioxidants can prevent
certain ethanol-induced neurodevelopmental damage (HEATON et al. 2003, MARINO et
al. 2004, KUMRAL et al. 2005).

As with other mechanisms, certain regions show

windows of vulnerability. Studies in rodents have demonstrated that the cerebellum,
hippocampus, and hypothalamus, and striatum are all vulnerable to increases in ROS
following alcohol exposure during the third trimester equivalent (HEATON et al.
2002b, HEATON et al. 2003, MARINO et al. 2004, DEMBELE et al. 2006). Further, oxidative
stress has been shown to have a long-lasting impact on the function of these regions.
For example, early neonatal ethanol exposure increases mitochondrial antioxidant
manganese superoxide dismutase levels within the hypothalamus at P7 in rats
(DEMBELE et al. 2006).

This is associated with decreased expression of pro -

opiomelanocortin that persists into adulthood, affecting hypothalamic-pituitaryadrenal signaling, endocrine function (DEMBELE et al. 2006) and anxiety and
depressive-like behaviours (BROCARDO et al. 2012).

While oxidative stress can

certainly trigger cell death, these studies demonstrate that it can also affect long-term
gene expression and cellular function, which then may contribute to FASD -associated
phenotypes.

1.4.3 Growth factor and neurotrophic factor signaling
Growth factors are secreted, diffusible proteins essential for neuronal survival,
proliferation, and maturation. Depending on the balance of mitogenic or antiproliferative trophic signals, developing cells make decisions regarding progression
or rate of mitosis, the initiation of programmed cell death, cell shape and size, and
dendritic arborization (BIBEL and BARDE 2000). Many growth factors that are critical
14
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to normal brain development such as the neurotrophins nerve growth factor (NGF),
brain derived neurotrophic factor (BDNF), neurotrophins 3, 4, and 5 (NT-3, NT-4, and
NT-5), as well as transforming growth factor-β (TGFβ) and insulin-like growth factors
(IGFs), are disrupted by neurodevelopmental ethanol exposure(HEATON et al. 1995,
HEATON et al. 2000b, MILLER 2003, PARKS et al. 2008, DE LA MONTE et al. 2011). This
disruption may be direct, with ethanol acting as an agonist or antagonist on the
growth factor receptor or within its signaling pathway, or indirect, inducing changes
to the expression of genes involved in growth factor signaling or expression of the
growth factor itself (RESNICOFF et al. 1993, ZHANG et al. 1998, MAIER et al. 1999, HEATON
et al. 2000b, MOORE et al. 2004). By whatever mechanism, it seems that ethanol acts
to reduce signaling of neurotrophic factors, encouraging the cell to undergo
apoptosis. Supplementation of cells (in vitro and in vivo) with specific neurotrophins
can reduce ethanol-induced neurotoxicity (LUO et al. 1997, JAURENA et al. 2011).
Transgenic studies have demonstrated that the deletion of BDNF can increase
ethanol-induced cell death in specific regions, while NGF overexpression can
ameliorate ethanol neurotoxicity (HEATON et al. 2000a, HEATON et al. 2002a). This may
be achieved via the up-regulation of anti-apoptotic and down-regulation of proapoptotic genes (ALOYZ et al. 1998, PEREZ-NAVARRO et al. 2005, CHIOU et al. 2007).
Other growth factors, however, such as TGFβ, can promote cell death following
ethanol exposure by up-regulating the expression of genes involved in apoptotic
pathways (HICKS and MILLER 2011). Given that growth factors play such essential
roles in brain development, altering their availability or signaling at critical
neurodevelopmental times or in vulnerable regions likely contributes to both short
and long-term ethanol effects.

1.4.4 Cell adhesion and interaction
During neurodevelopment, cell-cell recognition and adhesion are required for
numerous

processes

including

neuron

survival,

migration,

and,

during

synaptogenesis, synaptic formation, maturation, and plasticity (RUTISHAUSER 1984,
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YANG et al. 2014). Cell adhesion molecules (CAMs) establish synapse specificity by
mediating protein interactions to properly align the pre- and post-synaptic neurons,
recruit proteins integral to synaptic membranes such as neurotransmitter receptors
and scaffolding proteins, facilitate vesicle reuptake and neurotransmitter release , and
control the formation and balance of excitatory and inhibitory synapses
(WASHBOURNE et al. 2004, WILLIAMS et al. 2010). Further, disruption of neural cell
adhesion molecules leads to neurodevelopmental disorders resembling the
physiological and behavioural phenotypes of FAS (CREMER et al. 1994, KAMIGUCHI et al.
1998). Ethanol has been shown to interact with neural cell adhesion molecule
(NCAM) and L1-NCAM to affect neurodevelopmental cell adhesion (MINANA et al.
2000, AREVALO et al. 2008, LITTNER et al. 2013). The impact of this is likely substantial,
but the effect of ethanol on other cell adhesion molecules remains relatively
unexplored. However, given their pivotal role in synaptogenesis, any disruption of
cell adhesion molecules have the potential to strongly contribute to the phenotypes
associated with FASD that rely on synaptic maintenance and plasticity such as
learning, memory, stress response, and motor function.

1.4.5 Neurotransmitter signaling
Synaptogenesis, the process by which cells establish synaptic connectivity, relies
heavily on intercellular communication. Excitatory and inhibitory signals between
synapses and dendrites are formed, maintained, and deleted by neurotransmission
between pre- and post-synaptic neurons.

John Olney and colleagues have

demonstrated the profound effect of ethanol on neurotransmitter signaling during
synaptogenesis, showing that ethanol interferes with NMDA and GABA receptors to
trigger widespread neurodegeneration within the mouse brain (IKONOMIDOU et al.
2000, OLNEY et al. 2000, OLNEY et al. 2002c). Cell death, however, is not the singular
mechanism by which ethanol acts through developing neurotransmitter systems.
Ethanol is a unique drug in that it interferes with multiple neuronal signaling
mechanisms, including ligand-gated ion channels such as those associated with γ16
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aminobutyric acid (GABA), N-methyl-D-aspartate (NMDA), serotonin, dopamine,
catecholamines, opioids, and steroids (HARRIS et al. 2008). Brain regions implicated
in the phenotypic effects of prenatal alcohol exposure including the cerebellum,
hippocampus, and neocortex show changes such as altered expression of GABA and
NMDA receptor subunits, delayed developmental maturation of GABAergic and
glutamatergic neurons, altered receptor functionality, or impaired plasticity (HSIAO et
al. 2004, TOSO et al. 2006a, SERVAIS et al. 2007, INCERTI et al. 2010, PUGLIA and
VALENZUELA 2010). Additionally, impairments in serotonergic and dopaminergic
function result in reduced serotonin neuron innervation, alterations to hypothalamicpituitary-adrenal axis function, circadian rhythm abnormalities, and altered reward
pathway signaling (SHER 2004, ZHOU et al. 2005, HOFMANN et al. 2007, FERNANDES et al.
2015). The effects of neurodevelopmental disruption of neurotransmitter systems
have been shown to persist into adulthood (IZUMI et al. 2005, TOSO et al. 2005, TOSO et
al. 2006b), and as such have received much attention as contributors to the long-term
phenotypic changes associated with fetal alcohol exposure. Certainly, even subtle
changes to these major neurotransmitter systems during synaptogenesis likely has
significant implications for the formation and refinement of neural circuits and
contribute to learning and memory deficits, motor abnormalities, changes to stress
responsiveness, and other FASD-associated phenotypes. However, while ethanol
may act directly on neurotransmitter function during exposure, the persistent effects
of neurodevelopmental alcohol exposure may be attributed to more long-lasting
mechanisms, including changes to the expression of genes that facilitate and support
interneuron communication.

1.5 Gene expression and epigenetic patterning as targets of
neurodevelopmental alcohol exposure
Among the many biological mechanisms vulnerable to ethanol is the regulation of
gene expression. As such, prenatal ethanol exposure is particularly troubling given
that neurodevelopment is a carefully-orchestrated genetic process, involving precise
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spatial and temporal coordination of the transcriptome. This includes the epigenetic
patterning that is established during neurodevelopment and critical to appropriate
gene expression in differentiated cells.

The previously-mentioned biological

mechanisms rely, at least in part, by ethanol-induced changes to the expression of
genes involved in those processes. Alcohol acts pleiotropically in the adult brain, and
so may interfere with the transcriptional regulation of a number of developmental
pathways. Consequently, many of the studies examining ethanol-induced changes to
neurodevelopmental gene expression have focused on candidate genes chosen based
on evidence from these processes, including genes involved in cell survival, apoptosis,
migration, oxidative stress, and neurotransmission (CLIMENT et al. 2002, TOSO et al.
2005, CHEN et al. 2006a, DEMBELE et al. 2006, TOSO et al. 2006b, CAMARILLO and MIRANDA
2008, BEKDASH et al. 2014, TYLER and ALLAN 2014). The genes examined by these
studies include regulators of neurogenesis, NMDA and GABA receptor subunits, HPA
and circadian-associated transcripts, and neurotrophic molecules and their
receptors. However, a candidate approach does not fully account for the broad range
of neurological phenotypes characteristic of a multifactorial spectrum disorder , nor
does it capture the interactions between genes and biological pathways that support
the involvement of specific developmental mechanisms.

1.5.1 The necessity of genome-wide strategies
Given that ethanol is a well-established instigator of gene expression changes in the
adult brain (TREADWELL and SINGH 2004, MULLIGAN et al. 2006, CONTET 2012), it is
surprising that few studies have examined the effect of alcohol exposure on genomewide changes to neurodevelopmental mRNA expression. The studies that have
examined the effect of ethanol on the developing brain using expression arrays
typically focus on early neurodevelopmental exposure (ie, during the first trimester
equivalent) (HARD et al. 2005, GREEN et al. 2007, DOWNING et al. 2012), providing
insight into mechanisms that may produce physiological and neurological
abnormalities associated with FAS but not the mechanisms that may underlie the
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cognitive and behavioural changes in individuals as a consequence of later gestational
exposure. Further, research has indicated that neurodevelopmental processes have
windows of vulnerability to ethanol, suggesting that the genes affected during the
first trimester equivalent are likely very different from those affected during later
brain development. Given the amount of physiological and behavioural research that
has focused on the third trimester equivalent as a critical period of brain
development, the lack of data exploring the genetic mechanisms that may underlie
these findings is surprising. FASD is a complex disorder, affecting multiple brain
regions and associated with a broad range of phenotypic abnormalities. Therefore, a
candidate gene approach may be insufficient to fully appreciate the range of effects
that prenatal alcohol exposure induces on normal gene regulation and expression.
Genome-wide expression studies also cannot focus on a single stage of development;
understanding the effects of ethanol on late-gestation neurodevelopmental processes
are essential to understanding why the third trimester-equivalent is so critically
vulnerable to ethanol and why exposure during this period is sufficient to produce
profound behavioural deficits.
Microarray data and subsequent gene set enrichment analyses can be useful when
distilling the biological underpinnings of complex phenotypes and to identify major
pathways involved in its cause or maintenance (BUNNEY et al. 2003, MIRNICS and
PEVSNER 2004). This is particularly critical to FASD; ethanol exerts an initial cellular
response within the developing brain, but it has also been shown to interfere with
mechanisms, including epigenetic patterning, which may affect long-term gene
expression and cellular function.

While multiple studies have focused on the

immediate effects of neurodevelopmental ethanol exposure, fewer have evaluated
how exposure translates to mature brain dysfunction that contribute s to the
persistent phenotypes associated with FASD. Evaluation of the mechanisms that
contribute to these long-term effects are perhaps more critical and beneficial to those
prenatally exposed to alcohol, particularly if they may lead to potential diagnostic or
therapeutic strategies. Further, studies examining the relationship between the acute
effects of ethanol on gene expression at specific developmental stages, the persistent
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changes it induces within the mature brain, and the manifestation of these neural
changes as phenotypic characteristics would provide a more comprehensive picture
of FASD as a neurodevelopmental disorder with life-long psychiatric consequences.

1.5.2 MicroRNA expression as a contributing mechanism
Alcohol-induced changes to developmental epigenetic patterning has recently been
suggested as a mechanism of long-term maintenance of altered gene expression in
the brain. Non-coding RNAs (ncRNAs) are abundantly expressed, some exclusively,
in the mammalian brain (MEHLER and MATTICK 2007). They have demonstrated roles
in mature brain function, including long and short-term memory formation,
neuroprotective mechanisms, and in controlling the malleability and plasticity of
neural networks (MEHLER and MATTICK 2007, MERCER et al. 2008, QURESHI and MEHLER
2012, JIMENEZ-MATEOS 2015). MicroRNAs (miRNAs) are able to fine-tune protein
expression by interfering with mRNA translation (LAGOS-QUINTANA et al. 2001). Also,
miRNAs have important roles in normal neurodevelopment, including mitigating the
levels of gene expression that control cell proliferation, apoptosis, differentiation, and
synapse formation and remodeling (MEHLER and MATTICK 2007, COOLEN et al. 2013,
NOWAK and MICHLEWSKI 2013, HU et al. 2014).
In 2007, Sathyan et al. (2007) first explored the role of regulatory miRNAs in the
teratogenic effects of ethanol on the developing brain. This stu dy reported the
potential interplay of miR-9, miR-21, miR-153, and miR-355 and their target mRNAs,
illustrating the sensitive balance of antagonistic biological cues that may ultimately
determine cellular death or survival and adaptation following ethanol insult (SATHYAN
et al. 2007). Importantly, Sathyan and colleagues identified that miRNAs serve as an
effective intermediary between an environmental teratogen and cellular response
given their ability to rapidly affect the expression of multiple genes.
Not only are miRNAs involved in the immediate response of developing cells to
ethanol, but PAE may alter the epigenetic patterning that regulates miRNA
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expression, in turn changing the balance of mRNA regulation within the adult brain
(MIRANDA 2007, BALARAMAN et al. 2013, LAUFER et al. 2013). Few studies have yet to
explore the long-term dysregulation of miRNA expression as a potential mechanism
underlying the phenotypic changes associated with FASD, but work in has identified
a number of altered miRNAs in the adult brain of mice exposed to ethanol during
neurodevelopment (BALARAMAN et al. 2013, LAUFER et al. 2013, MANTHA et al. 2014a).
A number of the miRNAs identified in the adult brain of PAE mice have previously
been implicated by studies exploring the acute effects of ethanol exposure . These
include miR-335, which was found to be suppressed following high ethanol levels but
upregulated following more moderate exposures, affecting neural stem cell
differentiation (SATHYAN et al. 2007). Also found to be ethanol responsive during
neurodevelopment was miR-10b (WANG et al. 2009), which was found to be downregulated in the adult brain (MANTHA et al. 2014a). This miRNA is a regulator of the
Hox gene family, which play key roles in neuronal migration (GEISEN et al. 2008). The
relationship or significance between the alterations in miRNA expression acutely
following ethanol exposure as well as in the adult brain of mice prenatally exposed to
alcohol has yet to be determined. However, it is clear that miRNAs are powerful
modulators of gene expression with the ability to affect numerous mRNA targets.
Further, a given biological pathway or process may be affected from multiple
vantages simultaneously in an antagonistic or synergistic manner. Given that recent
results suggest a significant role for miRNAs in the etiology of FASD and that changes
to their expression may persist long after alcohol exposure, it appears critical to
evaluate their altered expression in the adult brain and their relationship to altered
mRNAs and associated biological pathways to more fully understand the scope of
changes that prenatal alcohol exposure may exert over the life of an affected
individual.
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1.6 Developmental timing and ethanol vulnerability
Mouse models have been invaluable in establishing that the structure of the
developing brain, the extent of neurological damage, and the resulting phenotypic
changes are highly dependent on the timing of alcohol exposure.

The normal

maturation of regions of the rodent brain follow a similar pattern as in humans, with
caudal regions such as the hindbrain developing earlier than more rostral areas and
a somewhat parallel sequence of processes in each region (RICE and BARONE 2000).
There are important differences, however, in the timeline of mouse and human
neurodevelopment that need to be acknowledged. In humans, neurodevelopmental
processes occur at the scale of months, with stages defined by three trimesters of
gestational development. In mice, these processes occur on a scale of days (BAYER et
al. 1993a).

Further, while the processes that occur during the first and second

trimester in humans (the first to sixth month of pregnancy) also occur gestationally
in mice, they equate to gestational day (G) 0 – 11 and G12-21, respectively. Given that
parturition in mice occurs at 21-22 days post-conception, the neurodevelopmental
processes associated with the third trimester in humans occur postnatally in mice
(postnatal day 0 to 14, approximately). This means that third trimester-equivalent
exposures must be modeled by neonate ethanol treatment, eliminating the kinetics of
maternal ethanol metabolism and transfer through the bloodstr eam and placenta
that certainly impact the effect of alcohol exposure during this period in humans.
Regardless, mouse models have been instrumental in establishing that the brain is
vulnerable to the teratogenic effects of alcohol throughout its developme nt, as well as
in determining specific neurodevelopmental processes and brain regions that may be
vulnerable to ethanol exposure at various times.

1.6.1 The vulnerability of synaptogenesis to ethanol exposure
During the third trimester of pregnancy in humans and the first three postnatal weeks
in mice, the brain undergoes a rapid period of growth and development during which
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much of the physiological and molecular basis of neural connections are established
(DOBBING and SANDS 1979, BAYER et al. 1993b, COHEN-CORY 2002). This process of
synaptogenesis includes an overproduction of dendritic arborization and synapse
formation, greatly increasing synaptic density and brain mass, lending this period the
designation the “brain growth spurt” (CHANGEUX and DANCHIN 1976, DOBBING and
SANDS 1979). This is followed by extensive apoptotic pruning and refinement of
synaptic connectivity hypothesized to maximize transmission efficiency (PURVES and
LICHTMAN 1980). This process is a fundamental developmental strategy and occurs in
multiple brain regions across mammalian species (ANDERSEN 2003).
The formation, maintenance, and deletion of synapses requires the careful regulation
of molecular cues such as neurotrophic factor expression, cell adhesion protein
regulation, and neurotransmitter signaling (JUNG and BENNETT 1996, KNOLL and
DRESCHER 2002, TAKASU et al. 2002, HERLENIUS and LAGERCRANTZ 2004, ZAGREBELSKY and
KORTE 2014). These processes are essential to establish mature excitatory synaptic
connectivity and required for the development of neuronal structure in an intact,
adult brain (CLINE and HAAS 2008, WANG and KRIEGSTEIN 2008, WONDOLOWSKI and
DICKMAN 2013). The importance of interneuron communication during this stage of
development, however, also makes it attune to environmental cues including
teratogens; indeed, synaptogenesis may be one of the most exquisitely ethanolsensitive periods of brain development (IKONOMIDOU et al. 2000, OLNEY et al. 2002b).
Even transient increases in blood alcohol at postnatal day 7 (P7), a peak period of
synaptogenesis in mice, can lead to widespread cell death in multiple brain regions
(WOZNIAK et al. 2004). This is associated with ethanol’s ability to act as an N-methylD-aspartate (NMDA) receptor antagonist and a γ-aminobutyric acid (GABA) agonist,
which can suppress the intensity of action potentials that are required to establish
synaptic connectivity leading to the inappropriate apoptosis of developing neurons
(IKONOMIDOU et al. 2000, OLNEY et al. 2002c). The regions that suffer a significant
deletion of developing neurons following ethanol expo sure during this ‘brain growth
spurt’ are consistent with many of the behavioural abnormalities observed in FASD,
including the hippocampus, cerebellum, cortex, amygdala, hypothalamus, and corpus
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callosum (IKONOMIDOU et al. 2000, OLNEY et al. 2002a, DIKRANIAN et al. 2005). Further,
early neonatal ethanol treatment (during synaptogenesis) is sufficient to produce
multiple FASD-related behavioural traits in adolescent and adult mice, including
spatial learning impairment, motor deficits, increased anxiety- and depression-like
behaviours, and

alterations to circadian regulation (SAKATA-HAGA et al. 2006,

BROCARDO et al. 2012, VOLGIN and KUBIN 2012, DIAZ et al. 2014a, DIAZ et al. 2014b,
WAGNER et al. 2014). However, not all cells exposed to ethanol during synaptogenesis
undergo apoptosis. Many are exposed to ethanol – even within vulnerable regions –
and survive to comprise the developmental basis of adult neural architecture. Also,
it has been shown that alcohol-induced neurodegeneration is dependent on the
transcription and translation of new molecules, including the caspase activator Blc2associated X protein (Bax) (NOWOSLAWSKI et al. 2005).

As such, the period of

synaptogenesis becomes an intriguing period of development in terms of how ethanol
may trigger a genetic or cellular response in developing neurons that initiates
programmed cell death, how cells may balance pro- and anti-apoptotic signals, and
what

biological

processes are affected

in

non-apoptotic cells

by

this

neurodevelopmental disruption and in the mature brain, long after the cessation of
alcohol, but while the phenotypes associated with FASD have manifested.

1.7 Summary and research rationale
It is apparent that FASD is an extremely socially and economically costly set of
disorders, despite its preventability. While research examining the complex array of
behavioural, physiological, and biological mechanisms that initiate or maintain the
features of these disorders continues to progress, there appears to be a gap in our
understanding of how disruptions to genetic processes may be involved. Further, the
variability of ethanol dosage, timing of exposure, animal model, and analytic assay
used prohibits any comparison between many FASD-associated studies, making the
identification of underlying mechanisms extremely difficult.
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Although our understanding of neurodevelopment is certainly incomplete, we a re
aware that the development of the brain is not uniform and that certain periods of
vulnerability exist for specific regions. The work included in this thesis seeks to
examine the effects of alcohol exposure on synaptogenesis, or the third trimester equivalent in humans, as a known period of exceptional sensitivity to ethanol and a
period important for the development of multiple behavioural and cognitive
processes. This requires the development of an effective animal (mouse) model that
can recapitulate a number of phenotypes associated with FASD across ontogeny.
Also, evaluating the changes in gene expression only acutely following ethanol
exposure, while important, will not be sufficient to predict how those changes will
affect genetic processes in the adult brain. This work seeks to examine not only the
acute genetic response, but those genes that exhibit altered expression in the adult
brain that may contribute to the maintenance of FASD-related phenotypes.
Finally, this work is part of a more comprehensive, genome-wide analysis of
transcripts disrupted at specific neurodevelopmental times, including all trimester
equivalents, using a consistent dosage regimen and a consistent evaluation strategy.
I feel this approach will provide a better understanding of the relationship between
timing of exposure, vulnerable neurodevelopmental pathways, and phenotypes
resulting from that treatment. This approach may facilitate a non-reductionist
(systems) approach to understanding the etiology of FASD features a nd aid in the
identification of molecular targets as diagnostic markers or for ameliorative
therapeutics.
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1.8 Hypothesis and research objectives
The primary goal of the research included in this thesis is to investigate, at a genome wide level, the effect of alcohol on neurodevelopmental gene expression and how the
disrupted genetic pathways may correlate with neurobehavioural changes consistent
with human FASD.
I hypothesize that a binge-like exposure to ethanol during synaptogenesis induces
alterations in behavioural and cognitive phenotypes relevant to FASD. These changes
are associated with acute changes to gene expression that occur at the time of exposure
as well as long-term changes that persist into adulthood. The genes affected by ethanol
exposure during synaptogenesis will have relevance to molecular pathways important
during the third trimester-equivalent as well as the behavioural changes observed in
ethanol-treated mice.
This thesis focuses on several objectives to address this hypothesis:
1.

Develop a behavioural battery appropriate to evaluate mouse models for a
variety of FASD-relevant behavioural and cognitive phenotypes.

2.

Evaluate behavioural changes resulting from a binge-like dose of ethanol
during synaptogenesis as a model for FASD. Included in this are the effects of
timing and the cumulative effect of a multi-day treatment.

3.

Establish if a binge-like dose of ethanol during synaptogenesis results in
acute changes to the transcriptome of the developing brain.

4.

Determine if ethanol treatment during synaptogenesis results in long-term
changes to mRNA and miRNA expression in the adult brain.

5.

Perform gene set analysis of the genes identified in (3) and (4) to evaluate
associations with biological pathways and relevance to brain development
and behaviour.

26

Chapter 2. Materials and Methods

Chapter 2
M ATERIALS

AND

M ETHODS

2.1 Animal care
All animal protocols were approved by the Animal Use Subcommittee at the
University of Western Ontario (London, ON) and complied with the ethical standards
established by the Canadian Council on Animal Care. Male and female C57BL/6J (B6)
mice were originally obtained from Jackson Laboratories (Bar Harbor, ME, USA) and
subsequently bred and maintained in the Health Sciences Animal Care Facility at the
University of Western Ontario. Prior to breeding, mice were housed in same-sex
colonies of two to four mice with ad libitum access to water and food. Environmental
factors (such as cage type and size, colony size, bedding, nestlets, and environmental
enrichment) were standardized between cages. Colony rooms were maintained in a
controlled environment on a 14/10-hour light/dark cycle (2000 h to 0600 h dark)
with 40% to 60% humidity and a temperature range of 21°C to 24°C.
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2.2 Breeding and ethanol treatments
Nulliparous female B6 mice of approximately 8 weeks of age were individually
housed and mated overnight with 8 to 12-week old B6 males. Males were removed
the subsequent morning and, during gestation, females were housed individually in
standard caging. Towards the end of gestation (gestational days 17-22) cages were
checked each evening at 5pm and each morning at 10am for the presence of pups.
Day of birth was noted as postnatal day (P) 0. Litters were culled to contain a
maximum of 10 pups and litters containing less than 4 pups were excluded from
further study. At P0, pups from each litter were assigned to one of three treatment
groups, each designed to mimic a binge-like ethanol exposure within the human third
trimester-equivalent (T3) of neurodevelopment: early T3 at P4, mid T3 at P7, or both
early and mid T3 (P4 and P7). On treatment days, dams were temporarily removed
from the cage and pups were divided into control and ethanol treatment groups as
equally as possible by sex and weight to account for litter effects. Treatmen ts
consisted of two subcutaneous injections spaced two hours apart (0 h and 2 h) of 2.5
g/kg ethanol in 0.15 M saline.

This paradigm results in peak blood alcohol

concentrations of over 0.3 g/dl for 4 to 5 hours following the initial injection
(IKONOMIDOU et al. 2000, WOZNIAK et al. 2004). Control mice were injected with an
equivalent amount of 0.15 M saline only. Following injection, the tail of each pup was
marked with non-toxic ink to allow for identification. Once the injections for all pups
were completed, the dam was returned to the cage. Pups remained with their
biological dams until weaning at P25, when they were re-housed into same-sex in
colonies of 2-4 littermate mice.

2.3 Behavioural phenotyping
When developing a behavioral battery for the assessment of FASD-relevant
behavioural phenotypes, I considered several criteria:
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1.

The assay measured phenotypes in mice that had been consistently observed
in children, adolescents, or young adults with FASD.

2.

The tests were well-established, appropriate to mouse behaviour, and
consistently shown to successfully test phenotypic features relevant to FASD.

3.

The battery was conducted from least intrusive and/or cognitively demanding
to those that tested higher executive functioning, in order to minimize pre testing confounds.

Given these criteria, I developed a behavioural battery that tested mice at several
stages of development, designed to evaluate a range of FASD-related behaviours. The
tests included in the behavioural battery are described below.

2.3.1

Early developmental milestone achievement

The appearance of early postnatal coordination, strength, sensory and motor skills
were assessed using a behavioural battery adapted from Wu et al.(WU et al. 1997) and
Hill et al.(HILL et al. 2007). Testing was performed from P2 to P21 at 1000 hrs. Dams
were removed and placed in a separate clean cage for the duration of the testing. Each
pup was weighed then assessed for its ability to achieve specific age -appropriate
developmental milestones. Testing lasted approximately four minutes per pup. Tests
were performed each day until the pup was able to perform the task on two
consecutive days. At the completion of testing, the pup was returned to its home cage.
Each developmental milestone task is outlined below and illustrated in Figure 2.1.

2.3.1.1

Postnatal weight

Pups were weighed daily from P2 until weaning at P25. Following weaning, pups
were weighed at P30 and P35, then every seven days until P70.
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2.3.1.2

Surface righting

The latency of the pup to right itself with all four paws touching the surface of the
table when placed on its back on a plastic surface was evaluated. If the mouse did not
respond or complete the task within 15 seconds (s), the test was terminated. The test
was continued daily until the pup was able to right itself on two consecutive days in
less than 2 s.
2.3.1.3

Negative Geotaxis

The pup was placed head-down on a mesh screen set at an incline of 45°. The time
required for the pup to turn its body 180° to a head-up position was recorded. The
task was considered complete when the mouse was successful on two consecutive
days within 30 s.
2.3.1.4

Cliff aversion

The pup was positioned at the edge of a plastic box, approximately 3.0 cm above the
surface of the table, with the digits of its forepaws and nose over the edge. The day
on which the mouse was able to rotate away from the edge and place its body fully on
the surface of the box (within 30 s) was recorded.
2.3.1.5

Forelimb grasp

The pup was placed with its forelimbs resting on a thin metal rod (1.5 mm diameter)
suspended 10 cm above a soft surface (a 5cm thickness of fine wood shavings). Task
was completed when the pup was able to grasp the rod and remain suspended for
more than one second on two consecutive days.
2.3.1.6

Auditory startle

The mouse pup was placed on a flat surface and the day it showed an audito ry reflex
response (an involuntary startle) to a handclap at a distance of 10 cm from its head
was recorded.
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2.3.1.7

Ear twitch

The reflex of the ear to flatten in response to a tactile stimulus was tested using a fine
cotton filament brushed gently against the pup’s ear three times. The pup’s ability to
flatten or twitch its ear in response on two consecutive days indicated a successful
achievement of the reflex.
2.3.1.8

Open field traversal

The pup was placed in the centre of a circle 13 cm in diameter on a smooth plastic
surface. The day the pup was able to extinguish pivoting behavior and move outside
of the circle with 30 s was recorded. Success on two consecutive days marked the
end of testing.
2.3.1.9

Air righting

The pup was gently held upside down, approximately 10 cm above a soft surface (5
cm thickness of fine wood shavings), and released. The day the pup was able to right
itself and land with all four paws on the wood shavings on two consecutive days was
recorded.
2.3.1.10

Eye opening

The first day both eyes were open on each pup was recorded.
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FIGURE 2.1. Images representative of behavioural tasks used to measure the
achievement of early postnatal developmental milestones. Pups were tested for their
ability to reach age-appropriate tasks assessing neuromuscular coordination and reflexes.
Task is indicated below the image.

32

Chapter 2. Materials and Methods

2.3.2 Juvenile locomotor activity
Locomotor activity in juvenile mice (P26-35) was tested using two methods. The first
tested spontaneous daytime locomotor activity in a novel environment, and served
as a measure of both activity and anxiety-related traits. The second method tested
nocturnal activity in a familiar home cage environment and was a measure of overall
activity. All locomotor testing occurred in a room reserved for testing that was
separate from the general colony. The experimenter was not present in the room
during the testing.

2.3.2.1

Activity in a novel open-field

At P26-P28, spontaneous locomotor activity and exploration of a novel environment
was assessed using an infrared Actimeter system (Panlab, Barcelona, Spain) (Figure
2.2).

The apparatus consisted of a 45 cm (width) x 45 cm (depth) arena of black

plexiglass enclosed with four clear acrylic walls (35 cm in height) (Figure 2.2B). A
square frame mounted outside of the arena created a 16 x 16 grid of intersecting
infrared beams used to track the horizontal movement of each mouse in real-time. A
second frame placed above the lower frame was used to track the vertical movement
of each mouse, set to detect hind-leg rearing. Locomotor measures were recorded
using ActiTrack software (Panlab), which uses infrared beam data to calculate
parameters such as overall locomotor activity (total number of beam breaks),
distance traveled, and number of rears. Testing was conducted during the light phase
between 1030 h and 1230 h for all mice. Mice were brought into the testing room in
their home cage a half hour prior to testing. An individual mouse was then placed in
the corner of the arena and allowed to freely explore it for 15 min. During testing, the
lighting of the arena was 100 lx so as not to inhibit normal exploratory behavio ur. At
the end of testing, the mouse was removed and returned to its home cage and the
surface and walls of the arena were wiped clean with 30% isopropanol.
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2.3.2.2

Home cage activity

Nocturnal locomotor activity in a familiar, home cage environment was evaluated
using the infrared Actimeter system (Panlab, Barcelona, Spain) (see apparatus
description above) at age P30-35 (Figure 2.2C). Prior to testing, mice were re-housed
individually in 38 cm (length) x 24 cm (width) x 14 cm (height) transparent plastic
cages (Innovive, San Diego, CA, USA) with standard woodchip bedding and ad libitum
access to food and water. After re-housing, mice were moved from the colony room
to the testing room. After a 24 h acclimation period, cages were placed within the
infrared Actimeter frame at least 3 h prior to the initialization of testing. Testing was
conducted over a 12 h-period from 1900 h to 0700h which spanned the dark phase
of the light/dark cycle. Data were collected using ActiTrack software (Panlab).
Recordings were taken for two consecutive nights and averaged to obtain data for
parameters such as locomotor activity per hour, distance traveled, mean speed, and
number of rears. Mice were re-housed in their original colony cages at the end of
testing.
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A.

Actimeter locomotor apparatus

B.

Novel open field exploration

C.

Home cage locomotor activity

FIGURE 2.2. Infrared Actimeter (Panlab) apparatus for locomotor activity tracking.
(A) Actimeter system four-arena set-up allowing for the concurrent assessment of four
animals. Lower frame is used to track horizontal movements, while the upper frame
tracks vertical movements (rearing). (B) Novel open field arena apparatus and sample
ActiTrack real-time tracking output. (C) Apparatus used for assessment of nocturnal
home cage activity, including a sample ActiTrack output.
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2.3.3 Anxiety-associated behavioural measures
Anxiety-related traits were assessed using three measures: locomotor activity in a
novel open field arena, a light-dark box assay, and an elevated plus maze assay (Figure
2.3). Each test relies on the innate behaviour of mice to avoid open or highly-lit areas
as these features are anxiogenic. All treatment groups were analyzed using the open
field arena. Only the P4+7 control (saline-treated) and ethanol-treated groups were
assessed using the latter two measures due to apparatus availability.

2.3.3.1

Thigmotaxis in a novel open field

Tracking of mouse locomotor activity using the Actimeter system (Panlab, Barcelona,
Spain) in a novel open-field arena is described above (open-field activity in a novel
environment). This open-field data was also analyzed by dividing the arena into a
11.25 cm-wide periphery zone bordering the walls of the arena and a 22.5 cm ×22.5
cm central zone to allow for the evaluation of thigmotaxis, or the tendency of mice to
explore mainly along the periphery walls of an enclosed arena rather than to travel
directly through the centre (SIMON et al. 1994) (Figure 2.3A).

Testing parameters

(time of day, presence of experimenter, duration of testing, and ambient lighting of
the arena) are described above under section 2.1.2 (Juvenile activity in a novel openfield).
2.3.3.2

Elevated plus maze

Mice were evaluated for anxiety-related testing using the elevated plus maze (EPM)
at P35-40. Mice were removed from the colony room and brought to the testing room
1 h prior to testing. Mice were placed in the centre of a maze consisting of four
adjoining arms that intersected at a 90° angle (Figure 2.3B), constructed from a
protocol described in Walf and Frye (2007). The central area was 5 cm (length) x 5
cm (width) and allowed the mouse to move freely between four 30 cm (length) x 5
cm (width) arms that extended from the central region, with two opposite arms
enclosed by 16 cm (height) walls along their length. The arms and walls were
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constructed of acrylic and plastic materials to facilitate cleaning and the removal of
olfactory cues. The maze was elevated atop a wooden support 100 cm above the
ground. Maze illumination from above by a bright (220 lx) ceiling-mounted light and
a computer-generated 85 dB white noise were used during testing as adversive
(anxiogenic) environmental stimuli. Each mouse was allowed to explore the maze
freely for one 5 min trial (WALF and FRYE 2007), during which its movements were
tracked by a video camera mounted above the centre of the maze. AnyMAZE video
tracking software (San Diego Instruments, San Diego, CA, USA) was used to analyze
the real-time movements of the mouse including entries into and time spent in the
open and closed arms. Following the conclusion of the trial, the mouse was returned
to its home cage and the maze was cleaned with 30% isopropanol.
2.3.3.3

Light/dark box

Mice were also assessed for anxiety-related traits using the light/dark box test (LDB)
at P35-40. The LDB was constructed from acrylic materials according to the protocol
outlined from Bourin and Hascoet (BOURIN and HASCOET 2003) (Figure 2.3C). The
apparatus consisted of a 45 cm (length) x 26 cm (width) arena enclosed by 30 cm
(height) walls. One third of the arena – 18 cm (length) x 26 cm (width) – was enclosed
using black acrylic creating the “dark” region.

This region was open to a 27 cm

(length) x 26 cm (width) uncovered “light” area of the arena via a 7cm (width) x 7 cm
(height) opening that provided the mouse free access between each area. At the
beginning of each trial, the mouse was transferred from the colony room to the testing
room and allowed to acclimatize for 1 h. Following acclimation, the mouse was placed
in the light area of the arena facing the opening to the dark area and the mouse was
allowed to freely explore the arena for one 5 min trial. Each trial was conducted using
a 220 lx ceiling-mounted light and an 85 dB white noise as a mild environmental
stressor. The experimenter was not present in the room during testing. Movement
was recorded using a ceiling-mounted video camera and analyzed using AnyMAZE
video tracking software (San Diego Instruments, San Diego, CA, USA). Measurements
recorded included the number of transitions between the light and dark areas, and
the time spent in the light versus dark region. Following cessation of the trial, the
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A.

Novel open field exploration

B.

Elevated plus maze

C.

Light-dark box

FIGURE 2.3. Apparatus used to assess anxiety-related traits.
(A) Actimeter (Panlab) open field arena (left image) and ActiTrack real-time monitoring of
mouse movement (right image), including the separation of the peripheral zone (red) and
the central zone (blue) used for analysis of thigmotaxis. (B) Elevated plus maze test
consisting of two “open” arms and two enclosed arms (left image). Beside the image of the
maze is a screenshot of the AnyMAZE (San Diego Instruments) video tracking output, with
the orange dot indicating the location of the mouse. (C) Light-dark box apparatus showing
the light (open) area and dark (enclosed) area (left image), as well as AnyMAZE (San Diego
Instruments) video tracking screenshot (right image).
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mouse was returned to its home cage and returned to the colony room. The arena
(light and dark regions) was cleaned with 30% isopropanol between mice.

2.3.4 Assessment of spatial learning and memory
Spatial learning and reference memory were evaluated in mice using a modif ied
Barnes maze constructed according to a protocol described by Sunyer et al. (2007)
(Figure 2.4). The apparatus consisted of a white circular platform, 92 cm in diameter,
elevated 75 cm from the floor. Along the periphery of the platform were 20 even lyspaced circular holes of 5 cm in diameter located 2cm from the edge of the table. Each
hole was sealed by black card (not visible from the surface of the table) except for
one, representing the target hole, under which a black plastic escape box of 13 cm
(length) x 13.5 cm (width) x 5 cm (height) was placed. Various large shapes of
different colours were placed on the walls of the testing room to serve as extra -maze
visual cues. A light ceiling-mounted directly above the centre of the table (220 lx) and
an 85 dB computer-generated white noise were used as adversive stimuli to promote
escape to the target (SUNYER et al. 2007). Due to the short duration of some trials, the
experimenter remained in the room during testing but stood in the same location and
was dressed in the same attire for each trial (white laboratory coat).

Mouse

movements were tracked in real-time using AnyMAZE video tracking software (San
Diego Instruments, San Diego, CA, USA) via an overhead-mounted video camera.
Testing consisted of two stages: a 4-day acquisition period testing spatial learning
and a 2-day probe period testing short and long-term recall memory, described
below.

2.3.4.1

Spatial acquisition learning

Acquisition training began at P45 (day 1) and consisted of four, 3 -min trials spaced
15 min apart per day for four consecutive days. Each testing day, mice to be tested
were removed from the colony room and brought to the testing room 1 h prior to the
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commencement of testing. Following the 1 h acclimation period, the mouse was
placed in a 14 cm (height) x 10 cm (diameter) cylindrical black start chamber in the
centre of the platform. The overhead light and the white noise were turned on and,
after 10 s, the start chamber was lifted to allow the mouse to freely explore the maze.
The trial was concluded once the mouse had entered the escape box, at which the
noise and light were turned off and the mouse was left undisturbed in the box for 1
min before it was returned to its home cage. If the mouse had not found or entered
the escape after the 3 min trial, the mouse was gently guided to the escape hole by the
experimenter using one hand and without lifting the mouse from the table. Again,
once the mouse had entered the escape chamber, the overhead light and the white
noise were turned off and the mouse was left in the chamber for 1 min before being
returned to its home cage. To avoid the influence of olfactory or proximal cues, the
table and the escape box were cleaned with 30% isopropanol between mice and the
table was rotated around its central axis between each of the four daily trials per
mouse.

This altered the specific hole that represented the target but not its

relationship to the extra-maze visual cues, which remained consistent between trials
for each mouse. AnyMAZE video tracking software was used to analyze variables
such as latency to reach target and mean speed. Number of errors (visits to non target holes) and search strategy were analyzed manually using video recordings of
each trial by two separate evaluators blind to treatment. Search strategies were
defined as the following:
1. Direct: mouse moves directly to the target hole or adjacent hole (+1 or –1 only)
before reaching and entering target
2. Serial: the first visit to the target hole is preceded by visiting at least two
adjacent holes in a serial manner, in a clockwise or counter -clockwise direction.
3. Mixed: searches to various holes separated by crossing through the centre of the
maze or in a general unorganized manner.
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A.

Schematic of Barnes maze construction specifications

B.

Barnes maze apparatus and testing room

FIGURE 2.4. Barnes maze apparatus for the testing of spatial learning and recall
memory.
(A) Specifications used for the construction of the Barnes maze apparatus.
(B) Photograph of the Barnes maze showing the position of the start chamber, the
target, and the placement of visual cues used for spatial orientation.
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2.3.4.2

Short and long-term recall memory

Following the conclusion of the acquisition days (days 1 – 4), the short-term spatial
memory of each mouse was tested on the subsequent day (day 5 of testing) and the
long-term spatial recall memory was tested 7 days later (day 12 of testing). During
these two “probe” trials, the escape box was removed and the target hole was closed
with black card. To initiate testing, the mouse was placed in the start chamber and
the light and white noise were turned on. After 10 s, the chamber was removed and
the mouse was allowed to freely explore the maze for 1 min before being gently
removed from the table by the experimenter and returned to its home cage.
Behaviours measured (via video recording) included explorations to each hole and
were scored manually by two separate evaluators blind to treatment groups.

2.3.5 Statistical analysis of behaviour data
All data were analyzed using SPSS v.16.0 (SPSS Inc., 2007, Chicago, IL, USA). Analysis
for developmental milestones were analyzed using Multivariate Analysis of Variance
(MANOVA) using sex and treatment as fixed factors and were Bonferroni-corrected
for multiple testing. Given the multiple measures tested for during the open-field
locomotor assay, these data were subjected to a principal components analysis (PCA).
These results revealed two main components, driven by activity (major slope) and
rearing (secondary slope). As such, total activity (number of beam breaks) was
analyzed as the main measure of activity and evaluated using a MANOVA (open-field
activity) or repeated-measure-MANOVA (RM-MANOVA) using sex and treatment as
fixed variables and hour as a repeated measure (home cage activity). Anxiety-related
data was analyzed using MANOVA (sex and treatment as fixed factors). Ba rnes maze
data were analyzed using a RM-MANOVA (where testing occurred over acquisition
days) or MANOVA for sex and treatment as appropriate. Latency measures were
cube-root transformed to meet equality of variance between days of testing, then
analyzed using RM-MANOVA. Barnes maze error data were analyzed for goodness of
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fit to expected explorations per hole using Chi-squared tests. All data are reported as
mean ± standard error of the mean (SEM). The null hypothesis was rejected at p <
0.05.

2.4 Analysis of ethanol-induced gene expression changes
Brain gene expression was assessed in two cohorts of mice using expression
microarray analyses: the first evaluated transcript alterations acutely (4 hours)
following ethanol exposure at P7 (short-term effects), and the second assessed mRNA
level changes in the adult (P60) brain of mice treated at P4+7 (long-term effects).
Only male mice were used for all molecular analyses due to estrous cycle gene
expression variation in females (JORGE et al. 2002, KIM et al. 2011). For the short-term
cohort, whole brain RNA from 30 male mice were used (18 for array hybridization
and 12 for qPCR confirmation). For long-term evaluation of gene expression, 24 mice
were used (12 for array hybridization and 12 for qPCR confirmation).

2.4.1 Tissue collection and RNA isolation
Male mice at P7 and P60 were euthanized using CO2 asphyxiation followed by cervical
dislocation. Whole brain tissue was isolated within 2 min of euthanization and snap frozen in liquid nitrogen and stored at -80° C. Total RNA was isolated using Trizol ®
(Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s instruction and
cleaned using RNeasy Mini kit (QIAGEN, Valencia, CA, USA). The quality and quantity
of RNA was assessed using the Agilent 2100 Bioanalyzer (Agilent Technologies Inc.,
Palo Alto, CA, USA) and a NanoDrop ND-1000 spectrophotometer (Thermo Fisher
Scientific Inc., Wilmington, DE, USA).

RNA samples used for all analyses had an

optical density OD 260/280 ratios of 2.0-2.1 nm and an RNA integrity number (RIN) of
8.0 – 10.0.
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2.4.2 RNA sample preparation for expression array analysis
For the analysis of immediate (4 hours post-treatment) gene expression alterations
induced by ethanol treatment, a total of six biological replicates – four control and
two ethanol-treated – were used. For sample preparation, whole brain RNA from 18
male mice (12 control and 6 ethanol-treated) was diluted to 200 ng/µl and RNA from
three non-littermate P7 males were pooled to create each biological replicate to
reduce potential expression differences due to litter effects. For each control (salinetreated) RNA sample within a replicate, a littermate ethanol-treated RNA sample was
included in the comparative replicate.
For the analysis of long-term (P60, 53 days post-treatment) changes to gene
expression induced by neurodevelopmental ethanol exposure, four biological
replicates – two control and two ethanol-treated – were used. Whole brain RNA from
6 saline-treated and 6 ethanol-treated males were diluted to 200 ng/µl and three nonlittermate RNA samples was pooled to create each biological replicate. For each
control RNA sample included within a replicate, a littermate ethanol-treated male
was included in the comparative replicate.

2.4.3 Microarray hybridization
Pooled whole-brain RNA samples were rechecked for concentration (200 ng/µl)
using a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific Inc.,
Wilmington, DE, USA). Subsequent sample preparation and hybridization steps were
performed at the London Regional Genomics Centre (Robarts Research Institute,
London, ON, CA).

Briefly, single-stranded complementary DNA (sscDNA) was

synthesized using 200 ng of total RNA using the Ambion WT Expression Kit for
Affymetrix GeneChip® Whole Transcript WT Expression Arrays (Applied Biosystems,
Carlsbad, CA, USA) and the Affymetrix GeneChip ® WT Terminal Labeling kit according
to the protocol outlined in the hybridization manual (Affymetrix, Santa Clara, CA,
USA).

First-cycle cDNA was transcribed in vitro to cRNA, which was used to
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synthesize 5.5 µg of sscDNA that was subsequently biotin-end-labeled and hybridized
for 16 h at 45°C to Affymetrix Mouse Gene 1.0 ST expression arrays. The arrays were
then stained using streptavidin-phycoethyrin prior to scanning. All liquid-handling
steps were performed by a GeneChip ® Fluidics Station 450 and arrays were scanned
using the GeneChip® Scanner 3000 7G using Command Console v1.1 (Affymetrix,
Santa Clara, CA, USA).

Command Console v1.1 was used to calculate the intensity

value per array cell based on the pixel intensity of each cell from the array scans
(DAT) file.

These data was converted to cell-based intensity calculations and

exported as .CEL files.

2.4.4 Microarray data analysis and gene identification
Probe-level (.CEL) data were imported into Partek Genomics Suite software v.6.6
(Partek Inc., St. Louis, MO, USA) for summarization to gene-level data and qualitycontrol analyses.

Data

were

background-corrected, quantile-normalized,

summarized using the GeneChip ®-Robust Multiarray Averaging (GC-RMA) algorithm
to take into account probe sequence (GC content) (IRIZARRY et al. 2003), and log2transformed. The Partek Suite was also used to determine gene-level ANOVA pvalues and fold changes. Genes meeting the criteria of a 1.2-fold change with a falsediscovery rate (FDR)-corrected p value of < 0.05 were considered for further
analyses.

Unannotated genes and standards used for array normalization were

removed from gene lists used for clustering and pathway analyses. Genes meeting
the criteria for significance were subjected to hierarchical clustering analysis using
Euclidean distance and average linkage to assess the consistency across replicates
and to evaluate the general (visual) trends in changes to gene expression across each
treatment. All data files from the array experiments have been deposite d in the
National Center for Biotechnology Information (NCBI) Gene expression Omnibus
(GEO) and can be found under the accessions GSE59512 (short-term P7 data) and
GSE34549 (long-term P60 gene expression data). Complete gene lists of transcripts
meeting the criteria for significance are given in Appendices A and B.
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2.4.5 Gene set analysis of differentially expressed transcripts
To examine the biological roles of genes identified as affected by ethanol, the g ene
lists generated from Partek were analyzed using publically and commercially
available bioinformatic tools to assess over-represented Gene Ontology (GO)
biological functions, molecular processes, canonical pathway associations, biological
pathway associations, and gene interaction networks. Gene o ntology biological
functions term enrichment was performed using the Database for Annotation,
Visualization, and Integrated Discovery (DAVID) (DENNIS et al. 2003). DAVID is a
freely-available bioinformatic tool which extracts biological themes and cluster s
genes into functional groups from an input gene list and assigns significance of gene enrichment in each annotation term via a modified Fisher exact p-value.

The

biological functions associated with differentially expressed genes were also
evaluated using Ingenuity ® Pathway Analysis, which clusters genes by functional
annotation using QIAGEN’s Ingenuity Ontology ‘Knowledge Base’ and assigns
significance to over-represented functions using a right-tailed Fisher exact test. The
Knowledge Base differs from standard gene ontology analyses in that it incorporates
processes to resolve synonyms and homographs in order to maintain term identity
and remove duplicate or redundant terms. Ingenuity ® software was also used to
evaluate the gene lists for significant associations to canonical biological pathways,
as well as to perform gene network analysis, which incorporates differentially
expressed genes into predicted and networks involving annotated interacting genes
and proteins.

2.4.6 Confirmation of mRNA levels by qRT-PCR
Quantitative reverse-transcription PCR (qRT-PCR) was performed to confirm the
expression of select genes identified by the short-term and long-term array analyses.
Whole brain RNA isolated from six non-littermate male mice not used for array
hybridization were used for confirmation.
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synthesized from 2 µg of total brain RNA using a High-Capacity cDNA Reverse
Transcription kit (Applied Biosystems, Foster City, CA, USA) according to the
manufacturer’s protocol. PCR reactions were run using Gene-specific TaqMan® Assay
Reagents and TaqMan ® Gene Expression Assay products in a StepOne™ Real Time
PCR System cycler (Applied Biosystems, Foster City, CA, USA). Gene-specific primers
and were obtained from Applied Biosystems Inventoried Assays and used according
to the instructions supplied by the manufacturer.

Genes were selected for

confirmation based on their functional relevance within significantly-identified
pathways affected by ethanol treatment, as identified during functional clustering
and pathway bioinformatic analyses, and are listed in Table 2.1. All reactions were
multiplexed with Glyceraldehyde 3-phosphate dehydrogenase (Gapdh) (long-term
genes) or Actin, beta (Actb) (short-term genes) as internal controls. Target genespecific probes were labeled with a 5’ 6-carboxyfluorescein (FAM) fluorophore and a
3’ tetramethylrhodamine (TAMRA) quencher.

Control gene probes were labeled

with a 5’ VIC fluorophore and a 3’ TAMRA quencher. Reactions were performed using
a standard ramp speed protocol using 10 µl volumes of cDNA. PCR cycling consisted
of an initial denaturing at 95°C for 10 min, followed by 40 cycles of a 15 sec 95°C
denaturation stage and an anneal and extension at 60°C for 60 seconds. Three
biological replicates per treatment group and three technical replicates per sample
were used (total N=6).

Relative expression was calculated according to the

comparative CT method (SCHMITTGEN and LIVAK 2008) using StepOne™ v.2.0 software
(Applied Biosystems).

Significant differences were assessed using a two -tailed

student’s t-test, assessed using SPSS v.16 (SPSS Inc., Chicago, IL, USA).
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Table 2.1. Genes selected for mRNA level confirmation by quantitative RTPCR
Treatment group

Gene
symbol

Gene name

Reference
gene*

P7 (short term)

Dusp1

dual specificity phophatase 1

Actb

Jun

jun proto-oncogene

Actb

Nr4a1

nuclear receptor subfamily 4,
group A, member 1

Actb

Pomc

pro-opiomelanocortin-alpha

Actb

Cnr1

cannabinoid receptor 1 (brain)

Gapdh

Grin2b

glutamate receptor, ionotropic,
NMDA2B (epsilon 2)

Gapdh

Htr5b

5-hydroxytryptamine (serotonin)
receptor 5B

Gapdh

Pomc

pro-opiomelanocortin-alpha

Gapdh

miR-26b

microRNA 26b

Actb

P4+7 (long term)

*Reference genes used for qRT-PCR: Actb: Actin, beta; Gapdh: Glyceraldehyde-3phosphate dehydrogenase
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2.5 Analysis of microRNA alterations in the adult brain
2.5.1 miRNA array hybridization
To evaluate changes to miRNA levels in the adult brain of mice exposed to ethanol
during synaptogenesis, whole brain RNA samples isolated from young adult (P60)
mice were evaluated for genome-wide microRNA (miRNA) expression differences
using Affymetrix miRNA 2.0 arrays (Affymetrix, Santa Clara, CA, USA). Similarly to
the mRNA expression arrays, a total of four arrays – two control and two ethanoltreated – were used. Each biological replicate consisted of pooled whole-brain RNA
samples from three P60 non-littermate male mice (total N=12 mice).

The

experimental design was balanced for litter, with an ethanol-treated male matched
for weight and litter with each control male. All labeling and hybridization steps were
performed at the London Regional Genomics Center (Robarts Research Institute,
London, ON, CA). One µg of total brain RNA from each replicate was labeled using
the Flash Tag Biotin HSR kit (Genisphere, Hatfield, PA, USA) and hybridized to
Affymetrix miRNA 2.0 arrays (Affymetrix, Santa Clara, CA, USA) for 16 hours at 45°C.
All liquid-handling steps were performed using a GeneChip ® Fluidics Station 450 and
arrays were scanned using the GeneChip ® Scanner 3000 using Command Console
v.1.1 (Affymetrix).

The expression data generated from the miRNA arrays were

deposited to the NCBI Gene Expression Omnibus database and are accessible under
the accession GSE 34413.

2.5.2 miRNA array analysis and mRNA target filtering
Probe-level (.CEL) data were imported into Partek Genomics Suite software v.6.6
(Partek Inc., St. Louis, MO, USA) for summarization to miRNA expression data and
quality-control analyses. Differential miRNA expression was evaluated using a one way ANOVA with treatment as the between-subjects factor. The miRNA genes
identified by this analysis were filtered using a 1.2-fold change and a FDR-corrected
p-value of 0.05. The complete miRNA list is shown in Appendix C.
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imported concurrently with the long-term mRNA gene list results into Ingenuity ®
Pathway

Analysis

software

(Ingenuity

Systems,

Redwood,

CA,

USA,

www.ingenuity.com) and analyzed using the microRNA Target Filter subprogram to
develop a list of potential regulatory interactions between alter ed mRNA and miRNA
transcripts. Results were further filtered based on brain-specific gene expression and
an inverse miRNA to target mRNA expression relationship. The subsequent miRNAmRNA transcript list meeting these criteria was evaluated using Ingenuity® Pathway
Analyses for biological function and pathway associations.

2.5.3 miRNA expression confirmation by quantitative RT-PCR
Whole brain RNA samples not used for array hybridization were used to confirm the
expression of miRNA mmu-miR-26b using quantitative reverse-transcription PCR
(qRT-PCR). The altered expression of the putative target of this miRNA, Cannabinoid
receptor 1 (brain) (Cnr1), was also confirmed using qRT-PCR. Two µg of whole brain
RNA was used in reverse-transcription reactions using the TaqMan® Small RNA
Reverse Transcription Kit (Applied Biosystems, Foster City, CA, USA), which includes
hairpin stem-loop primers for only one specific non-coding RNA.

Small nucleolar

RNA 202 (snoRNA 202) was used as an endogenous control (BRATTELID et al. 2011)
and it was not identified as differentially expressed between control and ethanoltreated by the miRNA array experiments. Reverse transcription was performed in a
StepOne™ Real Time PCR System (Applied Biosystems) according to the protocol
outlined by the reverse transcription kit. Non-coding RNA (ncRNA)-specific primers
and FAM-labeled TaqMan® probes were selected using the Applied Biosystems
search engine to identify gene-specific TaqMan® ncRNA assays. PCR reactions were
conducted using TaqMan® Small RNA Assay products on a StepOne™ Real Time PCR
System (Applied Biosystems). Reactions for each target ncRNA were run in separate
reaction tubes but using the same PCR master mix and assessed within the same PCR
plate. Six biological replicates were used for each ncRNA-of-interest, and three
technical replicates were included per biological replicate. Reactions were run
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following the recommended ramp protocol: an initial 2 min hold at 50°C, a 10 min
enzyme activation hold at 95°C, and 40 cycles of a 15 sec denature at 95°C and a 60
sec anneal/extend period at 60°C. Relative expression was determined using the
comparative CT method (SCHMITTGEN and LIVAK 2008) using StepOne™ v.2.0 software
(Applied Biosystems) and Excel (Microsoft 2007). All qRT-PCR data are described as
mean ± standard error of the mean relative expression values. Significant differences
were assessed using a two-tailed student’s t-test, assessed using SPSS v.16 (SPSS Inc.,
Chicago, IL, USA).
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FIGURE 2.5. Experimental design overview.
Important treatment or testing days are outlined and indicated as the
postnatal day of age of the pup (P).
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Chapter 3
RESULTS

3.1 Effect of ethanol exposure during synaptogenesis on FASDrelevant behaviours
The effect of ethanol exposure during synaptogenesis on behavioural phenotypes
were measured from time of treatment extending into early adulthood (P60). Early
postnatal characteristics such as weight and the achievement of tasks designed to test
the acquisition of neuromuscular coordination were performed given that these
features are affected in infants with FASD. As the pups matured, they were then
tested for other FASD-relevant behavioural characteristics such as hyperactivity,
anxiety-related traits, and learning and memory impairments. The results from these
analyses are outlined in the following sections.

3.1.1 Postnatal weight
Mice treated with ethanol at P4, P7, or P4+7 were assessed for differences in weight
during postnatal growth and into early adulthood. Weight graphs of each treatment
group stratified by sex are shown in Figure 3.1. Analysis using repeated-measures
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univariate ANOVA (RM-ANOVA) revealed a significant interaction between postnatal
day and sex, as expected, for both the single-treatment groups (P4, F 11, 30 = 23.23, p <
0.001; P7, F 11, 27 = 20.97, p < 0.001), but no interaction between treatment, sex, or day
of testing was detected. A significant interaction between postnatal day and sex (F 11,
29

= 35.30, p < 0.001) and between postnatal day and treatment (F 11, 29 = 3.27, p =

0.005) was detected for the P4+7 treatment group, with both males and females
showing a trend to be underweight as compared to littermate controls of the same
sex (Figure 3.1). This difference was most prominent in juveniles and adolescents
(P10 to P35) and was not maintained into early adulthood (P56 to P70).

3.1.2 Delayed achievement of early postnatal developmental milestones
Mice treated with ethanol at P4, P7, and P4+7 were assessed during early postnatal
development for reflexes, strength, coordination, and the appearance of early
neurobehavioural developmental milestones.

Multivariate ANOVA (MANOVA)

analysis of only the control (saline-treated) mice from all treatment groups showed
no overall significant effect of sex (F 10, 49 = 0.679, p = 0.738) or day of treatment (F 20,
98

= 0.269, p = 0.999), as well as no interaction between the two (F 20, 98 = 0.865, p =

0.993) suggesting consistency between the control groups. A number of differences
were identified by analysis of developmental milestone achievement between control
and ethanol-treated groups (Table 3.1). Generally, ethanol exposure resulted in the
delay of achievement of many of the developmental milestones tested. MANOVA
analysis using sex and treatment as fixed factors of the P4 treatment group showed
an overall significant effect of treatment (F 10, 32 = 6.71, p < 0.001). Pups treated with
ethanol at P4 showed delayed ability to right themselves when placed on their back
(surface righting) (F 1, 41 = 6.38, p = 0.022), delayed ability to grasp a metal rod using
their forelimbs and support their weight for greater than one second (forelimb grasp)
(F1,41 = 7.66, p = 0.011), delayed ear twitch reflex (F 1, 41 = 2.77, p = 0.015), delayed
extinguishing of pivoting behaviour (open field traversal) in 30 s (F 1, 41 = 15.09, p =
0.017) and in 15 s (F 1, 41 = 45.45, p < 0.001), delayed eye opening (F 1, 41 = 2.77, p =
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FIGURE 3.1. Weight graphs for mice treated with ethanol during the trimester threeequivalent and matched littermate controls. Mice were treated with ethanol in saline
or saline alone (control) at postnatal day 4 (P4), 7 (P7) or 4 and 7 (P4+7). Data is
presented as the mean of each group at select postnatal days ((n = 8 – 12 mice per group)
and is stratified by sex. Significant effect of treatment: *, p < 0.05; **, p < 0.01, ***, p <
0.001.
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0.034), and delayed ability to right themselves in the air (air righting) (F 1, 41 = 39.98,
p < 0.001). Similar analysis of the P7 treatment group as compared to their respective
saline-treated controls showed an overall significant effect of treatment (F 19, 28 = 5.48,
p < 0.001), but no significant effect of sex or interaction between sex and treatment.
Mice treated with ethanol at P7 showed delays in their ability to extinguish pivoting
behaviour and traverse and open field in 30 s (F 1, 37 = 16.12, p = 0.005) and in 15 s (F1,
37

= 51.60, p < 0.001), as well as a delayed ability to right themselves in the air when

dropped (air righting) (F 1, 37 = 68.69, p < 0.001). Finally, a MANOVA revealed a
significant overall effect of treatment in mice treated with ethanol on P4+7 (F10, 30 =
12.33, p < 0.001), with ethanol-treated mice showing a significant delay in milestone
achievement. No significant effect of sex or interaction between sex and treatment
were detected. Specifically, a significant effect of treatment was observed for the
ability for an ethanol-treated pup to right itself when placed on its back (surface
righting) (F 1, 39 = 10.07, p = 0.007), appearance of an acoustic startle reflex (F 1, 39 =
7.16, p = 0.004), appearance of an ear twitch reflex (F 1, 39 = 4.03, p = 0.016), ability to
grasp an object and support its own weight for more than 1 s (forelimb grasp) (F 1, 39
= 9.22, p = 0.004), achieve open field traversal in less than 30 s (F 1, 39 = 22.01, p <
0.001) or 15 s (F 1, 39 = 66.47, p < 0.001), achieve eye opening (F 1,39 = 5.40, p = 0.001),
and achieve the ability to right in the air when dropped from a small distance (air
righting) (F 1, 39 = 109.56, p < 0.001).
In general, pups exposed to alcohol experienced a delay in the ability to ach ieve
developmental milestones. The P4 ethanol-treated group experienced delays in
behaviours that perhaps required more motor control, such as surface righting,
forelimb grasp, extinguishment of pivoting behaviour (open field traversal), and air
righting. The P7-treated group showed some delays, but they were limited to
behaviours that required (arguably) substantially more neuromuscular coordination
and perhaps reflected delays in later-appearing milestones. Mice treated at P4+7
showed significant delays in the greatest number of tested behaviours (8/10), though
the behaviours affected were consistent with the other single-treatment groups.
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TABLE 3.1. Postnatal day of achievement of developmental milestone behaviours in control and ethanol-treated mice.
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3.1.3 Ethanol exposure alters juvenile locomotor behaviour
3.1.3.1

Changes to activity in a novel open-field arena are dependent on
treatment day

The activity of mice treated with ethanol at P4, P7, or P4+7 in an open-field arena was
assessed as a measure of novelty-induced exploration (Figure 3.2). ANOVA analysis
including only the control groups from all treatment paradigms detected a significant
effect of sex, with control males generally exhibiting less infrared beam-breaks than
control females across treatment groups (F 1, 54 = 6.88, p = 0.01).

No effect of

treatment day (F 2, 54 = 1.62, p = 0.21) nor an interaction between sex and treatment
day (F 2, 54 = 1.07, p = 0.35) was detected, suggesting consistency between the control
groups.
No significant difference in locomotor activity levels (all p ≥ 0.124) or rearing
frequency (all p ≥ 0.128) was detected between control and ethanol-treated mice
within the P4 treatment group.

Similarly, within the group treated on P7, no

significant effect of ethanol treatment on activity was observed. A signif icant effect
of treatment (F 1,37 = 14.77, p < 0.001) on rearing frequency, however, was detected,
with both male and female ethanol-treated mice displaying more vertical rears (total
mean = 156.67 ± 7.79) than saline-treated controls (total mean = 117.40 ± 6.56).
Within the P4+7 treatment group, an interesting interaction between treatment and
sex was observed (F 1,38 = 5.05, p = 0.031) with female ethanol-treated mice displaying
less activity (mean = 2650 ± 106) than control females (mean = 3180 ± 135). A main
effect of ethanol treatment on rearing behaviour was also observed (F 1,38 = 4.13, p =
0.049), driven by the increased rearing activity of ethanol-treated females (mean =
170.46 ± 8.74) as compared to controls (mean = 126.42 ± 10.64).

3.1.3.2

Ethanol exposure induces nocturnal home cage hyperactivity

To further evaluate effects of trimester three-equivalent ethanol exposure on
locomotor activity levels as well as an indicator of possible alterations to Circadian
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FIGURE 3.2. Open field activity of adolescent mice treated with ethanol during the trimester three-equivalent. Treatment day
(P4, P7, or P4+7) is indicated above the appropriate bar graphs showing average infrared beam breaks (A) and rearing frequency (B)
of control and ethanol-treated male and female mice within a 15 min period. Data are presented as mean ± SEM (n = 8 – 12 mice per
group). Significance is indicated: *, p < 0.05; **p < 0.01.
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rhythm, adolescent mice were assessed for nocturnal activity in a familiar, home cage
environment.

Due to the number of different measurements recorded by the

Actimeter system, a correlation matrix principal components analysis (PCA) was
conducted using the control data from each of the three treatment groups (P4, P7, and
P4+7) to see if the measurements were correlated with one another and a single
measure could accurately reflect the overall activity data trends. Measures included
in PCA analysis were overall activity (total number of infrared beam breaks),
locomotion (horizontal non-repetitive beam breaks), mean velocity, distance
traveled, and vertical rearing. Bartlett’s test of sphericity indicated that the dataset
was significantly collinear and that factor analysis could be performed (χ 2 = 474.22,
df = 10, p < 0.001). Also, Kaiser-Meyer-Olkin (KMO) measure of sampling adequacy
showed that the degree of common correlation between the variables was strong
(KMO = 0.622), indicating that the factors extracted by data reduction would account
for a substantial amount of variance in the data. The eigenvalues associated with each
extracted component determined that 90.10% of the variance in the data could be
explained by two components (Table 3.2, Figure 3.3) and that all measures were
positively correlated (Table 3.3). The component matrix indicated that two main
extracted components were driven primarily by a significant correlation between
total activity, locomotion, mean velocity, and distance travelled (component 1) and
number of rears (component 2) (Table 3.3). Given that overall activity (total number
of beam breaks) was significantly correlated with each of the other four measures
(Table 3.3), hourly activity was used as the measure of home cage activity in all
subsequent analyses.
Univariate ANOVA analysis of total nocturnal activity across the three control groups
from each treatment paradigm indicated no overall significant effect of sex (F 1,50 =
0.184, p = 0.670), day of saline treatment (F 2,50 = 1.835, p = 0.170), or an interaction
between the two (F 2,50 = 0.199, p = 0.821), suggesting statistical consistency across
control groups. Given that nocturnal activity of mice varies considerably from hour
to hour (TANG et al. 2002), activity was measured in 12 one-hour bins from 19:00h to
07:00h rather than one 12-hour period.
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T ABLE 3.2. Total variance explained by each extracted correlation matrix PCA
component for measures of home cage locomotor activity.
Initial Eigenvalues
Component

Total

% of Variance

Cumulative %

1

3.404

68.083

68.083

2

1.101

22.022

90.105

3

0.475

9.505

99.610

4

0.015

0.300

99.910

5

0.004

0.089

100.000
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FIGURE 3.3. Scree plot showing the total amount of variance
(eigenvalue) in the home cage activity dataset measures that can be
accounted for by each component extracted by a correlation matrix
PCA. Five indicators of locomotor activity were used in the analysis
(N=56).
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TABLE 3.3. Correlation matrix showing the relationship between five indicators of home cage locomotor activity (N=56).

total activity

Pearson
correlation
Significance (p)

locomotor
activity

Pearson
correlation
Significance (p)

mean velocity

Pearson
correlation
Significance (p)

distance
travelled

Pearson
correlation
Significance (p)

number of rears

Pearson
correlation
Significance (p)

total
activity

locomotor
activity

mean
velocity

distance
travelled

number of
rears

1.000

0.990

0.666

0.638

0.491

-

< 0.001

< 0.001

< 0.001

< 0.001

0.990

1.000

0.588

0.563

0.500

< 0.001

-

< 0.001

< 0.001

< 0.001

0.666

0.588

1.000

0.985

0.166

< 0.001

< 0.001

-

< 0.001

0.110

0.638

0.563

0.985

1.000

0.176

< 0.001

< 0.001

< 0.001

-

0.097

0.491

0.500

0.166

0.176

1.000

< 0.001

< 0.001

0.110

0.097

-
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Repeated-measures ANOVA (RM-ANOVA) of the P4 ethanol treatment group and
controls using “hour” as the within-subjects factor and sex and treatment as betweensubjects factors indicated a significant effect of “hour” on activity, as expected (F 11,24
= 33.06, p < 0.001) (Figure 3.4). However, ethanol treatment at P4 did not significantly
affect activity levels in the home cage envinronment, and no significant interaction
between hour and sex, hour and treatment, or hour and sex and treatment was
detected.
Analysis of home cage nocturnal activity in male and female mice treated with ethanol
at P7 indicated that ethanol treatment at P7 significantly increased nocturnal home
cage activity. The data show a trend for female mice show a more pronounced
increase in activity, and this difference was evident primarily from 21:00h to 01:00h.
There also seemed to be a trend for increased activity towards the end dark phase
and beginning of the light phase of the light/dark cycle. Where control animals
showed a marked reduction in activity from 06:00h to 07:00h (mean = 1596.7 ±
159.76 beam breaks per hour), the ethanol-treated mice remained significantly more
active (mean = 5833.9 ± 608.14 beam breaks per hour). RM-ANOVA indicated a
significant effect of hour on activity (F 11,21 = 44.29, p < 0.001) and a significant
interaction between hour and treatment (F 11, 21 = 18.11, p < 0.001) (Figure 3.5). No
significant interaction between hour and sex (F 11,21 = 1.81, p = 0.12) was observed.
Interestingly, however, a significant interaction between hour and sex and treatment
(F11,21 = 4.10, p = 0.003) on activity levels was observed.
Lastly, RM-ANOVA was performed on the activity levels of the group treated at P4+7
(Figure 3.6).

Again, a significant effect of hour on activity was observed (F 11,29 =

63.79, p < 0.001), as well as an interaction between hour and treatment (F 11,29 = 7.38,
p < 0.001), with ethanol-treated animals showing an increase in activity as compared
to controls. No interaction between hour and sex or hour, sex, and treatment was
observed. The pattern of increased activity was similar to the P7 treatment paradigm,
with much of the increase in activity towards the latter hours of the dark phase,
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FIGURE 3.4. Locomotor activity of mice treated with ethanol at P4 in a familiar home
cage environment. Data shown represent the mean (± SEM) infrared beam breaks by
ethanol-exposed and control males (A) and females (B) over a 12-hour period during the
dark phase (20:00h to 06:00h) and the last and first hour of the light phase of the light/dark
cycle (n= 8-11 mice per group). No significant differences between control or ethanoltreated male or females were detected.
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FIGURE 3.5. Locomotor activity of mice treated with ethanol on P7 in a familiar home
cage environment. Data shown represent the mean (± SEM) infrared beam breaks by
ethanol-exposed and control males (A) and females (B) over a 12-hour period during the
dark phase (20:00h to 06:00h) and the last and first hour of the light phase of the light/dark
cycle (n= 7-10 mice per group). *, p < 0.05; **, p < 0.01.
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FIGURE 3.6. Locomotor activity of mice treated with ethanol on P4 and P7 in a familiar
home cage environment. Data shown represent the mean (± SEM) infrared beam breaks
by ethanol-exposed and control males (A) and females (B) over a 12-hour period during
the dark phase (20:00h to 06:00h) and the last and first hour of the light phase of the
light/dark cycle (n= 9-12 mice per group). *, p < 0.05; **, p < 0.01.
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occurring between 21:00h and 02:00h. Also, similar to the P7 treatment group, there
was an increase in activity towards the latter hours of the dark phase and,
particularly, during the first hour of the light phase of the light/dark cycle (06:00h to
07:00h control mean = 1183.82 ± 178.23, ethanol mean = 4080.25 ± 340.88 beam
breaks).

3.1.4 Ethanol exposure increases anxiety-related traits in adolescent mice
3.1.4.1

Increased open field thigmotaxis is dependent on treatment day

Decreased tendency to explore the inner area of a novel open field arena was used as
an indicator of increased thigmotaxis as an anxiety-related behaviour. Univariate
ANOVA analysis of only the control groups for time spent in the centre zone, latency
to enter the center zone, and number of entries into the centre zone using “sex” and
“day of treatment” as between-subjects factors indicated no significant effect of
treatment day (P4, P7, or P4+7) between control groups. A significant effect of sex
was detected for amount of time spent in the centre zone (F 1,54 = 4.39, p = 0.04) and
latency to enter the centre zone (F 1,54 = 5,75, p = 0.02), with female mice (mean =
58.20 ± 3.70 seconds) spending less time in the centre than males (mean = 71.39 ±
4.82 seconds) as well as an increased latency to enter the centre zone (female mean
= 102.71 ± 10.74 seconds, male mean = 72.79 ± 7.02 seconds). Female mice also
showed a fewer number of entries into the centre zone (mean = 31.62 ± 2.44) as
compared to male mice (mean = 37.42 ± 2.38) but this trend did not reach significance
(F1,54 = 2.64, p = 0.11).
Analysis of thigmotaxis measures in adolescent control and ethanol-exposed mice
treated at P4 showed no significant effect of treatment or interaction between sex and
treatment were observed for any measures. Mice treated with ethanol at P7 showed
a trend for females towards increased thigmotaxic behaviours, but also detected
some significant effects of ethanol treatment (Figure 3.8). ANOVA analysis of time
spend in the centre showed a significant effect of sex (F 1,37 = 7.31, p = 0.010) and a
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significant effect of treatment (F 1,37 = 6..25, p = 0.017), with ethanol-treated males and
females showing a decreased amount of time in the centre zone. Effects of treatment
on latency to enter the centre zone (F 1,28 = 5.70, p = 0.022) and number of entries into
the centre zone (F 1,38 = 4.42, p = 0.042) were both detected, with ethanol-treated mice
showing an increased latency to enter the centre and a reduction in the number of
times each explored the centre zone as compared to their control littermates (Figure
3.8). No significant interaction between sex and treatment fo r any measures were
detected. Analysis of the P4+7 treatment group showed the most pronounced effect
of ethanol treatment on anxiety-related measures (Figure 3.9). Ethanol-treated mice
spend less time within the centre zone (F 1,38 = 5.86, p = 0.020), and increased latency
to enter the centre zone (F 1,38 = 5.70, p = 0.022), and a decreased number of entries
into the centre (F 1,38 = 4.42, p = 0.42). No significant interaction between sex and
treatment was detected for any measures within the P4+7 treatment group.
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A.

B.

C.

FIGURE 3.7. Anxiety-related behaviours in a novel open field arena in mice treated at P4 with ethanol. Data shown represent
the mean (± SEM) (A) time spent in the centre zone of the open field arena, (B) latency to enter the centre, and (C) Number of entries
into the centre zone, stratified by sex (n = 8-11 mice per group). No effect of treatment was detected for any measure.
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A.

B.

C.

FIGURE 3.8. Anxiety-related behaviours in a novel open field arena in mice treated at P7 with ethanol. Data shown represent
the mean (± SEM) (A) time spent in the centre zone of the open field arena, (B) latency to enter the centre, and (C) Number of entries
into the centre zone, stratified by sex (n = 7-10 mice per group). *, p < 0.05; **, p < 0.01.
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A.

B.

C.

FIGURE 3.9. Anxiety-related behaviours in a novel open field arena in mice treated at P4 and P7 with ethanol. Data shown
represent the mean (± SEM) (A) time spent in the centre zone of the open field arena, (B) latency to enter the centre, and (C) Number
of entries into the centre zone within a 15 min testing period, stratified by sex (n = 9-12 mice per group). *, p < 0.05; **, p < 0.01.
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3.1.4.2

Ethanol exposure results in sex-specific anxiety-related behaviour in
the light/dark box and elevated plus maze

Given the subtlety of the increased anxiety-related traits exhibited by ethanol-treated
mice in the open field test and the availability of other assays, the P4+7 treatment
group was also tested in two other assays designed to assess anxiety -related
phenotypes: the light/dark box and the elevated plus maze. For the light/dark box
test, univariate ANOVAs of the P4+7 group using “sex” and “treatment” as betweensubjects factor were performed on the time spent in the light section of the apparatus
and number of entries into the light section as a measure of movement between the
light and dark regions. Results indicated a significant interaction between sex and
treatment (F 1,39 = 5.13, p = 0.029), with both ethanol treated males and females
showing a reduced amount of time spent in the light as compared to controls (Figure
3.10A). This interaction was driven by the significant decrease observed in female
ethanol-treated mice, which, while this also appeared as a trend in ethanol-treated
males, did not reach significance. Analysis of the number of entries into the light
region indicated significant main effects of both sex (F 1,39 = 5.50, p = 0.024) and
treatment (F 1,39 = 12.86, p = 0.001). Female mice tended to be less explorative of the
light/dark box and move less between light and dark regions than males, and ethanol
treatment appeared to reduce movement between the light and dark regions further
in both sexes (Figure 3.10B).
The results from the light/dark box were consistent with those from the elevated plus
maze, indicating an increase in anxiety-related phenotypes resulting from ethanol
exposure that was more pronounced in females. Significant main effects of sex (F 1,39
= 11.93, p = 0.001) and treatment (F 1,39 = 22.88, p < 0.001) were detected by ANOVA
analysis of time spent in the open arms, with ethanol-treated mice (mean = 50.20 ±
5.43 s) spending less time in the open arms than controls (mean = 78.73 ± 3.49 s).
Similar main effects of sex (F 1,39 = 6.44, p = 0.015) and treatment (F 1,39 = 13.17, p =
0.001) were found for the number of entries into the open arms, again with ethanoltreated mice showing a reduction in the number of transitions (mean = 5.90 ± 0.61)
as compared to controls (mean = 8.73 ± 0.50).
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FIGURE 3.10. Light/dark box assay of anxiety-related phenotypes. Mice treated with
ethanol or saline (control) at P4+7 were tested over a 5 min period for (A) time spent in
the light region and (B) number of entries into the light region. Data presented represent
mean ± SEM (n = 9-12 mice per group). **, p < 0.01; ***, p < 0.001.
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FIGURE 3.11. Elevated plus maze assay of anxiety-related phenotypes. Mice treated
with ethanol or saline (control) at P4+7 were tested over a 5 min period for (A) time
spent in open arms and (B) number of entries into open arms. Data presented represent
mean ± SEM (n = 9-12 mice per group). *, p < 0.05; **, p < 0.01; ***, p < 0.001.
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3.1.5 Ethanol exposure results in deficits in spatial learning and memory
Mice treated at P4, P7 or P4+7 with ethanol or saline were assessed for learning
deficits in a mouse-oriented spatial learning task, the Barnes maze. The primary
measure of learning used was latency to reach the target (a measure of escape time),
though search strategy used to find the escape target was also analyzed for the four
acquisition (learning) days. Short and long-term recall memory were assessed using
number of explorations to each hole when the location of the “escape” hole was
blocked. It should be noted that due to the variance differences between latency
measures depending on day of testing, latency measures were natural-log (ln)transformed prior to analyses to improve the homoscedasticity of the data to meet
the assumptions of general linear models. Following transformation, Box’s M test of
homogeneity of covariance matrices and Mauchly’s sphericity test indicated that the
within-group covariance matrices of the latency data was not significantly different
(p values > 0.05) and that a RM-ANOVA could be applied appropriately.

3.1.5.1

Spatial acquisition is impaired by ethanol exposure

First, the control groups from each treatment paradigm were compared to ensure
consistency between latency measures. Escape latencies for the control groups
ranged from 77.39 ± 4.86 to 72.15 ± 6.68 seconds on the first learning day to 8.34 ±
0.73 to 7.85 ± 0.62 seconds (mean ± SEM) on the last training day (day 4). Repeatedmeasures ANOVA of ln-transformed latency to reach the target hole using “sex” and
“treatment day” (or “acquisition day”) as the between-subjects factors and “day of
testing” as the within-subjects factor showed a significant effect of testing day, as
expected (F 3,171 = 678.97, p < 0.001). No significant interaction between testing day
and sex (F 3,171 = 0.423, p = 0.737), interaction between testing day and day of
treatment (F 3,171 = 0.385, p = 0.888), or interaction between testing day, sex, and
treatment day (F 3,171 = 0.503, p = 0.806) on latency to reach the target were detected
for the control groups. This suggested consistency between the control groups of
each treatment paradigm.
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Latency to reach the escape hole in control and experimental mice treated at P4 were
assessed using a repeated-measures ANOVA using “sex” and “treatment” as betweensubjects factors and “day of testing” as the within-subjects factor. Mean escape
latencies of control and ethanol-treated mice across the four acquisition trial days are
shown in Figure 3.12A. Analysis indicated a significant effect of day of testing (F 3,117
= 389.37, p < 0.001), as expected, as well as a significant interaction between day of
testing and treatment (F 3,117 = 6.84, p < 0.001). No interaction between sex and day
of testing or sex, treatment, and day of testing was detected. Post-hoc univariate
ANOVA analyses were conducted with the a priori intention of comparing the control
and treatment group not stratified by sex (which was not indicated as significant by
the RM-ANOVA) at each particular testing day rather than performing a full set of
pairwise contrasts. These tests revealed that ethanol exposure at P4 resulted in a
significant increase in Barnes maze escape latency in young adult mice on acquisition
testing day 3 (F1,41 = 15.17, p < 0.001) and testing day 4 (F1,41 = 24.74, p < 0.001).
A similar approach was used to assess the escape latencies of mice treated with
ethanol or saline at P7. Mean escape latencies of P7-treated control and ethanolexposed mice across the four acquisition trial days are shown in Figure 3.12B. A
significant effect of testing day was detected (F 3,114 = 313.24, p < 0.001), as well as a
significant interaction between treatment and testing day (F 3,144 = 4.74, p = 0.004).
No significant interactions between sex and day of testing and sex, treatment, and day
of testing were indicated. Post-hoc univariate ANOVA analyses indicated that ethanol
treatment on P7 delayed the the latency to reach the target on acquisition day 2 (F 1,41
= 8.10, p = 0.007), day 3 (F 1,41 = 20.37, p < 0.001) and day 4 (F 1,41 = 55.11, p < 0.001).
Analysis of the latency to escape of mice treated with ethanol at both P4+7 indicated
a more pronounced delay to reach the target than the ethanol-treated mice of the
single-day P4 or P7 treatment groups (Figure 3.12C).

RM-ANOVA of the ln-

transformed latencies to reach the target indicated a significant effect of acquisition
testing day (F 3,117 = 270.29, p < 0.001) and a significant interaction between testing
day and treatment (F 3,117 = 10.12, p < 0.001). No other interactions between factors
were significant. Post-hoc univariate ANOVAs indicated that ethanol-treated mice
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showed delays in reaching the target on acquisition day 2 (F 1, 41 = 15.44, p < 0.001),
day 3 (F 1,41 = 47.51, p < 0.001), and day 4 (F1,41 = 41.20, p < 0.001). While control
animals tended to reach the target more quickly than ethanol-treated mice on the
later trials of acquisition day 1, the average between the two groups across all four
trials on the first day of testing did not significantly differ (F 1,41 = 3.60, p = 0.065).

3.1.5.2

Ethanol exposure alters learning strategy

The effect of trimester three-equivalent ethanol exposure on acquisition learning was
also evaluated using the search strategy used to find the target hole during the Barnes
maze trials. Each trial (four per acquisition day) was scored for one of three search
strategies: direct, serial, or mixed. The total number of trials using each strategy in
both control and ethanol-treated mice was evaluated using a chi-squared test to
determine if learning strategy was associated with treatment. Percentage of trials
using each learning strategy for control and ethanol-treated mice is shown in Figure
3.13. Generally, mice treated with ethanol at P4, P7, or P4+7 showed a reduced
tendency to use a direct search strategy as compared to contro ls. Ethanol treatment
resulted in a prolonged use of a mixed strategy through acquisition training and
increased use of a serial strategy towards the end of training. Mice treated at P4
showed a significant association between treatment and learning stra tegy on
acquisition testing day 3 (χ 2 = 7.35, df = 5, p = 0.03) and day 4 (χ 2 = 11.00, df = 5, p =
0.004). This trend held consistent for mice treated at P7, again with a significant
association between search strategy used and treatment at testing day 3 (χ2 = 7.38, df
= 5, p = 0.02) and day 4 (χ 2 = 15.08, df = 5, p < 0.001). Significant associations between
treatment and search strategy was detected in the P4 and P7-treated group at testing
day 1 (χ2 = 6.20, df = 5, p = 0.045), day 3 (χ 2 = 18.86, df = 5, p < 0.001) and day 4 (χ 2 =
30.82, df = 5, p < 0.001).
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FIGURE 3.12. Latency to escape in the Barnes maze task for spatial learning. The mean (±SEM) time (seconds) to reach the target for
mice treated with saline (control) or ethanol at P4 (A), P7 (B), or P4 and P7 (C). Data represent the average of four trials per day of each
animal across four consecutive acquisition (learning) days. Data shown are collapsed across sex (n = 20-23 per group). *, p < 0.01; **, p
< 0.001.
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FIGURE 3.13. Type of search strategy used to locate the escape in the Barnes maze task.
Data represent the percentage of trials mice treated with saline (control) or ethanol at P4,
P7, or P4 and P7 (P4+7) used a direct, serial, or mixed search strategy on each acquisition
(testing) day. Data shown are collapsed across sex (n = 20-23 per group).
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3.1.5.3

Short and long-term recall memory are impaired by ethanol exposure

Following the acquisition learning phase of the Barnes maze testing, each mouse was
tested for their ability to recall the location of the escape when all holes were closed.
This was accomplished by assessing the number of explorations to each hole during
a one minute testing period at testing day 5 (short-term recall memory) and day 12
(long-term recall memory).
Multivariate ANOVA analysis of the number of explorations to each hole using only
the control mice from all treatment groups (saline exposure at P4, P7, and P4+7) at
day 5 indicated no significant main effect of sex (F 20,37 = 1.18, p = 0.324), treatment
day (F 40,76 = 1.09, p = 0.367) or interaction between the two (F 40,76 = 0.77, p = 0.812),
indicating consistency between the control groups. Also, no significant difference
was detected in the total number of explorations between each group (mean = 37.64
± 1.76 to 41.55 ± 2.05), including no main effect of sex (F 1,56 = 1.18, p = 0.282),
treatment day (F 2,56 = 1.23, p = 0.301) or interaction between sex and treatment day
(F2,56 = 1.17, p = 0.318).
Analysis of mice treated at P4 with ethanol or saline revealed a trend for the ethanoltreated mice to exhibit less explorations to the target and surrounding holes, but this
trend did not reach significance (Figure 3.14A). No main effect of sex or interaction
between sex and treatment was detected (p > 0.05). No significant difference in total
number of explorations between control and ethanol-treated animals was detected
(F1,39 = 0.20, p = 0.654). Conversely, multivariate analysis of mice treated at P7
indicated a significant effect of treatment (F 20,18 = 2.50, p = 0.028), with ethanoltreated mice showing significantly less explorations to the target (mean = 2.95 ± 0.24
explorations) than controls (mean = 5.12 ± 0.23) and more explorations to holes
opposite to the target (Figure 3.14B). No significant effect of sex or interactio n
between sex and treatment was detected. Further, no significant difference in
number of explorations between sexes or between treatment groups was detected (p
> 0.05). Ethanol treatment at P4+7 resulted in a pronounced difference between
control and ethanol-treated groups, with a significant main effect of treatment (F 20,20
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= 3.57, p = 0.003) detected. Control mice showed more explorations to the target
(mean = 6.85 ± 0.33 explorations) than ethanol-treated mice (mean = 3.76 ± 0.28) and
less explorations to opposite holes (Figure 3.14C). No significant effect of sex or
interaction between sex and treatment was detected (p > 0.05). Also, no significant
differences between the total number of exploratio ns was indicated.
To evaluate if this deficit in recall memory persisted past the first week of testing,
mice were re-tested for long-term recall of the location of the escape during the
second week (at day 12) without further acquisition training. Multivariate analysis
of only the control mice of all treatment paradigms detected no effect of day of testing
(F40,76 = 0.76, p = 0.828). Also, no significant effect of sex or interaction between sex
and treatment was detected (p > 0.05). Analysis of total number of explorations
detected no significant effect of treatment day (F 2,56 = 1.27, p = 0.288), as well as no
significant main effect of sex or interaction between sex and day of treatment ( p >
0.05).
Analysis of the long-term (day 12) recall memory of mice treated with ethanol or
saline at P4 detected no significant effect of sex, treatment, or interaction between the
two (p > 0.05) across the average number of explorations to each hole (Figure 3.15A).
No significant main effects or interactions were detected in the total number of
explorations between sexes or treatment groups. Mice treated with ethanol at P7 did
show significantly less explorations to the target (mean = 3.52 ± 0.0.22) as compared
to controls (mean 5.02 ± 0.28) (F20,18 = 3.96, p = 0.002) during the long-term recall
testing (Figure 3.15B). No significant main effect of sex or interaction between sex
and treatment on hole exploration was detected, as well as no significant main effects
or interactions on the total number of explorations. A significant main effect of
treatment on the overall pattern of number of explorations to each hole during the
day 12 long-term recall trial was also detected for animals treated at P4+7 (F20,20 =
3.51, p = 0.004). Control animals showed significantly more explorations to the target
(mean = 5.10 ± 0.23) than ethanol-treated mice (mean = 3.10 ± 0.27) and fewer
explorations at the opposite side of the Barnes maze platform (Figure 3.15C). Again,
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no significant effect of sex or interaction between sex and treatment were detected.
There were no significant differences in total number of explorations.
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FIGURE 3.14. Number of explorations to each Barnes maze hole during short-term
recall memory trials. The mean number of explorations (±SEM) to each hole located
around the periphery of the Barnes maze is indicated for mice treated with saline (control)
or ethanol at P4 (A), P7 (B), or P4+7 (C). Data represent short-term recall memory, tested
on day 5 following four days of learning (acquisition) trials. Data shown are collapsed across
sex (n = 20-23 per group). *, p < 0.05; **, p < 0.01; ***, p < 0.001.
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FIGURE 3.15. Number of explorations to each Barnes maze hole during long-term
recall memory trials. The mean number of explorations (±SEM) to each hole located
around the periphery of the Barnes maze is indicated for mice treated with saline (control)
or ethanol at P4 (A), P7 (B), or P4+7 (C). Data represent short-term recall memory, tested
on day 12 following four days of learning (acquisition) trials. Data shown are collapsed
across sex (n = 20-23 per group). *, p < 0.05; **, p < 0.01; ***, p < 0.001.
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3.1.6 Summary of behaviour results
Exposure to ethanol during the third trimester-equivalent resulted in pronounced
changes in behavioural phenotypes that are apparent during early and late postnatal
development, adolescence and early adulthood. Interestingly, the effect of ethanol on
these phenotypes appeared to be dependent on the timing of ethanol exposure, and
some consistent differences emerged between animals treated at P4 versus P7 (Table
3.4).

Treatment at P4 appeared to affect early neuromuscular reflexes and

coordination, with ethanol-treated mice showing a delay in their ability to achieve
many developmental milestones. Ethanol treatment later during the trimester threeequivalent at P7 resulted in increased home-cage nocturnal activity levels and
increased anxiety-related traits in a novel open-field, the light/dark box, and the
elevated plus maze (particularly in females). All ethanol treatment paradigms
resulted in impaired learning during the Barnes maze acquisition trials; however, the
P7 and P4+7 treatment groups showed marked increases in latency to escape the
Barnes maze. This trend was consistent when assessing the search strategy used to
navigate the Barnes maze: while control mice were quickly able to travel directly
towards the escape, ethanol-treated mice showed a preference for a serial strategy in
which they would travel to numerous holes in a clockwise or counter-clockwise
fashion prior to locating the target.

Also, the ethanol-treated mice showed an

increased use of a serial strategy and a reduced use of a direct strategy.

This was

reflected in the short and long-term memory trials, with mice treated with ethanol at
P7 or at P4+7 showed a decreased tendency to explore the previous location of the
target hole. This difference was apparent at day 5 (short-term) as well as a week later
during the long-term recall memory trial (day 12).

Taken together, ethanol

treatment during the trimester three-equivalent results in behavioural phenotypes
consistent with those observed in human children, adolescents, and young adults
with FASD.
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TABLE 3.4. Summary of behavioural consequences of ethanol exposure during the third trimester-equivalent.
P4a
Day of

Behaviour

Assayb

Coordination and reflexes

Developmental milestones

2-21

Activity

Novel open field

P7a

P4+7a

male

female

male

female

male

female

↓ (7/10)

↓ (7/10)

↓ (3/10)

↓ (3/10)

↓ (8/10)

↓ (8/10)

26-28

NS

NS

NS

NS

NS

↓

Home cage

30-35

NS

NS

↑

↑

↑

↑

Novel open field

26-28

NS

NS

↑

↑

↑

↑

LDB

35-40

-

-

-

-

↑

↑

EPM

35-40

-

-

-

-

↑

↑

Spatial learning

Barnes maze

45-48

↓

↓

↓

↓

↓

↓

Learning strategy

Barnes maze

42-48

↓ direct

↓ direct

↓ direct

↓ direct

↓ direct

↓ direct

↑ serial

↑ serial

↑ serial

↑serial

↑ serial

↑ serial

Short-term memory

Barnes maze

49

NS

NS

↓

↓

↓

↓

Long-term memory

Barnes maze

56

NS

NS

↓

↓

↓

↓

Anxiety

testingc

aChanges

are relative to control mice: ↑: increased relative to control; ↓: decreased relative to control; NS: no significant difference relative to controls
box; EPM: elevated plus maze
cPostnatal day testing was conducted
bLDB: light/dark
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3.2 Gene expression changes following ethanol exposure
during synaptogenesis
To evaluate the changes to gene expression induced by ethanol exposure during the
trimester three-equivalent and how they may lead to the observed emergent
behavioural phenotypes, I examined the alterations to whole-brain gene expression
patterns acutely following ethanol exposure at postnatal day 7 (4 -hours posttreatment) (short-term) as well as those transcript changes that persisted into
adulthood at postnatal day 60 (long-term) using expression microarrays. The results
of these analyses comprise the following section of this chapter.

3.2.1 Gene expression changes acutely following ethanol treatment
The changes to whole brain gene expression following ethanol exposure at P7 four
hours post-injection were assessed using expression microarray analysis. This time
point was chosen due to the multi-phenotype behavioural alterations detected by the
behavioural battery after ethanol treatment at P7 as compared to P4.

Ethanol

exposure at P7 resulted in the acute alteration of 315 transcripts at a fold -change of
1.2 (FDR-corrected p < 0.05), with 138 (44%) showing up-regulation four hours after
ethanol exposure. A complete gene list using these stringency criteria is shown in
Appendix A. Changes ranged from -1.73-fold (Dual specificity phosphatase 6) to 2.63fold (Thioredoxin interacting protein), though most gene expression changes were
subtle, with 78 per cent (245/315) of gene expression changes showing less than a
1.3-fold difference.
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3.2.2 Array hierarchical clustering and functional annotation of genes
altered acutely following ethanol exposure
Hierarchical clustering of probe signal intensity values showed good consistency
between short-term arrays, with the two ethanol-treatment arrays clustering
together distinctly from the four control arrays (Figure 3.16). The clustering also
revealed four subsets of genes that responded similarly to ethanol treatment. Some
of these groups were not large enough to be subjected to meaningful g ene functional
clustering analysis, so the groups that showed up-regulation (one and four) or downregulation (two and three) in response to ethanol treatment were submitted to the
Database for Annotation, Visualization, and Integrated Discovery (DAVID) (DENNIS et
al. 2003) to assess Gene Ontology (GO) biological process terms common between
similarly-responsive genes.
Genes showing up-regulation four hours following ethanol exposure at P7 were
significantly enriched for GO terms associated with positive regulation of apoptosis,
which included genes such as Cysteine-serine-rich nuclear protein 3 (Csrnp3), a
transcriptional activator involved in apoptotic genes, Glutamate (NMDA) receptor
subunit epsilon-2 (Grin2b), growth factors (Tgfb3, Igfbp3), and Bcl2-like 11 (apoptosis
facilitator) (Bcl2l11) (Table 3.5). Interestingly, a large cluster of genes (61
transcripts) were associated with cell membrane integrity. Also significant were
genes with GO terms associated with post-synaptic density, amino acid
dephosphorylation, glycosylation, and regulation of synaptic transmission.
Down-regulated genes showed enrichment for GO terms related to ribosome
biogenesis, mitotic cell cycle regulation, MAP kinase phosphatase activity,
transcriptional regulation, and hormone activity, including a significant downregulation in genes associated with steroid hormone receptor activity (Table 3.5).
Other significantly reduced transcripts were associated with chromosomal
remodeling or a constituent of chromatin or DNA structure, such as Ube2a, required
for DNA damage repair, histone deacetylase 1 (Hdac1), and Nuclear FMRP-interacting
protein 1 (Nufip1).
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To further characterize the biological functions targeted by ethanol identified by the
broad GO analyses, the up- and down-regulated transcripts were also evaluated
independently for biological function clusters using Ingenuity Pathway Analysis™
(IPA) (Ingenuity Systems, Redwood, CA, www.ingenuity.com). The results confirmed
and extended the biological functions identified by DAVID and showed that many
genes altered by ethanol exposure influenced cell survival and development,
particularly those processes involving neuronal apoptosis and plasticity (Table 3.6).
IPA analysis identified abnormal expression of genes associated with dopaminergic
neuron development and neuroglia function. Also, this analysis identified alterations
to genes associated with endocrine system development and function including the
hydroxylation of melatonin, corticosterone secretion, phospholipid metabolism, and
calcium mobilization and influx.
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FIGURE 3.16. Heat map hierarchical clustering of arrays representing transcripts altered
in the brain acutely following ethanol treatment on P7 based on normalized intensity of
the probe sets. Heat map was generated by Partek ® Genomics Suite software based on
ANOVA-calculated significance levels and fold-changes. Clusters of up-regulated (green)
and down-regulated (red) genes are indicated.
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TABLE 3.5. Gene Ontology (GO) biological function annotation clustering of transcripts altered in the brain acutely following ethanol
exposure at P7.
GO Term

GO ID

positive regulation of apoptosis

0043065

integral to membrane

No.
genes

p-value

Up-regulated genes

10

0.000170

Csrnp3, Grin2a, Tgfb3, Trp53inp1, Foxo3, Sp110, Perp, Igfbp3, Bcl2l11, Jmy

0016021

61

0.00643

Mchr1, Slc16a14, B3galt5, Osmr, Slc44a5, Ints2, Sdc4, Megf10, Pigm, Clec4e,
Slc24a4, Grin2b, Slc25a24, Kcnk6, Slc2a1, Atp8b2, Htr1d, Htr5a, Slc43a2,
Gpr139, Vmn2r33, Pigv, Lifr, Grin2a, Vmn2r37, Ntsr1, Pik3ip1, Parp16,
Folh1, Cldn1, Mfsd11, Steap2, Vmn2r43, Gcnt2, Tmem194b, Enpp3, Aph1b,
St8sia1, Gpr6, Csmd3, Igsf10, Igf1r, Prrg4, B3gnt5, Pcdhb18, Scn9a, Tmc7,
Fam26e, Rnf144b, Fktn, St6gal1, Abca8b, Acer2, Bcg1, Cdhb21, Kctd6,
Slc7a3, Slc16a9, Itpripl2, Mertk, Perp

postsynaptic density

0014069

4

0.00761

Grin2b, Grin2a, Psd3, Cpeb1

protein amino acid dephosphorylation

0006470

5

0.0139

Dusp1, Ppmik, Ptpn4, Dusp16, Dusp8

glycosylation

0070085

4

0.0366

St6gal1, B3gnt5, B3galt5, St8sia1

regulation of synaptic transmission

0050804

4

0.0464

Grin2b, Edn1, Grin2a, Cpeb1

Down-regulated genes
ribosome biogenesis

0042254

7

0.0000618

Utp11l, Tbl3, Gtpbp4, Nop2, Utp18, Mphosph10, Nmd3

mitotic cell cycle

0000278

8

0.000719

Ccnd1, E2f4, Incenp, Aurka, Pmf1, Sirt7, Nup43, Rbbp8

MAP kinase phosphatase activity

0033549

3

0.00280

Dusp4, Dusp6, Dusp7

regulation of transcription

0045449

25

0.00293

E2f4, Nufip1, Zbtb17, Cited4, Med27, Per2, Olig2, Cry1, Etv5, Etv4, Klf6, Egr3,
Egr4, Snapc1, Rxrg, Nr4a1, Mcm2, Pmf1, Sirt7, Nrob1, Inhba, Hdac1, Vegfa,
Zfp143, Hdac9

chromosomal part

0044427

8

0.00363

Ube2a, Hdac1, Incenp, Nufip1, Pmf1, Mcm2, Sirt7, Nup43

hormone activity

0005179

4

0.0401

Inhba, Pomc, Apln, Adcyap1

steroid hormone receptor activity

0003707

3

0.0425

Rxrg, Nr4a1, Nrob1
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TABLE 3.6. Ingenuity Pathway Analysis™ biological functions associated with ethanol-induced gene expression changes at P7.
Category

Function annotation

p-value

No. genes

Up-regulated genes

Down-regulated genes

Cell death and survival

apoptosis of neurons

0.000497

17

Agt, Bcl2l11, Btg2, Dusp1, Grin2b,
Igf1r, Jun, Mt1e, Mt1h, Perp,
St8sia1, Tgfb3, Zfp110/Zfp369

Adcyap1, Hdac1, Klf6, Vegfa

Nervous system
development and
function

proliferation of pituitary cells

0.00220

3

Tgfb3

Inhba, Srsf2

proliferation of neuroglia

0.0155

5

Cpeb1, Foxo3

Adcyap1, Ccnd1, Etv5

abnormal morphology of
astrocytes
quantity of neurons

0.0252

3

Mt1e, Mt1h

Ldlr

0.0334

10

Dusp1, Igf1r

Adcyap1, Egr3, Inhba, Lifr,
Olig2, Pomc, Trpa1, Vegfa

plasticity of neuronal synapse

0.0371

2

Cpeb1, Grin2b

Tissue development

regeneration of nerves

0.000544

3

Agt, Jun, St8sia1

-

Cell cycle

mitosis

0.00175

3

Edn1, Tgfb3

Ccnd1

0.00216

2

Edn1, Tgfb3

-

Lipid metabolism

mitogenesis of central nervous
system cells
hydrolysis of phospholipid

0.0181

2

Agt, Edn1

-

turnover of phospholipid

0.00216

2

Edn1

Adcyap1

metabolism of membrane lipid
derivative
neuromuscular disease

0.0462

2

St8sia1

Pomc

0.0116

15

Agt, Mertk, Mt1e, Mt1h, Sdc4,
Slc16a9, Zfp932

Egr4, Etv5, Gabra5, Hla-b,
Lifr, Nr4a1, Rgs4, Rxrg

disorder of basal ganglia

0.0171

14

Mertk, Mt1e, Mt1h, Sdc4, Slc19a9,
Zfp932

Egr4, Etv5, Gabra5, Hla-b,
Lifr, Nr4a1, Rgs4, Rxrg

neuropathy of brain

0.00216

2

Mt1e, Mt1h

-

damage of brain

0.0479

4

Edn1, Folh1, Grin2a, Grin2b

-

Neurological disease
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TABLE 3.6. continued…
Category

Function annotation

p-value

No. genes

Up-regulated genes

Down-regulated genes

Cellular growth and
proliferation

proliferation of cells

0.0197

13

Cpeb1, Foxo3, Tgfb3

Vitamin and mineral
metabolism

mobilization of Ca2+

0.0122

2

-

Adcyap1, Ccnd1, Etv5, Gnl3,
Gtpbp4, Inhba, Klf6, Pomc,
Srsf3, Vegfa
Adcyap1, Trpa1

influx of Ca2+

0.0371

2

Grin2b

Trpa1

Cell-to-cell signaling and
interaction

damage of dopaminergic
neurons
plasticity of neuronal synapse

0.00356

2

Mt1e, Mt1h

-

0.0371

2

Cpeb1, Grin2b

-

Endocrine system
development and
function

proliferation of pituitary cells

0.00220

3

Tgfb3

Inhba, Srsf2,

hydroxylation of melatonin

0.0193

1

Cyp1b1

-

production of Ltriiodothyronine
secretion of corticosterone

0.0193

1

-

Dio2

0.0193

1

-

Pomc
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3.2.3 Canonical signaling pathways affected acutely following ethanol
exposure
To assess biological pathways that may be affected immediately following ethanol
treatment at P7, the genes identified by the array analysis were subjected to IPA’s
canonical pathway analysis to identify pathways associated with altered gene
expression and the identified biological functions. The canonical pathways identified
were also consistent with the gene ontology and biological functions analyses.
Canonical pathways that possessed a significant number of altered genes are shown
in (Table 3.7). Significantly affected pathways included p53 signaling (p = 0.0002),
which included the upregulated transcription factor jun proto-oncogene (Jun),
classically associated with early cellular stress response, and a down-regulation of
the histone deacetylase Hdac1. Circadian rhythm signaling was also significantlyaffected (p = 0.0002) and included altered genes that control the proper timing of
cellular and metabolic events such as glutamate neurotransmission (Grin2a, Grin2b),
period genes (Per1, Per2) and the cryptochrome protein Cry1. Other canonical
pathways identified as significantly affected acutely following ethanol exposure at P7
were associated with cell cycle: G1/S checkpoint regulation (p = 0.0008), which is
consistent with the cell cycle-associate genes identified by the IPA biological
functions analysis and included the growth factor transforming growth factor beta-3
(Tgfb3) as well as the histone deacetylases Hdac1 and Hdac9. Other pathways of note
included phosphoinositide biosynthesis (p = 0.11), associated with membrane
integrity, retinoic acid-associated TR/RXR activation (p = 0.017), and the related
canonical PTEN signaling pathway (p = 0.02), associated with regulation of cell
growth and mitotic progression.
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TABLE 3.7. Ingenuity ® canonical pathways associated with transcripts altered by ethanol exposure at P7.
Canonical pathway

p-value

No.

Up-regulated genes

Down-regulated genes

molecules
p53 signaling

0.00023

8

Jmy, Jun, Perp, Pik3r1, Tp53inp1

Ccnd1, Gnl3, Hdac1

Circadian rhythm signaling

0.00024

6

Grin2a, Grin2b, Per1

Adcyap1, Cry1, Per2

Cell cycle: G1/S checkpoint regulation

0.00077

6

Tgfb3

Ccnd1, E2f4, Gnl3, Hdac1,
Hdac9

Chronic myeloid leukemia signaling

0.00698

9

Pik3r1, Tgfb3

Ccdn1, E2f4, Hdac1, Hdac9

3-phosphoinositide biosynthesis

0.00927

7

Dusp1, Dusp8, Dusp16, Nudt11, Pik3r1,

Pptc7

Ppm1k
D-myoinositol tetraphosphate

0.0110

6

Dusp1, Dusp8, Dusp16, Nudt11, Ppm1k

Pptc7

0.0132

5

Tgfb3

Ccnd1, E2f4, Gnl3, Hdac1,

biosynthesis
Cyclins and cell cycle regulation

Hdac9
ErbB2-ErbB3 signaling

0.0165

4

Jun, Pik3r1

Ccnd1, Etv4

TR/RXR activation

0.0172

5

Pik3r1, Slc2a1

Dio2, Ldlr, Rxrg

PTEN signaling

0.0203

5

Pik3r1, Slc2a1

Dio2, Ldlr, Rxrg
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3.2.4 Interacting gene networks involving genes altered by ethanol
exposure
To evaluate how the ethanol-responsive genes altered acutely following ethanol
treatment at P7 may interact with one another, I utilized the gene network analysis
tool within the Ingenuity® software platform to predict interacting molecular
networks

(algorithmically

generated pathways).

The

molecular

networks

represented pleiotropic, broadly-acting functions and correlated well with the GO
functions and the canonical pathways identified by the previous analyses. Network
analysis identified three significant networks, shown in Figures 3.15, 3.16, 3.17. The
returned networks were associated with ‘cellular development, cellular growth and
proliferation, tumor morphology’ (CDCG), which contained 17 focus molecules
identified by the array (IPA network score = 20) (Figure 3.15), ‘tissue morphology,
cell-to-cell signaling and interaction, cellular growth and proliferation’ (TMCS) (focus
molecules = 13; score = 13) (Figure 3.16), and ‘behaviour, cell-to-cell signaling and
interaction, nervous system development and function’ (BCSN) (focus molecules =
11; score = 10) (Figure 3.17). As the network descriptors suggests, these networks
were highly interrelated. The CDCG network centralized on three highly connected
‘hub’ molecules: jun proto-oncogene (Jun), which was detected as highly up-regulated
in the ethanol-treatment arrays as compared to controls, and cAMP responsive
element binding protein 1 (Creb1) and FBJ osteosarcoma oncogene (Fos), which were
not detected as differentially expressed but served as connector molecules between
multiple up- and down-regulated transcripts (Figure 3.17). The TMCS also included
Jun, as well as tumor necrosis factor (Tnf) (not differentially expressed) and
transforming growth factor, beta 1 (Tgfb1)(up-regulated) as hub molecules, as well as
interleukins 15 (down-regulated) (Figure 3.18). Also relevant to this network was
adenylate cyclase activating polypeptide 1 (Adcyap1) (down-regulated) that acted as
a molecular hub connecting the down-regulated pro-opiomelanocortin-alpha (Pomc)
to tumor necrosis factor (Tnf) via expression regulation (E) and co-localization (LO)
annotations. Finally, the BCSN network was characterized by the presence of multiple
glutamate receptor subunits, including glutamate receptor, ionotropic, N-methyl
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as a

FIGURE 3.17. Ingenuity Pathway Analysis™ network analysis indicating annotated
interactions between transcripts altered acutely following ethanol exposure at P7
associated with ‘cellular development, cellular growth and proliferation, and tumor
morphology’ (CDCG). Up (red) and down (green) regulated genes are indicated. Arrowhead
indicates the direction of action. Notations in brackets adjacent to the edge key labels
indicate the number of lines of evidence (publically available data sourced by Ingenuity ®)
supporting the interaction.
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FIGURE 3.18. Ingenuity Pathway Analysis™ network analysis indicating annotated interactions
between transcripts altered acutely following ethanol exposure at P7 associated with ‘tissue
morphology, cell-to-cell signaling and interaction, cellular growth and proliferation’ (TMCS).
Up (red) and down (green) regulated genes are indicated. Arrowhead indicates the direction of
action. Notations in brackets adjacent to the edge key labels indicate the number of lines of
evidence (publically available data sourced by Ingenuity ®) supporting the interaction.
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FIGURE 3.19. Ingenuity Pathway Analysis™ network analysis indicating annotated
interactions between transcripts altered acutely following ethanol exposure at postnatal
day 7 associated with ‘behavior, cell-to-cell signaling and interaction, nervous system
development and function’ (BCSN). Up (red) and down (green) regulated genes are
indicated. Arrowhead indicates the direction of action. Notations in brackets adjacent to
the edge key labels indicate the number of lines of evidence (publically available data
sourced by Ingenuity ®) supporting the interaction.
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D-aspartate 2A (Grin2a) and Grin2b, both up-regulated (Figure 3.19). Further, this
network included components of circadian rhythm patterning (Per1) and histone
modification (Hdac1). Interestingly, Huntingtin (Htt) was implicated as a major hub
of this network which, though it was not detected as differentially expressed,
interacts with differentially expressed genes including Per1 (up-regulated),
glutamate receptor subunits, serotonin transporter genes (Slc1a1), and the RNA
spliceosome protein Srsf2 (down-regulated).
To identify molecules that may be key effectors of the ethanol-induced changes in
gene expression, the three networks were merged to identify hub molecules that may
unify the interactions of all three (Figure 3.20). Early immediate transcriptional
regulators controlling cell cycle and proliferation, such as cell-cycle control genes
such as Jun, Fos, early growth response 1 (Egr1) and Egr2, and Creb1, appeared as
central hubs. Also highly-represented are signaling molecules such as cytokines and
growth hormones, including growth hormone 1 (Gh1), nerve growth factor (Ngf),
Tumor necrosis factor (Tnf), Transforming growth factor, beta 1 (Tgfb1), and
interleukin 6 (Il6). The glutamate receptors (Grin2a, Grin2b, and Grin1) prominent in
the BCSN network remain as hubs in the merged model of molecular interactions, as
does Htt. Finally, an interesting interaction emerged between Adcyap1, Pomc, and
nuclear receptor subfamily 4, group A, member 1 (Nr4a1), all of which showed reduced
mRNA levels. Taken together, these genes and their interactions may be viewed as
the primary response of developing brain cells to ethanol exposure at synaptogenesis
and illustrate a balance between the role of cell cycle genes, genes critical to synaptic
formation and maintenance, and the expression of early response growth factors.
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FIGURE 3.20. Merged Ingenuity Pathway Analysis™ networks showing interactions
between the most significant gene networks (see Figure 3.15, 3.16, and 3.17) affected
acutely following ethanol exposure at postnatal day 7. Up (red) and down (green)
regulated genes are indicated. Centralized “hub” molecules linking multiple interacting
genes are enlarged. Arrowhead indicates the direction of action. Notations in brackets
adjacent to the edge key labels indicate the number of lines of evidence (publically
available data sourced by Ingenuity ®) supporting the interaction.
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3.2.5 Validation of array-identified mRNA levels by quantitative RT-PCR
Real-time quantitative RT-PCR (qRT-PCT) expression analysis was performed for
four genes, selected based on their fold changes and prominence in biological
functions and networks identified by bioinformatics analyses. Genes chosen for qRTPCR analysis were: Dual-specificity phosphatase 1 (Dusp1), jun proto-oncogene (Jun),
nuclear receptor subfamily 4, group A, member 1 (Nr4a1), and pro-opiomelanocortinalpha (Pomc). Real-time results as compared to array fold-changes are shown in
Figure 3.21. Fold-changes calculated from deltaCt values showed good consistency
with the array results. All genes confirmed (student’s t-test, p < 0.05) with the
exception of Pomc, which approached but did not reach significance (t = 2.078, p =
0.071).
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FIGURE 3.21. Quantitative RT-PCR confirmation of array-identified genes altered acutely
following ethanol treatment at P7. Data are shown as mean (±SEM). Genes are listed
alphabetically: Dual-specificity phosphatase 1 (Dusp1), jun proto-oncogene (Jun), nuclear
receptor subfamily 4, group A, member 1 (Nr4a1), and pro-opiomelanocortin-alpha (Pomc).
All genes were significantly different from controls (students’ t-test, p < 0.05) with the
exception of Pomc. ns: not significantly different from controls.
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3.3 Long-term alterations to brain gene expression following
ethanol exposure during synaptogenesis
In addition to identifying genes that were acutely affected by third-trimester ethanol
exposure (4 hours post-injection at P7), I examined the brain gene expression
changes in the adult brain (P60) resulting from ethanol exposure during
synaptogenesis, or the human third trimester-equivalent (at postnatal days 4 and 7).
These results represent alterations to the transcriptome that are initiated during
neurodevelopment but persist into adulthood in mice displaying behavioural
phenotypes relevant to FASD.

3.3.1 Gene expression changes in the adult brain
Expression microarray analysis identified 376 transcripts as differentially expressed
between ethanol-treated mice and controls (1.2-fold change, FDR-correct p < 0.05).
Changes to gene expression were relatively subtle, ranging from -2.21-fold (Triadin)
to 3.3-fold (Proline-rich protein 2). Interestingly, the distribution of up- and downregulated genes was not equal, with 92% of genes (361/376) identified as downregulated as compared to controls. Further, the gene expression changes were subtle
with 173/376 (47%) of genes showing less than a 1.3-fold change. A full list of genes
meeting the stringency parameters is provided in Appendix B. This list was used for
subsequent biological functions, pathway, and gene network analyses.

3.3.2 Array hierarchical clustering and functional annotation of genes
altered in the adult brain
Hierarchical clustering analyses of each array indicated that the consistency between
arrays was good, with the ethanol and control arrays cleanly pairing when grouped
by probe intensity (Figure 3.22). When subjected to statistical stringency measures
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for fold-change and p-value cutoffs, genes detected as up-regulated in the ethanoltreated samples as compared to controls were greatly reduced, indicating that many
up-regulated genes showed low fold-changes and/or p-value significance. Due to the
low number of significant up-regulated transcripts, the total gene list (both up- and
down-regulated transcripts) was analyzed using DAVID (DENNIS et al. 2003) for overrepresented gene ontology processes.

DAVID analysis identified a number of

biological processes associated with synaptic function, including glutamate receptor
activity, synaptic transmission, and regulation of synaptic plasticity (Table 3.8).
These annotations were comprised of a number of altered glutamate receptor
subunits, including Grin2b, Grin2c, Grin2d, Grin3b, Grik1, and Grik3.

These gene

ontology functions shared multiple genes with other significant functions related to
behaviour, such as “adult behaviour”, “learning”, and “locomotory behaviour”.
Interestingly, a significant number of genes were associated with folic acid
metabolism, including 5, 10-methenyltetrahydrofolate synthetase (Mthfs), and folate
hydrolase 1 (Folh1), and 5-methyltetrahydrofolate-homocysteine methyltransferase
(Mtr), involved in folate usage and one-carbon metabolism. Other gene clusters were
also related to epigenetic processes such as chromatin organization and histone
modification, indicating that these processes may be disrupted by trimester three equivalent ethanol exposure. Other significant clusters of genes were associated with
cytoskeletal transport and cell adhesion, protein phosphorylation, and mitogen activated protein (MAP) kinase signaling cascade.
The transcripts identified were independently analyzed for over -representation
within biological functions using Ingenuity Pathway Analysis™ (IPA) (Ingenuity
Systems, Redwood, CA, www.ingenuity.com) (Table 3.9). The results supported the
gene ontology biological functions and identified a significant number of differentially
expressed genes associated with neurotransmission and synaptic plasticity, including
again the glutamate receptor subunits Grik1 and Grin2b. Also identified were a
number of genes associated with retinoic acid signaling (Fadd, Casp3, Rarb, Tnfsf10,
Rxrb, Irf1), lipid metabolism and accumulation, involving the hormone precursor
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FIGURE 3.22. Heat map hierarchical clustering of arrays representing transcripts altered
in the adult (P60) brain of control (n=2) and ethanol-treated (n=2) mice exposed at P4 +7
based on the normalized intensity of the probe sets. Heat map was generated by Partek®
Genomics Suite software based on ANOVA-calculated significance levels and fold-changes.
Clusters of up-regulated (green) and down-regulated (red) genes are indicated.
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TABLE 3.8. Gene Ontology (GO) biological function annotation clustering of transcripts altered in the adult brain of mice treated with ethanol
at P4+7.
GO term

GO ID

No. genes

p-value

Genes

glutamate receptor activity

0008066

9

5.84E-7

Grm4, Grin2b, Grik1, Grin2c, Grik3, Grin2d, Ubc, Grin3b,
Grind1

synaptic transmission

0007268

16

0.000012

Grik1, Ntf3, Nlgn1, Grm4, Grin2b, Grin2c, Grin2d, Chrm1,
Cnr1, Pcdhb16, P2rx3, Dmd, Syngap1, Cacna1c, Sv2c, Apba1

regulation of synaptic plasticity

0048167

8

0.00035

Apoe, Grin2b, Grik1, Grin2c, Htt, P2rx3, Syngap1, Syngr1

cellular ion homeostasis

0006873

15

0.00071

Ftl1, Grik1, Ntf3, Htt, Grik3, Hexa, Pex5l, Vdr, Grin2b, Grin2c,
Apoe, Grin2d, Pth, Cacna1c, Cln5

folic acid and derivative metabolic
process

0006760

4

0.00189

Mthfs, Folh1, Mtr, Aldh1l2

chromatin organization

0006325

15

0.00408

Hist1h2bf, Crebbp, Hdac10, Dmap1, Mbd3, Hltf, Nap1l5,
Hist2h4, Hist1h2bm, Hist1h3c, Hist1h4d, Kdm5a, Rbm14,
Hdac8, Myst1, Kdm6b

histone modification

0016570

7

0.00982

Crebbp, Hdac10, Dmap1, Mbd3, Rbm14, Hdac8, Kdm6b

regulation of protein kinase cascade

0045449

9

0.0120

Traf3ip1, Spry1, Grin2b, Iltifb, Fgf9, Mdfic, Map3k1, Itsn1,
Syngap1

locomotory behaviour

0007626

11

0.0207

Cmtm2a, Npas3, Grin2c, Htt, Hexa, Grin2d, Pcdh15, Gpr77,
Cacna1c, Apba1, Itgam

regulation of transcription, DNAdependent

0006355

41

0.0220

Nkap, Kchn1, Irx5, Pax3, Dmap1, Vdr, Trp53bp1, Npas3,
Hsf1, Tgif2lx1, Elk4, Mdfic, Tead4, Pth, Etv2, Yeats2, Rarb,
Nfatc1, Maf, Ntf3, Rxrb, Crebbp, Gsx1, Mbd3, Zfp59, Six4, Hltf,
Mycn, Traf3ip1, Myt1l, Mef2d, Zfp9, Cmtm2a, Foxf1a, Irf5,
Iltifb, Thrap3, Irf1, Rbm14, Kdm6b, Tbx19
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TABLE 3.8 continued…
GO term

GO ID

No. genes

p-value

Genes

learning

0007612

5

0.0262

Grm4, Grin2b, Htt, Cacna1c, Syngap1

cytoskeleton-dependent intracellular
transport

0030705

4

0.0203

Htt, Rhot2, Dst, Hap1

neuron differentiation

0030182

15

0.0278

Irx5, Sox1, Ntf3, Htt, Wnt3a, Gsx1, Ntng2, Pcdh15, Pax3,
Ephb1, Tulp3, Dmd, Efna5, Syngap1, Dst

regulation of phosphorylation

0042325

12

0.0298

Egfr, Traf3ip1, Casp3, Spry1, Vav3, Iltifb, Mdfic, Map3k1,
Tlr1, ll34, Dnajc3, Kitl

regulation of MAPKKK cascade

0043408

6

0.0372

Spry1, Grin2b, Fgf9, Mdfic, Map3k1, Syngap1

adult behaviour

0030534

6

0.0373

Grik11, Adh1, Hexa, Grin2d, Pcdh15, Cacna1c

regulation of cell adhesion

0030155

6

0.0388

Lama4, Vav3, Prlr, Srcin1, Fbln2, Cml5
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TABLE 3.9. Ingenuity Pathway Analysis™ biological functions associated with gene expression changes in the adult brain of mice treated
with ethanol at P4+7.
Category

Function annotation

p-value

No. genes

Genes

Cell-to-cell signaling and
interaction

neurotransmission

0.0000829

10

Apoe, Chrm1, Cnr1, Ephb1, Grik1, Grin2b, Htr1a,
Htt, Nlgn1, Ntf3

Cell growth and proliferation

proliferation of cells

0.000378

17

Alk, Anxa2, Cnr1, Efnb2, Egfr, Htt, Irx5, Lama4, mir221, Mknk1, Mycn, Nbn, Npas3, Ntf3, Pomc, Spry1,
Wnt3a

Cell death

retinoic acid-mediated apoptosis
signaling

0.00055

6

Fadd, Casp3, Rarb, Tnfsf10, Rxrb, Irf1

Cell death

cell viability of cerebral cortex
cells

0.00141

5

Alk, Apoe, Htt, Ksr1,Ntf3

Lipid metabolism

secretion of steroid

0.00181

3

Apoe, Pomc

Lipid metabolism

accumulation of lipid

0.00360

3

Chrm1, Cnr1. Htt

Neurological disease

movement disorder

0.00534

9

Anxa2, Atxn3, Capn3, Casp3, Ftl, Htt, Nbn, Ptges3,
Ran

Carbohydrate metabolism

quantity of carbohydrate

0.00553

3

Htt, Inppl1, Insr

Cell death

neuronal cell death

0.00707

21

Alka, Apoe, Casp3, Cnr1, Efnb2, Fadd, Grin2b, Hsf1,
Htt, Inppl1, Insr, Itsn1, Kitlg, Ksr1, Map3k1, Mycn,
Nbn, Ntf3, Smpd2, Tyk2, Xrcc5

Cell-to-cell signaling and
interaction

plasticity of synapse

0.0144

6

Apoe, Grik1, Grin2b, Htt, Inppl1, Syngap1

Nervous system development
and function

quantity of microglia

0.0197

2

Apoe, Htt
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TABLE 3.9 continued…
Category

Function annotation

p-value

No. genes

Genes

Cell morphology

formation of cellular protrusions

0.0329

17

Apoe, Dst, Efna5, Efnb2, Egfr, Ephb1, Grm4, Htt,
Kif23, Nbl1, Ntf3, Ntng2, Pcdh15, Rhog, Syne1,
Syngap1, Wnt3a

Cell death

cell death of dopaminergic
neurons

0.0344

3

Casp3, Efnb2, Fadd

Neurological disease

gliosis of hippocampus

0.0400

2

Apoe, Htt

Nucleic acid metabolism

concentration of cyclic AMP

0.0400

2

Htt, Pth

Cellular assembly and
organization

transport of synaptic vesicles

0.0443

3

Apba1, Htt, Itsn1

Cellular assembly and
organization

microtubule dynamics

0.0446

18

Apoe, Dst, Efna5,Efnb2, Egfr, Ephb1, Grm4, Htr1a,
Htt, Kif23, Nbl1, Ntf3, Ntng2, Pcdh15, Rhog, Syne1,
Syngap1, Wnt3a
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protein pro-opiomelanocortin-alpha (Pomc), muscarinic cholinergic and cannabinoid
receptors Chrm1 and Cnr1, as well as groups of genes associated with cytoskeletal
function including genes important for the transport of synaptic vesicles and
microtubule dynamics.

3.3.3 Canonical signaling pathways associated with gene expressi on
changes in the adult brain
Genes differentially expressed between control versus ethanol-treated adults were
analyzed using the IPA for associations to canonical biological pathways (Table 3.10).
Consistent with the biological functions analyses, glutamate receptor signaling and
synaptic long-term potentiation were identified, driven by the altered expression of
a number of glutamate receptor subunits. Also identified was a significant cluster of
genes associated with retinoic acid signaling, ephrin receptor signaling, calcium
signaling, and neuronal nitric oxide synthase (nNOS) signaling.

Interestingly,

Circadian rhythm signaling and serotonin receptor signaling were also identified,
indicating that both glutamate and serotonergic-based neurotransmission may be
affected by trimester three-equivalent ethanol exposure. Other pathways of interest
were folate-mediated one-carbon metabolism, also identified by the biological
functions analyses, and mammalian target of rapamycin (mTOR) signaling.

3.3.4 Interacting gene networks involved in gene expression changes in the
adult brain
The genes detected as altered in the brain of adult mice exposed to alcohol at P4 and
P7 were analyzed using the gene network analysis tool within the Ingenuity ®
software platform to predict interacting molecular networks.

The predicted

networks were highly interrelated and focused around various glutamate receptor
subunits. While five networks were identified as significant, most of the interactions
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between altered transcripts were described by the first two, associated with the
functions of “neurological disease, psychological disorders, behaviour” (NPD) (focus
molecules = 17) and “cell morphology, cell-to-cell signaling and interaction, nervous
system development and function” (CCN) (focus molecules = 14). These networks are
shown in Figures 3.23 and 3.24. The NPD network contained huntingtin (Htt) as a hub
molecule, which was not differentially expressed acutely following ethanol exposure but
was identified as a major hub of the short-term gene network. Other hub molecules
included glutamate receptor, ionotropic, N-methyl D-aspartate 2B (Grin2b) and the
apoptosis enzyme caspase 3 (Casp3), both of which were also down-regulated. The CCN
network also contained a number of glutamate receptor subunits and Grin2b appeared
again as a network hub molecule. Other hub molecules included the synaptic protein discs,
large homolog 4 (Drosophila) (Dlg4) and, interestingly, retinoic acid receptor, alpha
(Rara). Given that the functions associated with these networks were interrelated, the
networks were merged to evaluate molecules that may be effectors of the neurologica l
changes associated with third trimester ethanol exposure (Figure 3.25). The merged
networks implicated Htt as a central hub, as well as the glutamate receptor proteins Grin2b
and glutamate receptor, ionotropic, AMPA1 (alpha 1) (Gria1). Neurotrophin 3 (Ntf3),
which appeared within many gene clusters identified by the biological functions analyses,
also appeared within the merged network as a central hub molecule, as did apolipoprotein
E (Apoe).
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TABLE 3.10. Ingenuity ® canonical pathways associated with transcripts altered in the adult brain of mice treated with ethanol at P4+7.
Canonical pathway

p-value

No. molecules

Genes

Glutamate receptor signaling

0.0000074

9

Grin2b, Grin3b, Gnb3, Grid1, Grin2c, Grin2d, Grik3, Grm4, Grik1

Retinoic acid-mediated apoptosis
signaling

0.000550

6

Fadd, Casp3, Rarb, Tnfsr10, Rxrb, Irf1

Ephrin Receptor Signaling

0.00224

11

Calcium Signaling

0.00417

10

nNOS Signaling in Neurons

0.00447

5

Grin2b, Grin3b, Grin2c, Grin2d, Capn3

Aminosugars Metabolism

0.00501

6

Gnpnat1, Gnpda1, Pde12, Mdp1, Hexa, Gfpt2

Circadian Rhythm Signaling

0.00692

4

Grin2b, Grin3b, Grin2c, Grin2d

One Carbon Pool by Folate

0.00794

3

Tyms, Mthfs, Mtr

CREB Signaling in Neurons

0.0170

9

Grin2b, Gnb3, Polr2d, Grid1, Grin2c, Grin2d, Grik3, Grm4, Grik1

mTOR Signaling

0.0288

14

Ephrin B Signaling

0.0295

5

Efnb2, Ephb1, Gnb3, Itsn1, Vav3

Serotonin Receptor Signaling

0.0347

3

Htr5b, Htr1a, Htr1d

Synaptic Long Term Potentiation

0.0347

6

Grin2b, Grin3b, Grin2c, Grin2d, Cacna1c, Grm4

Grin2b, Efnb2, Ephb1, Grin3b, Gnb3, Itsn1, Grin2c, Efna5, Grin2d, Vegfc,
Figf
Rcan1, Grin2b, Grin3b, Hdac8, Grin2c, Grin2d, Mef2d, Trdn, Hdac10, Grik1

Fau, Rhog, Rps10, Rhot2, Rptor, Vegfc, Figf, Insr, Rpsa, Efnb2, Ephb1, Gnb3,
Itsn1, Vav3
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FIGURE 3.23. Ingenuity Pathway Analysis™ network analysis indicating annotated
interactions between transcripts altered in the adult brain by ethanol exposure at P4+7
associated with ‘neurological disease, psychological disorders, behaviour’ (NPD). Downregulated (green) genes are indicated. Arrowhead indicates the direction of action.
Notations in brackets adjacent to the edge key labels indicate the number of lines of
evidence (publically available data sourced by Ingenuity ®) supporting the interaction.
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FIGURE 3.24. Ingenuity Pathway Analysis™ network analysis indicating annotated
interactions between transcripts altered in the adult brain by ethanol exposure at P4+7
associated with ‘cell morphology, cell-to-cell signaling and interaction, nervous system
development and function’ (CCN). Down-regulated (green) genes are indicated.
Arrowhead indicates the direction of action. Notations in brackets adjacent to the edge
key labels indicate the number of lines of evidence (publically available data sourced by
Ingenuity ®) supporting the interaction.
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FIGURE 3.25. Merged Ingenuity Pathway Analysis™ networks showing interactions
between the most significant gene networks (see Figures 3.23 and 3.24) affected in the
adult brain following ethanol exposure at P4+7. Down-regulated (green) genes are
indicated. Centralized “hub” molecules linking multiple interacting genes are enlarged.
Arrowhead indicates the direction of action. Notations in brackets adjacent to the edge
key labels indicate the number of lines of evidence (publically available data sourced by
Ingenuity ®) supporting the interaction.
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3.3.5 Quantitative RT-PCR confirmation of array-identified mRNA levels
Four genes detected by the array analysis were chosen for confirmation by real-time
quantitative RT-PCR (qRT-PCT), selected based on their fold changes and prominence
in biological functions and networks identified as affected following ethanol
treatment. Genes chosen for qRT-PCR analysis were: cannabinoid receptor 1 (brain)
(Cnr1), glutamate, ionotropic, N-methyl D-aspartate 2B (Grin2b), 5-hydroxytryptamine
(serotonin) receptor 5B (Htr5b), and pro-opiomelanocortin-alpha (Pomc). Real-time
results as compared to array fold-changes are shown in Figure 3.26. Fold-changes
calculated from deltaCt values showed good consistency with the array results. All
genes confirmed as significantly different from controls (student’s t-test, p < 0.05).
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FIGURE 3.26. Quantitative RT-PCR confirmation of array-identified changes in mRNA
levels in the adult (P60) brain of mice treated with ethanol at P4+7. Data are shown as
mean (±SEM). Genes are listed alphabetically: cannabinoid receptor 1 (brain) (Cnr1),
glutamate receptor, ionotropic, N-methyl D-aspartate 2B (Grin2b), 5-hydroxytryptamine
(serotonin) receptor 5B (Htr5b), and pro-opiomelanocortin-alpha (Pomc). Expression of
all genes was significantly different from controls (students’ t-test, p < 0.05).
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3.4 Comparison of acute and long-term gene expression
changes

resulting

from

ethanol

exposure

during

synaptogenesis
The gene expression changes that were identified by the short-term microarray
analysis (4 hours post-treatment) were compared to the transcript list generated by
adult gene expression analysis to evaluate potential common genes and pathways
that may represent the molecular adaptation of neural cells to developmental ethanol
exposure.

Twelve transcripts that showed altered expression acutely following

ethanol exposure at P7 were also detected as differentially expressed in the adult
brain (Table 3.11). Five of these genes showed down-regulation in both samples,
while the remaining seven showed an inverse relationship (upregulated acutely
following ethanol exposure but down-regulated in the adult brain samples) between
the acute versus long-term gene expression changes. Among these were genes critical
to both neurodevelopment and adult brain function, including glutamate signaling
(Folh1 and Grin2b), serotonin signaling (Htr1d, Slc16a6), hypothalamic-pituitaryadrenal stress response (Pomc), and cellular organization (Hmcn1, Pcdhb18). Other
genes identified have been previously implicated in neurological phenotypes, such as
seizure threshold 2 (Szt2) and XRCC6 binding protein 1 (Xrcc6bp1), or have roles as
zinc finger-containing transcription factors (Zbtb10 and Zfp9).
The DAVID gene ontology biological functions, IPA gene ontology and IPA canonical
pathways associated with the altered short- and long-term transcripts were
compared to identify common potentially-targeted pathways that may represent
some continuity between the acute and the persistent effects of ethanol exposure
during synaptogenesis. This analysis revealed that, while the number of overlapping
transcripts identified by both the short- and long-term gene arrays was limited, there
were a number of closely associated biological functions and canonical pathways
represented within both gene lists (Table 3.12). Genes associated with synaptic
transmission and plasticity were present in both the short- and long-term gene lists,
with both showing a number of glutamate receptor subunit transcripts including
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TABLE 3.11. Genes altered by alcohol exposure acutely following treatment (at P7) that remain altered during early adulthood (at P60).
Accession No.

Gene Symbol

Gene Name

Chr.
Location

NM_016770

Folh1

folate hydrolase 1

NM_008171

Grin2b

NM_144835

Fold Change
acute (P7)

long-term (P60)

7 D1-D2

1.44

-1.28

glutamate receptor, ionotropic, NMDA2B (epsilon 2)

6 G1

1.25

-1.27

Heatr1

HEAT repeat containing 1

13 A1

-1.31

-1.33

NM_001285482.1

Htr1d

5-hydroxytryptamine (serotonin) receptor 1D

4 D3

1.23

-1.27

NM_001024720

Hmcn1

hemicentin 1

1 G1

-1.20

-1.28

NM_053143

Pcdhb18

protocadherin beta 18

18 B3

1.21

-1.43

NM_008895

Pomc

pro-opiomelanocortin-alpha

12 A1

-1.21

-1.57

NM_001029842

Slc16a6

solute carrier family 16 (monocarboxylic acid
transporters), member 6

11 E1

1.35

-1.45

NM_198170

Szt2

seizure threshold 2

4 D2

-1.22

-1.24

NM_026858

Xrcc6bp1

XRCC6 binding protein 1

10 D3

-1.20

-1.36

NM_177660

Zbtb10

zinc finger and BTB domain containing 10

3 A1

1.38

-1.30

NM_011763

Zfp9

zinc finger protein 9

6 F1

1.25

-1.29
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TABLE 3.12. Related gene ontology biological functions and canonical pathways associated with transcripts altered acutely following
ethanol treatment at P7 and those altered in the adult (P60) brain of mice treated at P4+7.
Short term response

Long term response

Function

Identified by a

p-value

Genes

Function

Identified by a

p-value

Genes

regulation of
synaptic
transmission

DAVID

0.0464

Grin2b, Edn1,
Grin2a, Cpeb1

synaptic
transmission

IPA GO

0.00014

Apoe, Chrm1, Cnr1,
Ephb2, Grik1, Grin2b,
Htr1a, Nrgn1, Ntf3

plasticity of
neuronal synapse

IPA GO

0.0371

Cpeb1, Grin2b

plasticity of
synapse

IPA GO

0.0144

Apoe, Grik1, Grin2b, Htt,
Inppl1, Syngap1

glutamate receptor
signaling

IPA Canonical
pathway

0.000007

Grin2b, Grin3b, Gnb3,
Grid1, Grin2c, Grin2d,
Grik3, Grm4, Grik1

secretion of
steroid

IPA GO

0.0018

Apoe, Pomc

steroid hormone
receptor activity

DAVID

0.0425

Rxrg, Nr4a1,
Nrob1

hormone activity

DAVID

0.0401

Inhba, Pomc,
Apln, Adcyap1

secretion of
corticosterone

IPA GO

0.0193

Pomc

Circadian rhythm
signaling

IPA Canonical
pathway

0.000244

Adcyap1, Cry1,
Grin2a, Grin2b,
Per1, Per2

Circadian rhythm
signaling

IPA Canonical
pathway

0.00692

Grin2b, Grin3b, Grin2c,
Grin2d

TR/RXR activation

IPA Canonical
pathway

0.0172

Dio2, Ldlr,
Pik3r1, Rxrg,
Slc2a1

retinoic acidmediated
apoptosis signaling

IPA Canonical
pathway

0.00055

Fadd, Casp3, Rarb,
Tnfsf10, Rxrb, Irf1

PTEN signaling

IPA Canonical
pathway

0.0203

Dio2, Ldlr,
Pik3r1, Rxrg,
Slc2a1

mTOR Signaling

IPA Canonical
pathway

0.0288

Fau, Rhog, Rps10, Rptor,
Vegfc, Figf, Insr, Rpsa

aBiological

analysis.

functions or canonical pathways identified by DAVID gene ontology functional clustering, IPA gene ontology functional clustering, or IPA canonical pathways

122

Chapter 3. Results

Grin2a, Grin2b, and Grik1 . Also common between the short- and long-term lists were
GO functions related to hormone activity and signaling, specifically steroid and
corticosterone secretion and, interestingly, Circadian rhythm signaling. Finally,
retinoic acid signaling and the canonical PTEN/ATK/mTOR signaling pathway were
identified as associated with transcripts within both the short- and long term gene
lists.

3.5 microRNA expression changes in the adult brain following
ethanol exposure during synaptogenesis
Given that the long-term changes to mRNA levels may be mediated by epigenetic
regulatory mechanisms, I evaluated the changes to microRNA (miRNA) expression in
the adult brain (P60) following ethanol exposure at P4 and P7 as one possible
regulatory influence for the adult gene expression observations. miRNA expression
array analysis identified 33 miRNA transcripts that were differentially ex pressed
between control and ethanol-treated whole brain RNA (fold change > 1.2, FDRcorrected p = 0.05) (Appendix C). Fold changes ranged from -4.17 (mmu-miR-704) to
2.44 (mmu-miR-721). Again, most miRNAs were down-regulated following ethanol
exposure, with 73% (24/33) showing a negative fold-change as compared to salinetreated controls. A complete miRNA list showing differential expression between
control and ethanol-treated samples is provided in Appendix C.

3.5.1 Relationship between miRNA and predicted target mRNA expressi on
changes in the adult brain
Ingenuity Target Filtering™ analysis was performed using the gene lists from the
miRNA array and the long-term (P60) mRNA expression array to assess potential
regulatory interactions between altered miRNAs and mRNAs in the adult brain of
mice exposed to ethanol at P4+7. High-confidence (experimentally shown or strongly
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predicted based on sequence) interactions showing an inverse relationship between
altered miRNA and mRNA expression were included. A number of miRNAs were
paired with a number of potential mRNA targets (Table 3.13), suggesting that a single
miRNA may have multiple targets and exert an effect on multiple biological pathways,
shown in Table 3.13. These genes were associated with a number of previouslyidentified gene ontology functions and canonical pathways including axonal guidance
(Adam9, L ingo1, Sema6d, Shank2, Prkcb, and Efnb2), cytoskeletal organization
(Arhgap6, Shank2, Rhou), intracellular signaling (Lingo1, Lrrk2, Map3k7, Mras, Prkcb,
Rhou, and Ppm1b), chromatin organization and structure (Ino80, Ncor2), and
transcriptional regulation (Rbm9, Spen, Ncor2, Ncoa3).

Interestingly, hormonal

signaling-related transcripts were abundant among the potential mRNA targets
showing altered expression in the adult brain, including corticotrophin-releasing
hormone signaling, glucocorticoid receptor signaling, estrogen, and androgen
receptor signaling (Adam9, Cnr1, Mras, Ncor2, Ncoa3, Prkcb, Ppargc1a, Rbm9, and
Spen). Lastly, altered mRNA transcripts identified as potential targets of miR-721
were associated with retinoid acid signaling (Ncor2, Irf1, Ncoa3, Ppargc1) and the
canonical PI3K/AKT/mTOR signaling pathway (Tsc1).
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T ABLE 3.13. miRNAs and putative mRNA transcript targets showing altered inverse
expression in the adult (P60) brain following ethanol exposure at P4+7 and associated
biological pathways.
miRNA ID

miRNA
fold
change

Target
gene ID

Target
mRNA
fold change

Associated pathways

mmu-miR-26b
mmu-miR-26b

1.284
1.284

Adam9
Cnr1

-1.114
-1.332

mmu-miR-26b
mmu-miR-26b

1.284
1.284

Exoc8
Hs6st1

-1.221
-1.523

mmu-miR-26b
mmu-miR-26b

1.284
1.284

Lingo1
Map3k7

-1.153
-1.193

mmu-miR-26b

1.284

Mras

-1.200

mmu-miR-26b

1.284

Pfkfb3

-1.143

mmu-miR-26b
mmu-miR-26b

1.284
1.284

Ppm1b
Rhou

-1.429
-1.250

mmu-miR-26b
mmu-miR-26b
mmu-miR-26b
mmu-miR-26b
mmu-miR-26b

1.284
1.284
1.284
1.284
1.284

Sema6d
Shank2
Tab3
Tdrd7
Ube2j1

-1.181
-1.291
-1.253
-1.568
-1.151

Axonal Guidance Signaling
Corticotropin Releasing
Hormone Signaling
G-Protein Coupled Receptor
Signaling
Reelin Signaling in Neurons
cAMP-mediated signaling
Cdc42 Signaling
Cysteine Metabolism
LPS/IL-1 Mediated Inhibition
of RXR Function
Xenobiotic Metabolism
Signaling
Axonal Guidance Signaling
Acute Phase Response
Signaling
BMP signaling pathway
14-3-3-mediated Signaling
AMPK Signaling
Actin Cytoskeleton Signaling
Acute Phase Response
Signaling
Androgen Signaling
AMPK Signaling
Fructose and Mannose
Metabolism
AMPK Signaling
CXCR4 Signaling
Glioblastoma Multiforme
Signaling
Glioma Invasiveness Signaling
HMGB1 Signaling
Axonal Guidance Signaling
Axonal Guidance Signaling
NF-κB Signaling
Pluripotency
Hypoxia Signaling
Protein Ubiquitination
Pathway
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Table 3.13 continued…
miRNA ID

miRNA
fold
change

Target
gene ID

Target
mRNA
fold change

mmu-miR-184

1.485

Ncor2

-1.273

mmu-miR-184

1.485

Prkcb

-1.115

mmu-miR-721

2.437

Akap11

-1.111

mmu-miR-721
mmu-miR-721

2.437
2.437

B4galt5
Cnr1

-1.257
-1.332

mmu-miR-721

2.437

Efnb2

-1.261

mmu-miR-721

2.437

Fam20b

-1.271

mmu-miR-721
mmu-miR-721

2.437
2.437

Ino80
Irf1

-1.247
-1.323

mmu-miR-721

2.437

Lrrk2

-1.196

mmu-miR-721

2.437

Ncoa3

-1.247
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Associated pathways
Aryl Hydrocarbon Receptor
Signaling
Estrogen Receptor Signaling
Glucocorticoid Receptor
Signaling
Huntington's Disease Signaling
LXR/RXR Activation
PPAR Signaling
PPARα/RXRα Activation
RAR Activation
14-3-3-mediated Signaling
Aldosterone Signaling
Androgen Signaling
Axonal Guidance Signaling
β-adrenergic Signaling
Protein Kinase A Signaling
cAMP-mediated signaling
N-Glycan Biosynthesis
Corticotropin Releasing
Hormone Signaling
G-Protein Coupled Receptor
Signaling
Reelin Signaling in Neurons
cAMP-mediated signaling
Axonal Guidance Signaling
Ephrin Receptor Signaling
Inositol Phosphate Metabolism
Nicotinate and Nicotinamide
Metabolism
Purine Metabolism
Production of Nitric Oxide and
Reactive Oxygen Species
Retinoic acid Mediated
Apoptosis Signaling
Role of PKR in Interferon
Induction
Mitochondrial Dysfunction
Aryl Hydrocarbon Receptor
Signaling
Estrogen Receptor Signaling
Glucocorticoid Receptor
Signaling
PPARα/RXRα Activation
Role of Wnt/GSK-3β Signaling
TR/RXR Activation
VDR/RXR Activation
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Table 3.13 continued…

miRNA ID

miRNA
fold
change

Target
gene ID

Target
mRNA
fold change

mmu-miR-721

2.437

Pfkfb3

-1.143

mmu-miR-721

2.437

Ppargc1a

-1.123

mmu-miR-721
mmu-miR-721
mmu-miR-721
mmu-miR-721

2.437
2.437
2.437
2.437

Rbm9
Shank2
Spen
Sphk2

-1.311
-1.291
-1.140
-1.304

mmu-miR-721

2.437

Tsc1

-1.381

mmu-miR-721
mmu-miR-1970

2.437
-1.694

Wdfy3
Arhgap6

-1.327
1.188
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Associated pathways
AMPK Signaling
Fructose and Mannose
Metabolism
Estrogen Receptor Signaling
FXR/RXR Activation
PPAR Signaling
PPARα/RXRα Activation
PXR/RXR Activation
RAR Activation
TR/RXR Activation
Xenobiotic Metabolism
Signaling
Estrogen Receptor Signaling
Axonal Guidance Signaling
Estrogen Receptor Signaling
Ceramide Signaling
PDGF Signaling
Sphingolipid Metabolism
14-3-3-mediated Signaling
AMPK Signaling
Glioblastoma Multiforme
Signaling
PI3K/AKT Signaling
mTOR Signaling
N-Glycan Biosynthesis
RhoA Signaling
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3.5.2 Confirmation of miR-26b and putative mRNA target Cnr1 inverse
expression by quantitative RT-PCR
Given the roles of cannabinoid receptor 1 (Cnr1) in neurological phenotypes including
corticotropin releasing hormone signaling, the relationship between Cnr1 and its
putative regulatory miRNA miR-26b were confirmed by qRT-PCR.

The down-

regulation of Cnr1 was confirmed successfully, showing reduced transcript levels in
the brain of adult (P60) mice treated with ethanol at P4 and P7 as compared to salinetreated controls (fold-change = -1.13 ± 0.04, p = 0.0042) (Figure 3.26). The upregulation of mmu-miR-26b also confirmed successfully, showing increased
transcript levels (fold-change = +3.70 ± 0.20) in the adult brain of mice treated with
ethanol during the trimester three-equivalent (p < 0.001).

128

Chapter 4. Discussion

Chapter 4
DISCUSSION

This project was initiated to evaluate if human FASD could be effectively modeled
using mice and to utilize that model to investigate the molecular underpinnings of
the range of neural and phenotypic abnormalities associated with these spectrum
disorders. The work included in this thesis sought to assess if a binge-like dose of
ethanol during third trimester-equivalent could produce, in mice, behavioural and
cognitive phenotypes consistent with human FASD, and if that model could then
be used to elucidate molecular alterations in the brain that may initiate and
maintain these phenotypes. The results presented indicate that a trimester three equivalent binge exposure to alcohol is sufficient to produce multiple behavioural
phenotypes that reflect those commonly observed in human children,
adolescents, and adults prenatally exposed to alcohol.

Further, there is

substantial specificity and consistency with regard to the genes, biological
pathways, and processes that are associated with this exposure paradigm both
acutely following ethanol exposure and those that persist into adulthood. Finally,
utilization of the process outlined in this thesis is discussed in terms of its efficacy
to model human FASD, its contributions furthering our understanding of the
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disorder, and to evaluate the results within the context of potential diagnostic or
therapeutic strategies.

4.1 Effects of ethanol exposure during synaptogenesis on
behaviour
The results presented indicate that a binge-like dose of ethanol within a narrow
neurodevelopmental period during the trimester three-equivalent in mice is
sufficient to produce a number of behavioural and cognitive phenotypes relevant
to FASD in humans.
This finding is interesting given that a large proportion of prenatally-exposed
infants are likely exposed via low to moderate consumption (1-2 drinks) at
multiple points during gestation (KESMODEL and OLSEN 2001, ZELNER and KOREN
2013). Binge drinking is even more rare, and only a small percentage of women
(approximately 16%) of binge-drinkers self-report on binge-like alcohol
consumption after the first trimester (GLADSTONE et al. 1997). As such, most FASDrelated research has focused on physiological or cognitive consequences of earlygestation exposure. High doses of alcohol consumed during the first trimester of
pregnancy are associated with distinctive cranio-facial abnormalities, decreases
in brain volume, and detectable changes to neuronal tract connectivity in
numerous brain regions (ARCHIBALD et al. 2001, LEBEL et al. 2008, NORMAN et al.
2009, LIPINSKI et al. 2012). These features may assist in the identification of
alcohol-exposed children; however, the majority of prenatally- exposed offspring
show changes in cognitive function and behaviour in the absence of a ny
physiological abnormalities (MATTSON et al. 1998, GREEN et al. 2009).

It is

therefore important to understand the effects of alcohol on the developing brain
at all developmental stages to understand how timing contributes to specific
phenotypic changes, even in the absence of physiological markers. Further, it is
prudent to understand the biological mechanisms that underlie certain windows
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of ethanol vulnerability such as synaptogenesis, which is a critical period for
establishing the basis of neuronal communication that supports adult brain
function.

4.1.1 Effects of ethanol exposure on neonatal development
Early neonatal indications of prenatal alcohol exposure are useful both
diagnostically and prognostically, as they can facilitate FASD identification and
intervention to perhaps improve the later-life secondary behavioural and
cognitive outcomes associated with these disorders (STREISSGUTH et al. 2004). The
weight of pups treated with ethanol at P4 or P7 was not affected by ethanol
treatment, while exposure at both postnatal days (P4 and P7) did significantly
decrease the weight of neonates compared to their saline-treated controls. This
is likely attributable to reduced feeding ability and nutritional intake rather than
a direct effect of alcohol (BARRON et al. 1991), however it is interesting that this
difference persisted

well into

adolescence.

Low birth

weight

has

epidemiologically associated with moderate to high alcohol consumption,
including late-gestational binges (WHITEHEAD and LIPSCOMB 2003), though, studies
including self-reports of binge-like alcohol consumption during the third
trimester in humans are rare.

Animal studies corroborate these findings,

indicating that high, punctuated ethanol exposures producing low neonatal
weight (ABEL 1996, WOZNIAK et al. 2004); although, the pattern of ethanol
administration between studies varies considerably making comparisons
difficult.

Reduced birth and neonatal weight generally appears to be dose-

dependent with no clear threshold, but is consistently associated with prenatal
alcohol exposure.
Prenatal alcohol exposure has been linked to infant delays in muscle tone, motor
coordination, reflexes and balance (STAISEY and FRIED 1983, COLES et al. 1985,
JACOBSON et al. 1998, KALBERG et al. 2006), but literature on the effects of alcohol
exposure on early-life coordination and neuromuscular reflexes is somewhat
131

Chapter 4. Discussion

lacking in animal studies, particularly when compared to quantity of research
examining other behaviours such as learning. It is reasonable to believe that the
abnormalities consistently observed in higher cognitive functions would be
reflected in the disruption of basic neurodevelopmental achievement. Th erefore,
a more detailed evaluation of the early postnatal development of ethanol-exposed
neonates was a goal of this investigation. Ethanol exposure did not have a strong
effect on reflexive behaviours that appear early in postnatal development such as
negative geotaxis, cliff aversion, and auditory startle (Table 3.1). However,
milestones that rely on the concurrent development of strength and coordination
were affected in mice treated at P4 or P4+7, such as surface righting and forelimb
grasp. Also affected in these two groups were the later development of an ear twitch reflex and delayed eye opening, suggesting that ethanol was able to
differentially target multiple developmental systems.
These milestone delays were not observed in P7-treated mice, suggesting that
treatment earlier during the trimester three-equivalent synaptogenesis period
affected the development of these traits but that the neuromuscular coordination,
acoustic startle reflex, and ocular maturation processes responsible for the
achievement of these milestones were sufficiently established by P7.

Alcohol

exposure at P7 resulted in the delay of more complex coordination-dependent
milestones such as air righting and open field traversal. During the early period
of neonatal development in mice (as well as in humans), forelimb coordination
and strength develops prior to hindlimb and interlimb coordination (ALTMAN and
SUDARSHAN 1975, THELEN 1985). Given that these milestones are dependent on this
rostal-caudal gradient of limb maturation, the results suggests that ethanol
exposure may significantly delay this ability to coordinate reflexes with full limb
control. As motor development and motor learning are largely determined by the
cerebellum (ITO 2000), these delays in developmental milestone achievement
may be due to ethanol’s teratogenic effect on this brain region. Indeed, the
cerebellum matures along a protracted timeline, including a rapid period of
growth during synaptogenesis (VOLPE 2009), and has been shown to be
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exquisitely sensitive to ethanol-induced apoptosis during this period (IKONOMIDOU
et al. 2000, OLNEY et al. 2002a). This is consistent with reports of reduced
cerebellar volume in children with FASD (RILEY et al. 2004, NORMAN et al. 2009,
MEINTJES et al. 2014). Additionally, cerebellar Purkinje cells that survive third
trimester-equivalent ethanol exposure show altered GABA subunit expression,
affecting GABAergic tone of remaining neurons (DIAZ et al. 2014b). Interestingly,
delayed motor development may be indicative of cognitive performance given
that the cerebellum is also involved in higher-level cognitive processes (DIAMOND
2000, BEN-YEHUDAH and FIEZ 2008, BELLEBAUM and DAUM 2011). At the least,
neonatal developmental assessment was able to reveal consistent delays in early
postpartum milestone achievement in ethanol-treated pups, a hallmark of which
was delayed limb coordination that may be an indicator of third trimesterequivalent exposure and also, potentially, of performance at older ages on more
complex behavioural tasks.

4.1.2 Ethanol exposure during synaptogenesis results in environmentdependent hyperactivity
Hyperactivity, impulsivity, and inattention has been consistently associated with
children prenatally exposed to alcohol, with significant differences from non exposed children detectable at very young ages (BHATARA et al. 2006, NASH et al.
2008, ALVIK et al. 2013). There is further evidence that these traits show some
gender specificity, with males more likely to be diagnosed with attention
deficit/hyperactivity disorder (ADHD), a common psychiatric co -morbidity to
FASD (HERMAN et al. 2008). Literature is conflicted, however, on the effect of
prenatal ethanol exposure on locomotor activity in animal models. Depending on
animal model, ethanol dosage, and timing of administration, studies have found
hyperactivity, hypoactivity, or a lack of effect of ethanol (TRAN et al. 2000, ALLAN
et al. 2003, DOWNING et al. 2009, MARCHE et al. 2010, MANTHA et al. 2013). We have
published data supporting that the timing and method of ethanol exposure is
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critical to this phenotype, suggesting there are windows o f vulnerability (KLEIBER
et al. 2011, MANTHA et al. 2013). The results generated from the novel open field
exploration assay were subtle, and showed that individual ethanol treatments on
P4 or P7 alone did not significantly alter locomotor activity in a novel open field
arena, and that treatment on both days (P4 and P7) resulted in hypoactivation in
females only (Figure 3.2). This was contrasted by an increased number of rears
in both the P7 group and the P4+7 females. Given the increased rearing activity
and the sex-specificity of the hypoactivity in P4+7 females, it is possible that the
lack of significant effect may have been confounded by neophobia caused by
exposure to a novel environment. This was supported by the trend towards
decreased time spent in the centre zone by ethanol-treated animals (Figure 3.6),
an indicator of anxiety-associated behaviour. Consequently, I examined the
nocturnal locomotor activity of ethanol-exposed and control mice in a familiar,
home cage environment to evaluate activity in the absence of novelty-induced
stress.
The infrared Actritrack system is able to record a variety of measures related to
locomotor activity, including total number of infrared beam breaks, which
includes locomotor activity and stereotypic movement, velocity of motion,
distance travelled, and rearing behaviour. In young children and adolescents
with FASD, hyperactivity is among the most consistently-associated phenotype,
but a recent meta-analysis has also suggested impairments in balance and
coordination (LUCAS et al. 2014), which is certainly consistent with the ability of
ethanol-treated mice to achieve early developmental milestones (Table 3.1). As
such, I sought to assess the locomotor behaviour of control and ethanol-treated
mice, including changes in other activity and motor-related features captured by
the Actimeter system, over the course of the nocturnal dark cycle. Following PCA
analysis, the Actimeter measures were found to be all significantly positively
correlated with total activity (Table 3.3), suggesting that this measure could give
an adequate indication of the overnight behaviour of control and ethanol-treated
mice. Increases in activity were detected during the early part of the dark cycle in
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ethanol-treated mice, significant in mice treated at P7 and P4 and P7, suggesting
that treatment at P7 was critical to this behaviour. There is also evidence that
hyperactivity is associated with altered glutamate and GABA signalling in the
neural pathways linking the hippocampus, accumbens, and subpallidal region
(MOGENSON and NIELSEN 1984). The hippocampus and areas of the mesolimbic
pathway are particularly susceptible to ethanol exposure during the brain growth
spurt. In particular, binge-like ethanol exposure during the third trimester
equivalent results in drastic reductions of the CA1 region of the hippocampus
(OLNEY et al. 2002a) and reduced expression of numerous glutamate receptor
subunits in the adult brain (KLEIBER et al. 2013), presumably altering the efficiency
of glutamatergic synaptic transmission involving this region – a feature that is also
a hallmark of animal models of hyperactivity (JENSEN et al. 2009).
Interestingly, mice treated at P7 and P4+7 also show increased activity at the end
of the dark cycle and beginning of the light cycle (Figures 3.5, 3.6). Whereas
control mice typically show extremely low levels of activity during this period,
ethanol-exposed mice continue to remain active. Altered activity patterns during
light/dark cycling may be an indication of impairments in suprachiasmatic nuclei
control of circadian clock function (HOUBEN et al. 2014).

Prenatal alcohol

exposure is a strong predictor of sleep disturbance in children that are
characterized by frequent sleep disruption, shortened sleep duration, and
increased sleep anxiety as compared to non-ethanol exposed children (STRATTON
et al. 1996, WENGEL et al. 2011, CHEN et al. 2012). While the association between
altered activity levels during the early light cycle and circadian rhythm disruption
in this study may be speculative, it is intriguing given the strong evidence from
animal models that ethanol exposure during the third trimester-equivalent leads
to shortened sleep-wake cycles, delayed sleep onset, and delayed sleep cycle
transitions (EARNEST et al. 1997, SAKATA-HAGA et al. 2006, VOLGIN and KUBIN 2012).
These phenotypes may be attributed to a number of biological mechanisms,
including vulnerability of the suprachiasmatic nuclei to ethanol teratogenesis
leading to the dampening of BDNF rhythmicity (EARNEST et al. 1997, EARNEST et al.
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2001), reduction in serotonergic tone and neuronal density (TAJUDDIN and DRUSE
1999, SARI and ZHOU 2004), and, as reported by this study, altered mRNA levels of
serotonin receptor subunit genes, Period genes, and Cryptochome genes that
regulate Circadian function (CHEN et al. 2006a, KLEIBER et al. 2013, KLEIBER et al.
2014b). Given this biological and epidemiological data, it is evident that the third
trimester equivalent may be a window of vulnerability for phenotypes associated
with alterations in activity levels and circadian function resulting from ethanol’s
ability to target those systems governing these behaviours. While evaluating
sleep disturbance and circadian cycling was not directly assessed by this study,
evidence suggests that altered circadian function may play a role to, in the least,
exacerbate risk for other phenotypes such as hyperactivity, anxiety, and cognitive
impairments that are hallmarks of fetal alcohol exposure, and that later
gestational exposures appear to be a stronger window of vulnerability as
compared to early exposures (TRAN et al. 2000, O'LEARY-MOORE et al. 2006).

4.1.3 Ethanol exposure results in anxiety-related phenotypes
In the assessment of anxiety-related phenotypes, this study utilized three wellestablished assays that are indicative of behavioural responses to perceived
environmental stress: thigmotaxis in a novel open field, exploratory behaviour in
the light region of a light/dark box (LDB) assay, and willingness to explore a
narrow, elevated open arm of the elevated plus maze (EPM). Unfortunately, the
latter two assays became available late during the course of this study and only
the double-treatment (P4 + 7) group was able to be tested using all three assays,
but the results revealed some interesting features regarding anxiety-related
phenotypes and third trimester-equivalent ethanol exposure.
Thigmotaxic behaviour was observed in mice treated with ethanol at P7 (Figure
3.8) and at P4+7 (Figure 3.9). These data indicated that ethanol exposure during
this neurodevelopmental period may contribute to anxiety-related behaviours,
and that the severity of these behaviours may be dose-dependent. Also, they
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suggested a possible sex difference in vulnerability to anxiety-related traits. As
such, mice treated at P4+7 were also assessed in the LDB and EPM, both of which
are more anxiogenic tasks than open field exploration, to perhaps more
sensitively assess anxiety-related phenotypes related to third trimesterequivalent exposure. Interestingly, results from the LDB assay showed that while
both males and females showed a decrease in the amount of time spent in the light
region and a reduction in the number of entries into the light zone, a clear
distinction between males and females emerged with females showing
significantly less light zone exploration than their control counter parts (Figure
3.10). This trend was echoed in the EPM assay, with both males and females
showing increases in anxiety-related open arm exploration, but with females
showing a marked decrease in the time spent in the open arms and number of
open arm entries (Figure 3.11).
These findings are interesting given that maternal binge drinking during
pregnancy confers risk for adult anxiety and depressive disorders in ethanolexposed individuals (FAMY et al. 1998, BARR et al. 2006). These disorders are
frequently linked to altered hypothalamic-pituitary-adrenal (HPA) axis function,
either via altered cortisol or adrenocorticotropin (ACTH) levels, or altered
expression of HPA axis regulator genes at basal or under stressful conditions (DE
KLOET et al. 2005). Prenatal alcohol exposure is linked to hypothalamic-pituitaryadrenal (HPA) dysregulation, with heavy drinking during pregnancy associated
with higher basal cortisol levels and elevated post-stress cortisol (JACOBSON et al.
1999).

Further, the appearance of anxiety-related behaviours seems to be

dependent on timing of exposure as mice exposed to alcohol during the first
trimester-equivalent show no differences from control mice in the LDB or EPM
assays, while exposure during the second trimester equivalent leads to a decrease
in anxiety-related phenotypes (MANTHA et al. 2013). This is in contrast to the
findings of this study, which suggest that late-gestation ethanol exposure may
result in an increase in some anxiety-related phenotypes in mice.
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HPA axis hyper-responsiveness has been identified in both male and female
animal models of prenatal alcohol exposure; however, sexually dimorphic
phenotypes have also been consistently reported. The findings within this study
corroborate other reports of higher instances of anxiety-related behaviour in the
EPM in females (OSBORN et al. 1998), potentially due to higher stress hormone
reactivity in female rodents (CHOI et al. 2008). Further, Brocardo et al. (2012)
showed that prenatal alcohol exposure resulted in anxiety and depressive -like
behaviours in both male and female mice; however, only males showed an
improvement in these phenotypes following voluntary exercise. In humans, a
strong effect of sex has been reported among a sample of adults with fetal alcohol
exposure; a study by Famy et al. (1998) (FAMY et al. 1998) reported 50% of women
diagnosed with anxiety disorder co-morbidity as compared to no instances in
men. These results may be attributed to the interaction between alcohol and the
development of the HPA axis and activational effects related to gonadal hormonal
differences (VIAU and MEANEY 1991, KOFMAN 2002, KUDWA et al. 2014).

4.1.4 Ethanol exposure affects spatial learning and learning strategy
Learning deficits are a hallmark of FASD and are well-documented in human and
animal studies of prenatal alcohol exposure (COLES et al. 1991, CLARREN et al. 1992,
KODITUWAKKU 2009, MATTSON et al. 2010, BRADY et al. 2011). Human studies have
emphasized the role of impairments in “executive control” in individuals with
FASD (COLES et al. 1997, GREEN et al. 2009, MATTSON et al. 2010), which depends on
inhibition of task-inappropriate responses and a working memory of the goal. In
particular, prenatal alcohol exposure appears to affect executive function, spatial
processing, attention, and memory, with binge-like exposures more detrimental
to these processes than mild-to-moderate exposures (MATTSON et al. 2010, FLAK et
al. 2014). Given that cognitive behaviours such as learning and attention are such
a widely-reported consequence of prenatal alcohol exposure, it is important that
any animal model of the disorder replicates these phenotypes. The findings of this
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study corroborate this human literature and indicate that spatial learning is
impaired, in a timing and dose-dependent manner, in mice exposed to alcohol
during the third trimester equivalent (Figure 3.12). Ethanol treatment at P4
resulted in minor delays in reaching the target on acquisition days three and four,
whereas exposure at day 7 resulted in more severe deficits beginning at day 1 and
significantly lasting throughout days 2 to 4. This may reflect the sensitivity of
hippocampal-dependent learning circuitry to ethanol at later stages of
neurodevelopment, particularly at the peak of the brain growth spurt that occurs
postnatally in mice but during the third trimester in humans (LIVY et al. 2003,
WOZNIAK et al. 2004). This finding is consistent with other studies that suggest
that ethanol treatment at a specific neurodevelopmental window (P7) can
produce significant and enduring impairments in spatial learning (SULIK 2005,
WAGNER et al. 2014). Learning ability appeared to be susceptible to dose effects
as multiple ethanol exposures at P4+7 appeared to increase the severity of spatial
learning deficits during adulthood (Figure 3.12). These deficits may be attributed
to the effect of ethanol on learning-associated brain structures, such as apoptosis
to diencephalic structures that form the hippocampal circuit (OLNEY et al. 2002a,
WOZNIAK et al. 2004) as well as decreases in cell volume in the within CA1 and CA3
pyramidal cells and dentate gyrus neurons (LIVY et al. 2003, TRAN and KELLY 2003).
It is important to note that all mice – ethanol and saline treated alike – showed
evidence of learning in the Barnes maze task. The delayed latency to reach the
target during the later acquisition days in ethanol-treated mice may be attributed
to differences in learning strategy. This is perhaps most evident following
analysis of the type of search strategy used by ethanol and control mice during the
acquisition learning trials (Figure 3.13). Interestingly, control mice were rapidly
able to utilize extra-maze cues to learn the precise location of the target, and the
number of trials during which they utilized a “direct” search strategy, that is,
travelled directly to the target hole following release from the central starting
zone, dramatically increased during acquisition days 2 to 4. Conversely, ethanoltreated mice did not exhibit the same increase in “direct” search strategies;
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observationally, they tended to travel toward the quadrant of the maze in which
the target was placed, but often the initial hole visited was two or more holes away
from the target and they progressively searched, hole by hole, in a clockwise or
counterclockwise manner until they had located the target. This finding is
illustrated by the divergence between control and ethanol-treated animals in the
increase in “direct” search strategy in controls and the increase in “serial” search
strategy in ethanol-treated mice in later acquisition days (Figure 3.13). It is
important to note that both groups showed clear reductions in their use of a
“mixed” strategy, suggesting that, in both groups, the search for the target was not
random. However, the differences in search strategy used may indicate that
prenatal ethanol exposure may alter spatial learning acquisition styles.
The spatial learning deficits apparent during the acquisition trails were reflected
in both the short- and long-term memory recall trials on day 5 and day 12 of
Barnes maze testing (Figure 3.14, Figure 3.15). Mice treated with ethanol at P4
showed a small and non-significant reduction in explorations to the target hole
location at day 5, but treatment at P7 or at P4+7 resulted in a significant reduction
of explorations at or around the target, which was not driven by a decrease in the
total number of explorations. These trends persisted during the long-term recall
task at testing day 12. These results suggest that ethanol exposure may not only
impair learning during task acquisition, but also the ability of the mouse to recall
the relationship between the maze layout, the extra-maze cues, and the target
during spatial memory trials. Further, the increase in explorations to non -target
holes opposite the target in ethanol-treated mice may reflect the learning strategy
acquired during the acquisition phase of testing: while control mice tended to
travel back and forth remaining around the previous location of the target, the
ethanol-treated mice persisted in searching each hole on the Barnes maze
platform in a clock-wise or counter-clockwise direction, as they had during
acquisition.
There is evidence that certain types of learning occur similarly in ethanol-exposed
and non-exposed children but learning in FASD individuals is benefitted by
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increased repetition and more frequent positive reinforcement (ROEBUCK-SPENCER
and MATTSON 2004, ENGLE and KERNS 2011). Other studies have suggested that
learning and memory strategies do differ between exposed and non-exposed
children, including variations in visual versus verbal learning styles, deficits in
attention, problems with planning and spatial working memory, and deficits in
cognitive flexibility, planning, and strategy use (RASMUSSEN 2005, GREEN et al.
2009, RASMUSSEN et al. 2009). Results from this study suggest that ethanol
treatment during the third trimester-equivalent results in alterations to both
learning, memory, and overall strategy in a spatial learning task, consistent with
findings from the human studies. Also, while these findings show that prenatal
alcohol exposure does not prevent learning altogether, they do indicate that
ethanol induces changes to attention and learning style that are detectable in early
adulthood. In humans with FASD, this may establish a pattern of educational
disadvantage that, when matched with poor early environmental enrichment or
educational support that recognizes these changes to learning styles, may
ultimately lead to poor long-term educational and socio-economic outcomes
(STREISSGUTH et al. 1994, FAMY et al. 1998, JIRIKOWIC et al. 2008b).

4.1.5 Ethanol exposure during synaptogenesis in mice as a model for
human FASD: a summary
Modeling complex human disorders in animals requires careful attention to
behavioural endophenotypes commonly observed in humans with the disorder
and an appropriate choice of animal and behavioural battery that can most
accurately represent these phenotypes. Most neurobehavioural or psychiatric
disorders are extremely complex via their mode of causation, their effect on
multiple neurological pathways, and their interaction with environmental factors.
Usually, modeling them in in their entirety in animals is not possible either
conceptually or practically (e.g., (O'NEIL and MOORE 2003, O'TUATHAIGH and
WADDINGTON 2015)); however, it is possible to model smaller aspects of a larger
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phenotype, with the results to be used with caution when extending beha viours
observed in an animal model to any human disorder, particularly one that
involves changes to behavioural and cognitive phenotypes (NESTLER and HYMAN
2010b, KOOB 2012).
As compared to other neurobehavioural disorders, the causation of FASD is clear.
As such, any model involving ethanol exposure during neurodevelopment has a
certain etiological validity. In humans, however, the timing and dose of ethanol
exposure is extremely variable from case-to-case, and not likely to be accurately
reported (HANNIGAN et al. 2010, LANGE et al. 2014). It is difficult to ascertain,
therefore, the relationship between ethanol exposure and the numerous
behavioural phenotypes that may result. I thought it important that a behavioural
battery attempting to evaluate a mouse model of FASD should test a number of
relevant phenotypes reliably and with regard to the innate behaviour of mice.
The behavioural battery used in this study was designed to evaluate behaviours
that are common in humans with FASD as they appear across infanthood,
childhood, adolescence, and early adulthood within the confines of a mouse model
system. This study was the first to use a thorough evaluation of early postnatal
coordination and reflexive behaviours, given that infants with FASD often show
delays in the appearance of these behaviours. Also, this is the first behavioural
paradigm to take into account the emergence of various behavioural changes
across development and maturation. The results indicate that the analysis of early
behaviours are indeed informative, and may be predictive of later -life neuromotor and cognitive impairments. Further, single binge-like exposures during the
third trimester-equivalent were able to reliably produce changes to activity,
anxiety-related traits, and learning ability, which often were made more severe
by a subsequent second ethanol treatment. The behavioural battery is certainly
not exhaustive, and there are a number of behavioural phenotypes exhibited by
humans with FASD that cannot accurately be modeled in mice, but the results
suggest that at least some of the behaviours exhibited in humans can be replicated
by this paradigm. Also, this particular type of treatment paradigm itself may have
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limited face validity in that it is likely an uncommon practice for women to
consume a substantial quantity of alcohol only during late gestation; however, it
serves as a mechanism to evaluate the specific changes that may occur resulting
from third trimester ethanol exposure in the absence of confounding previous
exposures. Also, it serves to show that there may be temporal windows of
neurodevelopmental vulnerability of brain regions responsible for specific later life emergent phenotypes. Finally, while this thesis is focused on a third-trimester
paradigm, we have previously shown that the model developed here may be
applied to other exposure paradigms to evaluate and compare the effects of dose
and timing of exposure (KLEIBER et al. 2011, MANTHA et al. 2013).

These are

etiologically valid models that then can be used within a larger experimental and
theoretical framework to evaluate underlying biological mechanisms including
developmental trajectories of genetic and epigenetic changes that result from
neurodevelopmental alcohol exposure (KLEIBER et al. 2012, KLEIBER et al. 2013,
LAUFER et al. 2013, KLEIBER et al. 2014b, MANTHA et al. 2014b).
As a whole, the results presented suggest that this trimester three -equivalent
exposure paradigm can provide an effective model for the evaluation of
behavioural and cognitive phenotypes associated with FASD that may be
particularly vulnerable to late-gestation alcohol exposures in humans. Also, the
data suggests that this multi-phenotype behavioural battery is a useful strategy to
evaluate phenotypes that reflect a more holistic neurocognitive profile common
to human individuals prenatally exposed to ethanol. As with any model, its value
lies not only in its ability to recapitulate behaviours observed in humans, but also
if it can be used to examine the underlying biological causes of those behaviours.
This second goal forms the focus of the following sections of discussion.

143

Chapter 4. Discussion

4.2 Disruption of gene expression during neurodevelopment
by ethanol and its role in FASD
This study sought to evaluate the changes in gene expression that occur in the
developing brain acutely following a binge-like dose of ethanol during
synaptogenesis in the B6 mouse strain. These changes represent the in vivo
response within a previously naïve biological system that is highly dynamic and
acutely sensitive to the effects of ethanol. The response also represents a
discontinuity in normal developmental processes that may result in apoptosis
(IKONOMIDOU et al. 2000, OLNEY et al. 2002a, DIKRANIAN et al. 2005) or, in surviving
cells, a ‘molecular footprint’ of neurodevelopmental disruption that may persist
long past the initial ethanol insult (SANDERSON et al. 2009, PUGLIA and VALENZUELA
2010, KLEIBER et al. 2013).

The discussion below evaluates how the mRNAs

detected by array analysis of short and long-term gene expression changes
resulting from ethanol exposure may affect neurodevelopment, adult brain
function, and how they may be reflected in the cognitive and behavioural
phenotypes associated with FASD.

4.2.1.Effects of ethanol exposure on gene expression in the postnatal
brain
Ethanol is known to affect the expression of a large subset of genes in the brain
acutely following exposure (TREADWELL and SINGH 2004), including in the
developing brain (HARD et al. 2005, GREEN et al. 2007). I analyzed the effects of
ethanol exposure at P7 in mice, a time neurodevelopmentally equivalent to the
human third trimester, and known to be particularly sensitive to ethanol (OLNEY
et al. 2002a).

The 315 transcripts affected acutely (4h) following ethanol

exposure (Appendix A) were categorized into broader biological functions and
gene networks, identifying over-represented affected molecular processes. The
genes differentially expressed between control and ethanol-treated mice and the
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associated biological processes were perhaps unsurprising given that the ethanol
insult occurred at such a vulnerable developmental time for synapse formation
and neuronal pruning (DOBBING 1974).

The ability of ethanol to affect the

expression of ionotropic glutamate receptor subunits likely has some impact on
excitotoxic cell death triggered by abnormal glutamate signaling. Not all cells,
however, succumb to cellular death; many of the identified changes to the
transcriptome were certainly categorized by an acute stress r esponse, but there
appeared to be a precarious balance between cell death and survival cues,
including alterations to genes associated with cell cycle signaling, cell
proliferation and maturation, neurotransmitter signaling, cell membrane
integrity, and protein modification.

4.2.1.1

Acute stress response, apoptosis and cell survival

Up- and down-regulated gene lists were separated and subsequently submitted
as two gene groups to DAVID for over-represented biological functions, which
allowed for the evaluation of processes that may be activated or inhibited by
ethanol exposure.

Up-regulated transcripts were strongly associated with

‘positive regulation of apoptosis’ and ‘cell death and survival’ (Table 3.5, 3.6).
These results corroborate physiological evidence that this binge-like ethanol
treatment at synaptogenesis results in wide-spread cell death across the cortex,
hippocampus, cerebellum, and other brain regions (OLNEY et al. 2002a, WOZNIAK
et al. 2004, DIKRANIAN et al. 2005). A number of GO annotations and genes present
within these annotations suggest a series of events by which ethanol may trigger
this apoptotic response, including a number of stress-related mechanisms.
Several

studies

have

shown

that

ethanol

exposure

during

rodent

neurodevelopment, particularly during the early postnatal period, can interfere
with a number of neurotrophic factors (HEATON et al. 2000b, CLIMENT et al. 2002,
MOORE et al. 2004) that play key roles in neuronal survival and maturation
including normal apoptosis of cells during brain maturation (KIRSTEIN and FARINAS
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2002, LYKISSAS et al. 2007). The results from this study corroborate these findings,
with a number of pro-survival and pro-maturation factors growth and
transcription factors showing down-regulation, including Etv4, E2f4, Egr3, Egr4,
and Tgfb3, Vegfa (Table 3.5, 3.6). Other studies using early postnatal ethanol
exposure paradigms have also implicated the nerve growth factor receptor
tropomyosin receptor kinase A (TrkA), brain-derived neurotrophic factor (Bdnf)
and its receptor TrkB, nerve growth factor (Ngf), and the neurotrophin p75
receptor (HEATON et al. 2000b, HEATON et al. 2003, TOESCA et al. 2003). These
molecules have well-established roles in multiple developmental processes and
their reduced expression may alter the maturation of neurons, extent of dendritic
branching, synapse formation, and neuronal plasticity (RUZHYNSKY et al. 2007,
ROSENSTEIN et al. 2010, PEREZ-CADAHIA et al. 2011). Alterations in levels of survival
factors can alter the signaling function of cell survival pathways, including
mitogen-activated protein kinase (MAPK/ERK) and phosphoinositide 3kinase/protein kinase B (PI3K/AKT) pathways, which is associated with
increased levels of apoptosis in the developing cortex (CLIMENT et al. 2002).
It is interesting that a number of up-regulated transcripts associated with ‘protein
amino acid dephosphorylation’ and down-regulated transcripts under the
annotation ‘MAP kinase phosphatase activity’ (Table 3.5) are dual-specificity
phosphatase (Dusp) genes. A number of these genes are present in the genome,
each with different target specificity, cellular, and tissue localization, and are
rapidly activated in response to oxidative stress or growth factor signa ling
(induced as early response genes). They function to inactivate various MAPK
isoforms, negatively regulating cellular proliferation (reviewed in (LANG et al.
2006)). The regulation of Dusp genes is somewhat gene-dependent, with Dusp
genes acting through the inhibition of the MAPK/ERK pathway, the mammalian
target of rapamycin (mTOR) pathway or both (BERMUDEZ et al. 2008, LAWAN et al.
2011, RASTOGI et al. 2013). An increase in transcription in some Dusp genes and a
down-regulation of others suggest a fast-acting induced response to cellular
stress that may indicate a balance between pro- and anti-apoptotic pathways to
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decide cell fate. Further, the abnormal increased or decreased presence of these
genes may also affect the regulation of other genes via epigenetic mechanisms, as
they have also been shown to have the ability to alter histone phosphorylation
states (LAWAN et al. 2011).

The simultaneous up- and down-regulation of

members of this gene family may mediate a balance between pro-survival and
pro-apoptotic signaling through the activation and deactivation of specific MAPK
signaling pathways.
Cellular stress response leading to cell cycle arrest and potential cell death via
MAPK/ERK and PI3K/AKT/mTOR pathways is also indicated by the up-regulation
of the p53 pathway-associated proteins Jun proto-oncogene (Jun), PERP, TP53
apoptosis effector (Perp), and Junction-mediating and regulatory protein (Jmy).
The p53 pathway may be initiated by both oxidative and osmotic stress, both of
which are induced in the developing brain by high doses of ethanol (GOLDSTEIN
1986, BROCARDO et al. 2011). Jun is an immediate early gene (IEG) canonically
associated with the p53 pathway, but may act as a pro-apoptotic or pro-survival
cue, depending on other signals present in the cell (HUGHES et al. 1999, SCHREIBER
et al. 1999). However, Perp is expressed in a p53-dependent manner at high levels
in apoptotic cells (ATTARDI et al. 2000), while Jmy, a p53 cofactor, has been shown
to be a negative regulator of neuritogenesis (FIRAT-KARALAR et al. 2011) (Table 3.7)
and has also been identified by array analysis of gene expression changes
associated with trimester two-equivalent ethanol exposure (MANTHA et al. 2014a).
Also indicative of changes in MAPK and PI3K/AKT signaling is the up-regulation
of Forkhead transcription factor Foxo3, which has been shown to be involved
oxidative stress-induced apoptosis in mouse neurons (Table 3.5, 3.6).

In the

neonatal mouse brain, the expression and apoptotic function of Foxo3 is
associated with Jun N-terminal kinase 3 activity (PIRIANOV et al. 2007),
phosphorylation and activation of Jun and, interestingly, has recently shown to be
exerted via its association with histone deacetylase 2 (Hdac2) (PENG et al. 2015).
While Hdac2 was not identified in this study, the expression of Hdac1 and Hdac9
were found to be down-regulated. Given the sequence similarity of Hdac family
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genes, it is likely that Forkhead transcription factors may also be regulated by
other Hdac molecules. In support of this, Hdac1 was found to be sufficient to
activate Forkhead family transcription factors and trigger apoptosis associated
with muscle fiber atrophy (BEHARRY et al. 2014).
While the genes identified in this study represent a snap-shot of gene response
four hours following a binge-like dose of ethanol across the multitude of cell types
found in whole brain tissue, it is clear that ethanol triggers a strong cellular stress
response in the postnatal brain that likely involves a number of pathways.
Further, there appears to be changes to molecules associated with both pro survival and pro-apoptotic cues. Overall, these results support other studies
reporting that ethanol exposure during this early neonatal period instigates an
acute stress response that leads to apoptotic neurodegeneration in a large
number of brain regions (IKONOMIDOU et al. 2000, OLNEY et al. 2002a). Also, these
results suggest that a number of cells that undergo this stress response and
experience an interruption to normal developmental processes, but do not
succumb to apoptosis. It is these cells that form the foundation for further
neurodevelopment.

4.2.1.2

Maintenance of cell viability

A number of altered transcripts may be functionally grouped as having an
association with the maintenance of cell integrity, including an up-regulation of
‘integral to membrane’-associated transcripts and the down-regulation of
notoriously energetically costly processes, such as ‘ribosome biogenesis’, ‘mitotic
cell cycle’ progression, ‘cellular growth and proliferation’, and ‘regulation of
transcription’ (Table 3.5, 3.6). While ‘integral to membrane’ is a fairly broad Gene
Ontology classification and the transcripts identified within this group play
numerous roles with regard to their association to membrane dynamics, cell
membrane composition can strongly affect the function of intrinsic membrane
proteins.

High alcohol concentrations have been shown to force the
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transmembrane proteins into unfavorable conformations affecting the chemical
and physical functioning of the cell, including at synaptic plasma membranes
(AVDULOV et al. 1994). In support of this, a number of up-regulated genes are
involved with the maintenance of cell membrane-associated molecules such as
oligosaccharides

and

cell-surface

carbohydrates

(Bgalt3,

St6gal1),

phosphatidylinositol (Pigm, Pigv, Pik3ip1, Itprip2), sphingosine (Acer2), and
aminophospholipids (Atp8b2). Coinciding with this, the up-regulation of genes
associated with glycosylation (Table 3.5) may be related to reinstating membrane
integrity as glycoproteins are developmentally integral to cell membrane stability,
cell-cell recognition and interaction (KLEENE and SCHACHNER 2004), as well as
regulating excitatory synapse development and modulation of synaptic efficacy
(DE WIT et al. 2013). These findings agree with previous reports that ethanol
targets glycosylation machinery (TOMAS et al. 2002).
Conversely, the down-regulation of genes associated with ribosome biogenesis
may also be a response to re-direct cellular energy to stress response and cell
survival mechanisms. The synthesis of ribosomal protein mRNAs requires a large
proportion of the cell’s energy, and is balanced by the growth requirements of the
cell, and is regulated by nutrient availability, cell cycle, and cell stress (THOMAS
2000, MOIR and WILLIS 2013).

Similarly, down-regulation of cell cycle

progression, proliferation, and differentiation-associated transcription factors,
growth factors, and cyclins may provide a comparable function (Table 3.5, 3.6,
3.7) and act to halt developmental processes to deal with the acute cellular insult.

4.2.1.3

Neurotransmitter signaling systems

In addition to the prominent effect of ethanol on cell survival and stress response
mechanisms, a number of transcripts were identified that, while they may have
roles in cellular stress, also have demonstrated roles in neurodevelopment and
have been implicated in long-term risk for neurological disorders. Particularly
notable is alteration of genes associated with major excitatory and inhibitory
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neurotransmitter systems, including glutamate and γ-aminobutyric acid signaling
(Table 3.5, 3.6; Figure 3.17). Among the genes affected by ethanol treatment were
Cpeb1, Gabra5, Grin2a, and Grin2b all of which are canonically critical to synaptic
formation and maintenance (Table 3.6). Cpeb1 regulates translation at synapses
and reduced or elimination of expression during development results in poor
synaptic efficacy leading to reduced long-term potentiation (ALARCON et al. 2004)
and, in adulthood, rapid extinction of hippocampal-dependent spatial learning
memories (BERGER-SWEENEY et al. 2006). Cpeb1 protein is activated in response to
N-methyl-D-aspartate ionotropic (NMDA) glutamate receptor stimulation to
facilitate activity-dependent gene transcription (WELLS et al. 2000). Further,
during early postnatal development, the formation of functional circuit formation
is dependent on the synchronous activity of depolarization of GABA A receptors
and activation of NMDA receptors (WANG and KRIEGSTEIN 2008, CSEREP et al. 2012).
In this study, γ-aminobutyric acid (GABA) A receptor, subunit alpha 5 (Gabra5),
glutamate receptor, ionotropic, NMDA2A (epsilon 2) (Grin2a), and Grin2b
transcript levels were identified as altered following ethanol exposure, with
Gabra5 down-regulated and the glutamate subunits up-regulated (Table 3.5, 3.6)).
While these genes are associated with the major inhibitory (GABA) and excitatory
(glutamate) neurotransmitter systems in the adult brain, it has also been
established that they play key roles in the neurodevelopmental patterning of
synaptic networks (LUJAN et al. 2005). Both NR2A, encoded by Grin2a, and NR2B,
encoded by Grin2b are modulatory NMDA receptor subunits, with Grin2a widely
expressed in the postnatal brain and Grin2b expressed in multiple regions
embryonically, but restricted to the forebrain during postnatal stages (LUJAN et al.
2005), the transition of which occurs during synaptogenesis (YASHIRO and PHILPOT
2008).

NR2B-containing receptors are important for circuit formation and

establishment, and the developmental switch to NR2A-containining receptors
results in excitatory postsynaptic currents with a more rapid decay (VAN ZUNDERT
et al. 2004). It is possible that the up-regulation of both Grin2a and Grin2b
modulatory subunits may alter the sensitivity of developing synapses,
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contributing to abnormal synapse formation and arborization, as well as (in some
cells) excitotoxic cell death.

Other studies have shown that the subunit

composition

NR2B)

(NR2A

versus

of

NMDA

receptors can

control

neurodevelopmentally-critical processes such as dendritic spine motility, synapse
formation and stabilization (GAMBRILL and BARRIA 2011). The Gabra5 subunit is
expressed in the brain throughout pre-and postnatal development (KILLISCH et al.
1991). The coincident down-regulation of inhibitory neurotransmitter receptor
subunit Gabra5 and the up-regulation of excitatory neurotransmitter receptor
subunits Grin2a and Grin2b suggest that ethanol exposure during the third
trimester-equivalent may lead to general over-excitatory signaling within the
developing brain. This would have broad effects on multiple brain regions, given
that role of NMDA and GABA receptors in the formation, maturation, and pruning
of synapses has been well-established (BOLTON et al. 2000, COHEN-CORY 2002, LUJAN
et al. 2005, CSEREP et al. 2012). Disruption of regulatory control of subunit
expression by ethanol at this developmental stage has potent consequences for
neural network connectivity, consequently affecting brain function not only
acutely but establish an abnormal foundation for adult cellular communication
and plasticity (MALENKA and BEAR 2004), a crucial impairment associated with
prenatal alcohol exposure.

4.2.1.4

Hormone signaling and endocrine system development

The DAVID analyses identified hormone activity and hormone receptor activity as
biological functions with a significantly over-represented proportion of altered
transcripts (Table 3.5), most of which were significantly down-regulated
following ethanol exposure. These genes included Adcyap1 and Pomc, as well as
Nuclear receptor subfamily 4, group A, member 1 (Nr4a1), Nuclear receptor
subfamily 0, group B, member 1 (Nrob1) and Retinoid X receptor gamma (Rxrg).
These genes play varying roles in the development of the brain, most notably in
the proper function of the HPA axis (VAZQUEZ 1998) including altered stress
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reactivity, a consistent endophenotype associated with fetal alcohol spectrum
disorders (HELLEMANS et al. 2008, WEINBERG et al. 2008, HELLEMANS et al. 2010). It
is possible that this period of neural development is critically susceptible to
molecular changes that affect HPA connectivity and maturation, leading to stress
vulnerability in prenatally-exposed adolescents and adults (WEINSTOCK 2010).
The down-regulation of Nr4a1 is interesting given that it is able to mediate both
pro- and anti-apoptotic effects (LI et al. 2006), as well as mediating thyrotropinreleasing hormone stimulation within the pituitary (NAKAJIMA et al. 2012). Also
relevant to HPA axis function is the reduced expression of Rxrg. This gene is part
of the family of retinoic acid receptors that mediate the anti-proliferative effects
of retinoic acid and act as ligand-dependent transcriptional regulators (DAWSON
and XIA 2012). These results follow other studies that have implicated retinoic
acid signaling in the effects of prenatal alcohol exposure (GRUMMER and ZACHMAN
1995, KANE et al. 2010, KUMAR et al. 2010), the reduced expression of which can
delay cellular differentiation and myelination (HUANG et al. 2011), most notably in
the HPA axis structures but also in the cerebellum and hippocampus, affecting
developmental and behavioural phenotypes (LU et al. 2001).

4.2.1.5

Gene network interactions highlight the impact of ethanol on
stress response and neurotransmission

In addition to functional classification and grouping of the transcripts identified
as altered following ethanol exposure at P7, the genes were also assessed for
known interactions to provide further information for how these genes may
interact to regulate each other, and via which other molecules and pathways.
Figures 3.17, 3.18 and 3.19 represent significant networks identified by Ingenuity
Pathway Analysis™ and the findings from these analyses reinforced the
involvement of the cellular processes identified by the functional annotation
clustering results in the acute transcriptional response to ethanol. It is evident
that ethanol exposure results in a cellular stress response through the up 152
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regulation of key effector molecules such as Jun and its interactions with Duspfamily genes, and the mitochondria-associated apoptosis regulator Bcl2l11
(Figure 3.17). These genes are central modulators of oxidative stress -related
neuronal apoptosis, a process which includes the Wnt and Akt pathways that act
on downstream effectors such as Forkhead family transcription factors and Bclfamily genes (CHONG et al. 2005) (Figure 3.17). This analysis also indicated the
complex balance of factors that act to direct or halt cell growth and proliferation,
such as the down-regulation of the tumor suppressor transcription factor Klf6 and
coincident down-regulation the Etv4, a transcriptional activator that acts to drive
cell proliferation. Similarly, cell cycle arrest is indicated by the up-regulation of
Btg2, an antiproliferation protein that interacts with NGF to regulate G1/S cell
cycle transition via the down-regulation of cyclin Ccnd1 (MONTAGNOLI et al. 1996,
GUARDAVACCARO et al. 2000); however, the steroid-thyroid hormone and retinoid
receptor Nr4a1 can act as a powerful instigator of programmed cell death (MOLL
et al. 2006), but was found to be down-regulated.
Network analysis also highlighted the role of factors affecting cellular growth and
tissue morphology in ethanol response (Figure 3.18), including the up-regulation
of growth factor Tgfb3, which appears to act as a hub molecule linking other
altered growth factors such as Vegfa, insulin-like growth factor (Igf) family genes,
and implicating interleukin and MAP kinase molecules in Jun-associated cellular
stress response.

We have previously reported that trimester two -equivalent

ethanol exposure results in an inflammatory response, including an alteration to
the expression of interleukin genes (MANTHA et al. 2014b). The expression of
interleukin 15 has also been implicated as having a role in neural stem cells and
differentiating neurons, and that down-regulation may increase microtubuleassociated protein 2 (Map2) protein levels to support neurite outgrowth (HUANG
et al. 2009).
Also included in this network are genes associated with HPA axis development
and function, including a down-regulation of Pomc and Adcyap1 (Figure 3.18).
Pomc is a polypeptide hormonal precursor that yields multiple biologically active
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peptides such as corticotrophin, α-melanotropin, and β-endorphin, with diverse
functions. Early postnatal reductions of Pomc, including those associated with
ethanol exposure, is associated with apoptosis, altered Circadian regulation, and
altered stress reactivity in later-life (CHEN et al. 2006a, GREENMAN et al. 2013,
AGAPITO et al. 2014, LIU et al. 2014). Adcyap1 is also a secreted peptide that is
further processed into a number of neurologically active molecules. Evidence
from Adcyap1-null mice suggest that reductions in Adcyap1 signaling plays an
important role in neurodevelopmental-associated psychiatric behaviours such as
altered psychomotor behaviour, stress response, memory, ethanol sensitivity, and
circadian rhythm (HASHIMOTO et al. 2006, YAMADA et al. 2010). The alteration of
these HPA axis-associated genes by ethanol may be directly related to the altered
expression of growth factors, cytokines, and interleukins, given that these
molecules can act to affect HPA axis gene expression and function (DUNN 2000).
Though the precise impact on long-term phenotype is speculative, it is evident
that the cellular stress response triggered by a binge-like dose of ethanol has
consequences for the development of brain regions that are sensitive to cellular
stress-associated molecules, leading to long-term changes to the architecture of
brain circuits and setting up the physiological basis for long-term changes to
behavioural phenotypes.
Network analysis also highlighted the prominent role of glutamate signaling and
NMDA receptor expression in the acute response to ethanol at P7 (Figure 3.19).
Up-regulation of Grin2a and Grin2b may be a response to ethanol’s ability to act
as a NMDA receptor antagonist, and an attempt to curb the excitotoxic response
in developing cells in a number of regions within the postnatal brain (IKONOMIDOU
et al. 1999). However, this analysis also indicated the interaction between
glutamate receptor subunit genes and other biological processes. Of note are the
interaction of Grin genes with Tubb6, a tubulin isoform, through Dlg4. Increases
in Tubb6 expression can profoundly destabilize microtubules and block cell
proliferation (BHATTACHARYA and CABRAL 2004), suggesting that the downregulation may help stabilize microtubule formation that support axonal
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branching and synapse formation occurring during this developmental stage.
This is supported by observations that prenatal alcohol exposure increases
neurite branching in the cerebellar macroneurons (ZOU et al. 1993) and
disorganized dentritic morphology in the medial prefrontal cortex (LAWRENCE et
al. 2012). This network also outlines the potential interaction between glutamate
receptor up-regulation and the up-regulation of the Circadian rhythm pacemaker
gene Per1 through huntingtin (Htt) as well as down-regulation of histone
deacetylase 1 (Hdac1) via survival of motor neuron genes Smn1/Smn2 (Figure
3.19).

Given that regions of the hypothalamus are extremely vulnerable to

apoptosis caused by ethanol’s ability to block NMDA receptors during the
postnatal period (IKONOMIDOU et al. 2000), it is logical ethanol exposure at this time
may also affect genes expressed within the suprachiasmatic nucleus such as
Period genes. However, it is likely that the up-regulation of Per1 is associated with
its roles in cellular stress and rather than its canonical circadian clock function:
Per1 mRNA is a target for the unfolded protein stress response, which can be
induced by ethanol-associated oxidative stress, and increasing its expression is
associated with increased cell survival and reduced tumorigenesis in certain
carcinomas (PLUQUET et al. 2013).
The gene network analysis of genes acutely altered in the brain of mice treated
with ethanol at P7 further reinforced the findings of the functional annotation
analysis, and a summary of genes and processes implicated in this ethanol
response are further highlighted following a merging of these individual gene
networks (Figure 3.20). The major gene hubs may be categorized into two main
functions: stress response and apoptosis, and cellular signaling and interaction.
These functions are certainly not disparate, as evidenced by the substantial
interaction between all molecules, and a number of these genes play critical roles
during synaptogenesis. The most prominent hub gene appears to be Jun, which
appears to serve as a mediator between numerous growth factors (such as Gh1,
Ngf, Tnf, Tgfb, and Vegf), early growth response (EGR) genes, apoptosis-associated
molecules (such as Bcl2l11), and a variety of developmentally-important
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transcription factors (such as Sp1 and Foxo3).

Related both to ethanol

excitotoxicity and synaptic transmission are the marked up-regulation of
glutamate receptor subunit genes (Grin2a, Grin2b), suggesting that ethanol
exposure at P7 may alter the balance of excitatory neurotransmission that is
extremely

critical

for

synaptic

stabilization

and

pruning

at

this

neurodevelopmental stage. Finally, an interesting relationship emerged between
HPA axis-associated genes Pomc, Adcyap1, and Nr4a1, all of which were downregulated. Given their modulatory roles in HPA axis development and function,
their responsiveness suggests that the developing HPA axis is particularly
vulnerable to trimester three-equivalent ethanol exposure.

4.2.2.

Effects of ethanol exposure on gene expression in the adult
brain

In addition to examining the gene expression profile immediately following
ethanol exposure during the trimester three-equivalent, an investigation into the
effects of neurodevelopmental ethanol exposure on adult gene expression became
intriguing given the observed long-term behavioural effects exhibited by
adolescent and adult mice. It is clear that some developing cells succumb to
ethanol-induced apoptosis (OLNEY et al. 2000); however, some cells encounter
teratogenic adversity and undergo molecular adaptation, and form the foundation
for further brain development.

These surviving cells then undergo further

mitosis, differentiation, migration, and establish synaptic connectivity to form the
final cellular network of the mature brain. These cells that survive represent a
population

that

must

reinitiate

neurodevelopment and

adjust

their

developmental trajectories to recoup, at least somewhat, the functionality of those
cells that are lost. These cells must do so within a relatively limited amount of
time, via alterations to gene expression patterns. These expression changes may
represent an adaptive response, involving the reorganization of gene expression
in surviving cells undergoing development. These changes set up a pattern of
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long-lasting genomic dysregulation that can be detected in the adult brain, long
after the cessation of alcohol exposure. This analysis was performed to examine
how this interruption to developmental cues during the third trimester equivalent may lead to an altered pattern of gene expression and genomic
regulation that may be persistent throughout the lifetime of the individual
(Appendix B). Also, it facilitates the evaluation of those biological processes that
remain affected in the adult brain of mice exposed to ethanol during
neurodevelopment that may contribute to the persistence of altered brain
function, resulting in long-term cognitive and behavioural phenotypes that are
observed in individuals with FASD.

4.2.2.1

Glutamate-associated synaptic neurotransmission

The expression differences identified in the adult brain were much more subtle
than the acute ethanol response and biased heavily towards a significant downregulation of transcripts (Appendix B). Gene ontology functional annotation of
these transcripts showed some similarities to the short-term analyses,
particularly with respect to the number of transcripts associated with glutamateassociated neurotransmission and synaptic function (Table 3.8). A large number
of glutamate receptor subunits showed altered expression, including both
metabotropic and ionotropic type members of the glutamate receptor family. It is
interesting that exposure to ethanol during synaptogenesis has such a long-lasting
effect on glutamate receptor expression, given that regulation of subunit
expression can greatly impact synaptic function, plasticity, and maintenance
(AAMODT and CONSTANTINE-PATON 1999, CLINE and HAAS 2008, YASHIRO and PHILPOT
2008). This analysis indicates that not only can ethanol alter glutamate-based
regulation of developing neurons, including during initial synapse establishment,
but that alterations to this process have long-term repercussions on adult
glutamate receptor subunit expression and, likely, glutamate neurotransmission.
Gene ontology, Ingenuity® biological annotation clustering, and Ingenuity ®
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canonical pathway analyses all identified

glutamate receptor

activity,

neurotransmission, and signaling as the most significant biological process overrepresented among altered transcripts (Table 3.8, 3.9, 3.10), suggesting that
altered glutamate signaling may be among the most pervasive long-term
consequences of ethanol exposure during synaptogenesis. The implications of
this with regard to behavioural phenotypes is likely quite broad given that
glutamate is the predominant excitatory neurotransmitter in the mammalian
brain (HAYASHI 1954), and altered glutamate signaling has been implicated in a
number of cognitive and psychiatric phenotypes. Reduced brain volume and
connectivity in cortical and limbic regions, and consequently reduced
glutamatergic signaling, underlie the “neuroplasticity hypothesis” of anxiety and
mood disorders (PRICE and DREVETS 2010, DUMAN and AGHAJANIAN 2012). Given
that regions such as the prefrontal cortex and the limbic system are vulnerable to
ethanol-induced apoptosis, particularly during the third trimester-equivalent
(IKONOMIDOU et al. 2000), the reduction in brain volume and dendritic
reorganization observed in individuals with FASD could contribute to reduced
glutamate signaling in the adult brain. Also, interference with the developmental
and functional properties of synapse formation is likely to lead to the formation
of abnormal brain circuits and contribute to complex behavioural phenotypes, as
has been observed in schizophrenia and autism spectrum disorders (SIGURDSSON
et al. 2010, CANITANO 2014).
In addition to reduced brain volume as a potential cause for reduced glutamate
receptor expression, other molecules that impact the stability of synapse
formation, maintenance of synaptic strength, and synaptic plasticity were also
found to be affected in the adult brain of ethanol-exposed mice. These include
membrane receptors such as ephrins Ephb1, Efnb2, and Efna5 (Table 3.10), which
are critical to axon guidance and target recognition during the formation of
dendritic spines (FLANAGAN and VANDERHAEGHEN 1998), as well as drive NMDAtype glutamate receptor clustering and enhance NMDA receptor calcium influx
(DALVA et al. 2000, TAKASU et al. 2002). Ephrin receptors are therefore important
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for NMDA-dependent synaptic plasticity and long-term potentiation, and a
reduction in the expression of these genes may imply reduced dentritic spine
density and reduced glutamate receptor clustering on remaining synapses.
Studies have indicated that mice lacking Ephb1 expression also show fewer
hippocampal neural progenitor cells and abnormal positioning of CA3
hippocampal pyramidal neurons (CHUMLEY et al. 2007), which has implications for
performance on learning and memory tasks – a phenotype frequently associated
with prenatal alcohol exposure and an impairment observed in adult mice treated
with ethanol within this study.
Other genes of note associated synaptic function are Cacna1c and the postsynaptic
density proteins Syngap1 and Syngr1, all of which were also found to be downregulated (Table 3.8). Cacna1c encodes a subunit of a voltage-dependent calcium
channel that has been identified by unbiased genome-wide association studies as
a risk gene in multiple psychiatric disorders (BHAT et al. 2012, YOSHIMIZU et al.
2015). Animal studies have shown that hippocampal and forebrain-specific
knock-out of Cacna1c in mice results in a severe impairment of NMDA-receptorindependent spatial memory and long-term potentiation, leading to a decrease in
MAP/ERK signaling and a sustained reduction in CREB-dependent transcription
(MOOSMANG et al. 2005). CREB signaling has a well-documented role in neuronal
plasticity and long-term memory formation (SILVA et al. 1998, WON and SILVA
2008), and was identified by this study as an over-represented canonical pathway
associated with transcripts altered in the adult brain (Table 3.10). Consistent with
this, Cacna1c knockout animals exhibit deficits in hippocampus-dependent spatial
learning and memory in maze testing paradigms (WHITE et al. 2008).
Syngap1 is a neuron-specific Ras-GTP activating protein that is expressed in
glutamatergic neurons and is highly enriched at excitatory synapses where it co localizes with postsynaptic density proteins and NMDA receptors to regulate
excitatory synaptic function and dendritic spine size (KIM et al. 1998, CLEMENT et
al. 2012). Altered expression or function of Syngap1 has been identified in
numerous whole-genome studies evaluating the contribution of DNA variants to
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neurodevelopmental psychiatric disorders including as autism, schizophrenia,
and intellectual disability (KREPISCHI et al. 2010, HAMDAN et al. 2011a, HAMDAN et
al. 2011b, RAUCH et al. 2012, STEFANSSON et al. 2014). Further, reductions in
Syngap1 expression has a multitude of pathological consequences on the
dynamics and structure of postsynaptic structures that guide not only the initial
development of cortical circuitry, but that also provide the foundation for synaptic
plasticity associated with learning (ACETI et al. 2015). Syngap1 was not identified
as acutely altered following ethanol exposure, raising the question of whether
changes in its expression in a mature brain can have a significant impact on
synaptic function, or if the effects of abnormal Syngap1 expression are restricted
to neurodevelopment. Interestingly, reductions in Syngap1 expression initiated in
adulthood using a Cre/loxP knockout resulted in disorganized glutamatergic
receptor localization and a decline in spontaneous excitatory currents.
Phenotypically, this resulted in impairments in spatial recognition memory and
elevated spontaneous locomotor activity in an open field assay (MUHIA et al. 2012),
suggesting that reduced Syngap1 expression in the adult brain of mice exposed to
ethanol during the third trimester-equivalent may contribute to the observed
deficits in spatial learning and memory tasks (Figure 3.12, 3.14).
Similarly, Syngr1 encodes a membrane protein that is abundant in presynaptic
vesicles (WIEDENMANN and FRANKE 1985) and is a candidate susceptibility gene for
psychiatric disorders such as schizophrenia and bipolar disorder (VERMA et al.
2005, IATROPOULOS et al. 2009). While the specific function of Syngr1 is not
completely elucidated and it may have a redundant function with other
synaptogyrin and synaptophysin proteins (MCMAHON et al. 1996), it has been
linked to impairments in long term potentiation and synaptic plasticity without
being directly related to the probability of presynaptic neuro transmitter release
(JANZ et al. 1999).
It is clear that ethanol exposure during the third trimester -equivalent in mice
leads to long-term alterations to glutamate neurotransmission systems.
Alterations to glutamate signaling has profound implications to brain structure
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and function, particularly within cortical and hippocampal structures, and could
certainly explain a number of phenotypic observations such as impaired learning
and memory and changes to locomotor behaviour. Interestingly, these extensive
changes to glutamate receptor subunit and associated gene expression seems to
be specific to third trimester-equivalent exposure as these genes were not
identified as altered in the adult brain of mice treated during the first or second
trimester equivalent (KLEIBER et al. 2013). This suggests that altered glutamate
neurotransmission and synaptic function is an important consequence of
exposure at this developmental stage, with long-term and broad consequences to
neurological function.

4.2.2.2

Retinoic acid signaling

A number of gene clustering and functional annotation analyses identified an
over-representation of transcripts with roles in both retinoic acid and folate associated processes. The importance of vitamin A and its derivative retinoic acid
to the developing brain is well-established (ROSS et al. 2000), and numerous
studies have implicated disruptions to retinoic acid signaling in fetal alcohol
spectrum-associated cognitive and physiological abnormalities (GRUMMER and
ZACHMAN 1995, KANE et al. 2010, KUMAR et al. 2010). Retinoid signaling is also
important for aspects of adult brain function, however, and its disruption may
impact the regulation of a number of neuronal genes. Genes known to be
responsive to retinoic acid include transporters, metabolic enzymes, receptors,
and signaling molecules associated with acetylcholine, dopamine, glutamate, and
GABA, as well as oxytocin, nerve growth factor, neural cell adhesion molecule, and
apolipoprotein E (reviewed in (LANE and BAILEY 2005).
The genes identified as down-regulated in the adult brain were specifically
associated with retinoic acid-mediated apoptosis pathways (Table 3.9, 3.10). The
pleiotropic actions of retinoic acid are mediated through retino ic acid receptors
or retinoid X receptors, and both retinoic acid receptor, beta (Rarb) and retinoid X
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receptor, beta (Rxrb) were found to be down-regulated in the adult brain of mice
treated with ethanol during synaptogenesis. These genes are members of the
steroid/thyroid hormone superfamily of transcriptional activators and act as
ligand-dependent transcription factors. Upon binding to retinoic acid, they are
able to alter the expression of a large number of genes including those associated
with cell cycle arrest and apoptosis (BASTIEN and ROCHETTE-EGLY 2004). Retinoic
acid can trigger apoptosis through the increased expression of interferons and
TNF-related apoptosis inducing ligands (TRAILs), which bind to their associated
death receptors leading to the recruitment of Fas (Tnfrsf6)-associated death
domain (Fadd) that serves as a molecular bridge to Caspase 8, initiating caspasemediated mitochondrial apoptotic processes (NOY 2010).

Consistent with

evidence that ethanol exposure disrupts retinoic acid signaling is the reduced
expression of a number of genes involved in this pathway in addition to the
retinoic acid receptors, including interferon regulatory factor 1 (Irf1), Fadd, Tumor
necrosis factor (ligand) superfamily, member 10 (Tnfsf10) (which, when bound to
TRAIL protein receptors, can recruit Fadd), and caspase 3 (Casp3). It is interesting
to hypothesize how ethanol exposure during the third trimester -equivalent can
lead to such an extensive footprint on adult retinoic acid signaling pathways, but
it may be a result of ethanol’s ability to alter neurodevelopmental retinoic acid
signaling through a variety of mechanisms, including mobilizing hepatic retinol
stores, altering enzyme activity including its ability to compete as a substrate for
alcohol dehydrogenase and acetalydehyde dehydrogenase, changing retinoid binding protein expression, or disrupting retinoic acid receptors (GRUMMER and
ZACHMAN 1995, DUESTER 1996, LIU et al. 2002). Regardless, adult deficiencies in
retinoic acid signaling and, specifically, reduced retinoic acid receptor expression,
is associated with synaptic efficacy including impaired hippocampal long-term
potentiation and long-term depression of synaptic function (CHIANG et al. 1998).
Hippocampal long-term potentiation was found to be absent in mice lacking Rarb,
suggesting a specific role of Rarb-containing receptors in learning and memory
formation. Reduced expression of this retinoic acid receptor isoform may have a
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role in the learning deficits observed in adult mice exposed to ethanol during
synaptogenesis.
4.2.2.3

Folate metabolism

A number of transcripts altered in the adult brain were associated with folate
metabolism and the ‘one carbon pool by folate’ canonical pathway (Table 3.8,
3.10). Folate is a B-vitamin that acts as an enzyme cofactor that chemically
activate 1-carbons, which are required for the synthesis of purine and thymidine
nucleotides, and for the remethylation of homocysteine to methionine.
Methionine can be used for protein synthesis or also adenosylated to S adenosylmethionine (SAM) that acts as the major methyl donor for numerous
processes including the methylation of proteins such as histones and cytosine
bases within DNA (SELHUB 2002).

The genes identified as altered by

neurodevelopmental ethanol exposure play a role in the metabolism of folate into
molecules that are used in both DNA repair and DNA methylation processes. The
enzyme thymidylate synthetase (Tyms) catalyzes the creation of deoxythymidylate
using 5,10-methylenyltetrahydrofolate as a cofactor, which maintains the dTMP
(thymidine-5-prime-monophosphate) pool essential for DNA replication and
repair (NAZKI et al. 2014).

Also, the enzyme 5,10-methenyltetrahydrofolate

synthetase (Mthfs) catalyzes tetrahydrofolate to 5,10-methenyltetrahyrofolate, a
precursor to methionine produced by 5-methyltetrahydrofolate-homocysteine
methyltransferase (Mtr). This methionine is then converted to SAM to methylate
DNA at CpG sites (NAZKI et al. 2014). Down-regulation of Mthfs nd Mts likely has
an impact on methionine availability for this process. Further, as a consequence
of methylation, SAM is converted into homocysteine, a potent neurotoxin that
must be excreted or drawn back into the methionine cycle by Mts and additional
folate (NAZKI et al. 2014). Reduced expression of Mts may result in increased
concentrations of homocysteine.
Folate availability is critical during neurodevelopment for DNA replication, repair,
and appropriate epigenetic patterning.
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consumption during pregnancy can affect the transfer of dietary folate to the
developing fetus (HUTSON et al. 2012), leading to an array of developmental
abnormalities (BEAUDIN and STOVER 2009); however, these results suggest that
neurodevelopmental interruptions to folate metabolism can lead to a long-term
effect on the expression of a number of genes involved in this process. It is
interesting that our lab and others have observed global hypermethylation across
the genome of mice exposed to ethanol during neurodevelopment (LAUFER et al.
2013, KHALID et al. 2014), a phenotype that is consistent with a long-term lack of
dietary methyl donors (POGRIBNY et al. 2008). This hypermethylation is also
consistent with the bias towards down-regulation observed in the expression of
genes in the adult brain observed in this study.
Phenotypically, there is evidence that impairments in folate metabolism can lead
to neurological abnormalities including adult cognitive function (SHEA and ROGERS
2014). In the adult brain, SAM-dependent histone methylation impacts learning
and

memory

(JAROME

and

LUBIN

2013).

Alterations

to

histone

methylation/demethylation cycles that control memory cycles are associated
with a spectrum of neurological disorders, such as intellectual disability, autism,
depression, fear and anxiety, and schizophrenia (SHULHA et al. 2012, JAROME and
LUBIN 2013, ISHII et al. 2014, MORISHITA et al. 2015), suggesting that factors that
affect methylation-associated processes during neurodevelopment, including
prenatal alcohol exposure, can set up altered gene expression patterning that
persists into adulthood and may alter cognition and behaviour.

4.2.2.4

Chromatin organization and histone modification

In keeping with the hypothesis that alterations to epigenetic regulation of genes
in the adult brain drive the persistent changes to gene expression, a number of
genes identified as altered were involved in histone modification and chroma tin
remodeling (Table 3.8).

These included genes found within the large histone

gene cluster 1 located on chromosome 13 in mice such as Hist1h2bf, Hist1h2bm,
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Hist1h3c, and Hist1h4d, which are replication-dependent histones that are
predominantly expressed during S phase (MARZLUFF et al. 2002). Also affected
were histone deacetylase genes Hdac8 and Hdac10 and the histone acetyl
transferase gene CREB binding protein (Crebbp). These results support previous
findings that perinatal alcohol exposure decreases the expression of Crebbp in the
cerebellum (GUO et al. 2011), which was associated with decreased lysine
acetylation on histones H3 and H4 with motor activity changes observed in
individuals with FASD. Other down-regulated genes critical to epigenetic control
of gene regulation included DNA methyltransferase 1 associated protein 1
(Dmap1), a co-repressor that supports the maintenance as well as the de novo
methylation by DNA methyltransferase 1 (LEE et al.). The down-regulation of this
gene is interesting due to the general hypermethylation observed in the genome
of ethanol-exposed individuals; however, knock-down of Dmap1 has been shown
to inhibit cellular proliferation via activation (demethylation) of the p16 tumor
suppressor gene pathway, as well as lead to hypomethylation of regions
controlling DNA repair products (LEE et al. 2010). By contrast, methyl-CpG binding
domain protein 3 (Mbd3) is a strong inducer of demethylation (BROWN et al. 2008)
and was also identified as down-regulated in the brain of adult ethanol-exposed
mice.

Down-regulation of Mbd3 was found to be associated with global

hypermethylation and increased methylation in CpG islands associated with the
control of cell cycle genes (CUI and IRUDAYARAJ 2015).

Other studies have

examined the effects of neurodevelopmental alcohol exposure on epigenetic
patterning in the brain and suggest that ethanol impairs spatiotemporal
establishment of appropriate epigenetic marks that guide differentiation and
cellular maturation, and that these changes are correlated with neurobeh avioural
phenotypes associated with FASD such as stress vulnerability, social interaction,
and learning and memory deficits (CHEN et al. 2013, VEAZEY et al. 2013, BEKDASH et
al. 2014, SUBBANNA et al. 2015). Results from our lab also suggest that these
epigenetic changes are genomically wide-spread and may provide a mechanism
for long-term gene expression dysregulation (LAUFER et al. 2013).

The

identification of a number of genes associated with chromatin structure by this
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study suggests that ethanol may affect the subtle interplay between epigenetic
control mechanisms, including DNA methylation and histone modifications,
exerting a global change in regulation of gene transcription.
4.2.2.5

Gene

network

interactions

highlight

alterations

to

neurotransmission
A gene network analysis was performed on genes identified as altered in the adult
brain of mice treated with ethanol on P4 and P7 to predict interacting molecules
and evaluate and predominant biological pathways that may integrate the
observations gathered by the GO and IPA gene enrichment analyses. All the genes
included in these networks were down-regulated, which reflects the bias
observed from the array results (Appendix B). Also, the significant networks were
less intricate than those generated from the short-term analyses and showed a
number of common molecules (Figures 3.23, 3.24). Glutamate receptor subunit
Grin2b appeared as a major hub in all networks, consistent with previous analyses
suggesting that glutamate neurotransmission may be among the most significant
processes affected by ethanol exposure during the third trimester -equivalent.
Interestingly, huntingtin (Htt) appears as a central hub both in the ‘neurological
disease, psychological disorders, behaviour’ (NPD) network (Figure 3.23) and in
the merged network (Figure 3.25). We have observed that Htt is consistently
identified as a major hub in gene network analyses of multiple ethanol treatment
paradigms (KLEIBER et al. 2013). While the involvement of Htt with regard to
prenatal ethanol exposure is, as far as we are aware, unreported in prenatal
alcohol exposure literature, it is known that Htt is widely expressed in the
developing brain and has roles in cell survival, proliferation, and migration, and it
is essential for the formation of normal excitatory synapses (TONG et al. 2011,
MCKINSTRY et al. 2014). In the adult brain, mouse knock-down models have shown
that reduced huntingtin levels were associated with neuronal loss and
degeneration in the subthalamic nucleus and global pallidus, resulting in
increased motor activity and cognitive deficits (NASIR et al. 1995, O'KUSKY et al.
1999). Despite the well-established role of Htt in neuropathology, its relationship
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with neurodevelopmental alcohol exposure remains an unexplored avenue,
though its down-regulation and consistent appearance as a ‘hub’ gene in multiple
treatment paradigms is intriguing.
Also prominent in the NPD network (Figure 3.23) and in the merged network
(Figure 3.25) is 5-hydroxytryptamine (serotonin) receptor 1A (Htr1a). Serotonin
receptors Htr1a, Htr5b, and Htr1d were all identified as down-regulated in the
adult brain (Table 3.10). This is consistent with studies reporting impaired
serotonin neuron innervation in the forebrain, hypothalamus, frontal and parietal
cortices, and hippocampus in mice prenatally exposed to alcohol (ZHOU et al. 2001,
ZHOU et al. 2005).

Reduced expression of human HTR1A is associated with a

number of psychopathological states such as increased anxiety, stress reactivity,
and depression (ALBERT 2012). In mice, Htr1a knock-out results in heightened
stress reactivity and anxiety-like phenotypes (HEISLER et al. 1998, PARKS et al.
1998), which can be ameliorated by postnatal handling (ZANETTINI et al. 2010).
This is consistent with findings that Htra1 and other serotonin receptors may be
sensitive to gene-environment interactions that result in altered epigenetic marks
that impact transcriptional control of these genes (ALBERT and FIORI 2014,
HOLLOWAY and GONZALEZ-MAESO 2015).

Also associated with altered anxiety-

related phenotypes is apolipoprotein E (Apoe), which was identified as downregulated in the adult brain of mice exposed to ethanol at P4 and P7, and appears
within all three gene networks (Figures 3.23, 3.24, 3.25). Apoe plays an important
role in the metabolism and redistribution of lipoproteins and cholesterol (HUANG
and MAHLEY 2014). Further, Apoe-deficient mice show age-dependent structural
and functional changes to the cortex and hippocampus (MASLIAH et al. 1995,
BUTTINI et al. 1999), as well as age-dependent dysregulation of the HPA axis via
increased levels adrenal corticosterone both at the basal level and following
restraint stress (RABER et al. 2000). This was associated with increased anxietyrelated behaviours in the elevated plus maze, reduced activity in a novel open field
arena, and learning deficits (RABER et al. 2000, GROOTENDORST et al. 2002).
Persistently reduced expression of Apoe in the adult brain certainly may
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contribute to the maintenance of anxiety and learning-related phenotypes
observed in mice exposed to ethanol during the third trimester -equivalent. Also,
it is interesting that Apoe and Pomc, which appears in the NPD gene network as
well as the merged network (Figures 3.23, 3.25), were identified as altered
following third trimester-equivalent ethanol exposure but not following other
treatment paradigms (KLEIBER et al. 2013), suggesting that late gestation may be
a critical window of vulnerability for HPA axis-associated processes.
Interestingly, there is evidence that ethanol-induced gene expression changes
associated with HPA axis dysfunction are the result of altered epigenetic
mechanisms that are malleable and can be corrected (BEKDASH et al. 2013,
GANGISETTY et al. 2014).
The genes identified as altered in the adult brain of mice exposed to ethanol
during neurodevelopment at P4 and P7 suggest changes to critical neural
processes that are important for behaviours observed in these animals, such as
altered glutamate neurotransmission, changes to serotonin signaling, and HPA
axis dysfunction. These processes are certainly interrelated, and also associated
with the altered expression of genes related to apoptosis (Casp3), neurotrophic
signaling (Ntf3), extracellular matrix integrity and signal transduction (Mmp2,
Map3k10) (Figure 3.25).

While these processes are consistent with the

behavioural and physiological phenotypes observed in individuals with FASD, it
remains to be evaluated how the altered expression of these genes may impact
cellular function and contribute to these phenotypes.

4.2.3 Molecular pathways acutely affected by ethanol exposure during
synaptogenesis that remain modified into adulthood
Given the similarities between biological process affected both acutely following
ethanol exposure during synaptogenesis and those altered in the adult brain, it is
intriguing to make comparisons between the two gene sets. Such a comparison is
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valuable in the understanding of the events that establish long-term neural
dysfunction resulting from neurodevelopmental ethanol exposure, which
ultimately manifests as long-lasting cognitive and neurobehavioural phenotypes.
The results included indicate that binge-like ethanol exposure alters two sets of
genes: the first represents a rapid cellular stress response that leads to the
apoptosis of vulnerable cells. Ultimately, this modified expression profile impacts
the further developmental trajectory of surviving cells, resulting in a ‘molecular
footprint’ of third trimester-equivalent ethanol exposure observed in adult mice
that may, in part, account for the behavioural deficits presented by these animals
(KLEIBER et al. 2013, MANTHA et al. 2013).
While few transcripts were identified as altered in both analyses (Table 3.11),
there is a great deal of overlap in the biological processes associated with genes
altered at P7 and in adulthood at P60 (Table 3.12). Genes identified as altered
both acutely following ethanol exposure and within the adult brain suggest that
third trimester-equivalent ethanol exposure has a significant impact on the
regulation of synaptic transmission and plasticity, involving the altered
expression of a number of glutamate receptor subunit genes as well as genes
involved in synapse formation, organization, and maintenance.

Glutamate

neurotransmission is essential for the formation of functional neural circuits
(AAMODT and CONSTANTINE-PATON 1999, BOLTON et al. 2000), and is a major target
of ethanol, which is able to act as a strong NMDA receptor antago nist (IKONOMIDOU
et al. 2000). Altered glutamate neurotransmission also plays a role in an array of
cognitive and behavioural phenotypes, including those asso ciated with FASD such
as motor coordination delays, hyperactivity, increased anxiety, and impaired
learning (KIYAMA et al. 1998, MOHN et al. 1999, JENSEN et al. 2009, BARKUS et al. 2010,
ARAKAWA et al. 2014).

Important to this study, synaptogenesis seems to be a

critical period of vulnerability to ethanol-induced changes to glutamate
neurotransmission (OLNEY et al. 2002a, PUGLIA and VALENZUELA 2010, KLEIBER et al.
2013), which has led us to the hypothesis that neurodevelopmental processes that
are active at the time of exposure are most responsive to environmental
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interference, leading to long-term alterations in sets of genes that are involved in
these processes (or the ‘molecular footprint’ of timing of exposure) (KLEIBER et al.
2014a).
Also implicated as a consequence of third trimester-equivalent ethanol exposure
by both short- and long-term gene sets were alterations in steroid hormone
signaling and potentially abnormal HPA axis development and function in the
adult brain. Genes involved have well-established roles in stress response and
glucocorticoid regulation, including pro-opiomelanocortin (Pomc), apolipoprotein
E (Apoe), and the steroid-thyroid hormone-retinoid receptor nuclear receptor
subfamily 4, group A, member 1 (Nr4a1). Interestingly, this is associated with
altered Circadian rhythm signaling as identified in both the short-term and longterm canonical pathways. We observed altered expression of Period genes Per1
and Per2, as well as long-term altered expression of pro-opiomelanocortin (Pomc)
(CHEN et al. 2006a). Altered sleep-wake cycles have previously been observed in
human infants and adolescents exposed to alcohol during neurodevelopment
(CHEN et al. 2006a). Consistent with this study and others, these effects are most
pronounced in animal models when exposure occurs during the brain-growthspurt period (EARNEST et al. 2001, SAKATA-HAGA et al. 2006). Altered Circadian
rhythm, and corresponding altered HPA axis corticosterone signaling, are further
associated in FASD individuals or models with increased vulnerability to stress,
depression, hyperactivity, and diminished cognitive function (EARNEST et al. 2001,
SAKATA-HAGA et al. 2006, GIROTTI et al. 2007, WEINSTOCK 2010).
A comparison between the biological processes associated with both the shortterm and long-term gene sets also identified thyroid hormone/retinoid X receptor
signaling (TR/RXR) pathway as affected by trimester three-equivalent ethanol
exposure (Table 3.12). Some genes implicated were also associated with altered
hormonal signaling given that RXRs are nuclear receptors that mediate retinoic
acid-induced gene expression through the formation of homo or heterodimers
with other receptors including thyroid hormone receptor (TR), among many
others (CHAMBON 1996, BASTIEN and ROCHETTE-EGLY 2004). Again, these processes
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seem to be affected primarily by ethanol exposure during this developmental
period as they were not identified by analyses of first or second trimester equivalent exposure paradigms (KLEIBER et al. 2013, MANTHA et al. 2014b),
suggesting that late-gestation may be a critical period for the appropriate
development and function of systems reliant on retinoic acid receptor signaling.
Lastly, the PTEN canonical pathway was identified as significantly affected in the
short-term and long-term effects of ethanol (Table 3.12). Given the broad
intracellular signaling functions of the PTEN and associated PI3K/AKT/mTOR
pathway and its ability to respond to nutrient availability, stress, hormones, and
growth factors to modulate protein synthesis, a comprehensive discussion of this
pathway with relevance to prenatal alcohol exposure would be assumptive. The
pathway is worth attention, however, in light of recent findings implicating that
this pathway may be a consistent target of neurodevelopmental alcohol exposure
given its consistent identification in the analysis of brain expression profiles and
methylation alterations resulting from multiple treatment paradigms (KLEIBER et
al. 2013, LAUFER et al. 2013).

4.2.4 Maintenance of long-term gene expression changes, altered
miRNA expression, and epigenetic patterning
The results included in this study offer an evaluation of potential epigenetic
mechanisms that may help establish a long-term footprint of altered gene
expression following ethanol exposure during synaptogenesis. There has been
increasing

evidence

that

epigenetic

processes

established

during

neurodevelopment, such as DNA methylation, chromatin structure, and miRNA
expression are altered by prenatal ethanol exposure (MIRANDA 2011, BEKDASH et
al. 2013, VEAZEY et al. 2013). Histone deacetylases (Hdac1, Hdac9) appear as
target molecules within multiple canonical pathways identified as altered acutely
(at P7) following ethanol exposure (Table 3.5). These genes play an important
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role in controlling gene expression and cell signaling events via histone
modifications and chromatin remodeling, and play an established role in a
number of neurodegenerative disorders including fetal alcohol spectrum
disorders (BUTLER and BATES 2006, LAUFER et al. 2013, VOGEL-CIERNIA and WOOD
2013). These genes act by not only altering chromatin structure but also in
interacting with tissue-specific transcription factors to control apoptosis and
differentiation (PARRA and VERDIN 2010, CONWAY et al. 2012).
Evaluation of miRNA changes in the adult brain of mice exposed to alcohol at P4
and P7, within the brain “growth spurt” period, identified a number of miRNAs as
altered at P60 following ethanol exposure at synaptogenesis (Appendix C). The
genes identified as potential targets of some of these miRNAs play important roles
in the function of mature neuronal communication and signaling (Table 3.13).
Interestingly, many of the biological pathways associated with these miRNAs and
their targets showed similarities with the pathways affiliated with the modified
short-term (P7) transcripts and relevance to synaptogenesis. Further, these
pathways showed higher relevance to synaptic function and neural function
rather than cell survival processes, as may be expected given that these results
highlight the residual effects of exposure at synaptogenesis rather than immediate
stress response. Of note are the miRNAs posed to regulate genes associated with
HPA-associated corticotrophin and retinoic acid signaling such as miR-26b and its
putative cannabinoid receptor target (Cnr1), miR-184 and its putative target
Ncor2, miR-721 and its targets Ppargc1a and Ncoa3 (Table 3.13).

The effect of

ethanol exposure on Cnr1 expression in the developing brain has previously been
reported. Subbanna et al. (2013) reported that ethanol exposure at P7 resulted in
increased Cnr1 expression in the hippocampus and cortex that was associated
with Erk1/2 phosphorylation and neurodegeneration. Further, Cnr1 knock-out
eliminated

ethanol-induced

neurodegeneration,

inhibited

Erk1/2

phosphorylation, and rescued normal adult synaptic plasticity and novel object
recognition (SUBBANNA et al. 2013). Nuclear receptor coactivator 3 (Ncoa3) and
nuclear receptor corepressor 2 (Ncor2) both are thyroid hormone and retinoic acid
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receptor-associated proteins that act to activate or repress, respectively,
transcription of certain gene sets. A recent study suggested that Ncoa3 is itself an
important regulator of miRNA action by promoting the expression of Argonaute
proteins, core components of miRNA-induced silencing complex (miRISC), and
regulates dendritic complexity and spine maturation in the hippocampus
(STORCHEL et al. 2015). NCOR proteins have well-established roles in neural
function and memory, with disruption of NCOR-regulated gene expression
associated with cognitive and memory impairments in both humans and rodent
models (XING et al. 2006, HAWK et al. 2012, GILBERT and LASLEY 2013, LYST et al.
2013). Ncor2 has been experimentally shown to be regulated by miR-184 (WU et
al. 2011) and itself regulates gene expression via its interactions with histone
deacetylases (SUN et al. 2013).
Correspondingly, the Target Filter™ results suggested that PI3K/AKT/mTOR
signaling may be altered via aberrant miRNA regulation of the tumor suppressor
protein Tubular sclerosis 1 (Tsc1) (Table 3.13). The up-regulation of miR-721 and
subsequent down-regulation of Tsc1 is significant with relevance to FASD-related
abnormalities given current evidence that knock-down of Tsc1 or its functional
partner, huntingtin-associated protein 1 (Hap1), profoundly impairs the
positioning of pyramidal neurons in the hippocampus (MEJIA et al. 2013), leading
to long-term neurological impairment including cognitive deficits and learning
impairments (ORLOVA and CRINO 2010).
Taken together, these results argue that altered epigenetic mechanisms, including
histone modifications and miRNA regulatory control, may reflect consequences of
neurodevelopmental ethanol exposure that do not have a specific relationship to
cellular stress response but nonetheless exert long-term functional changes
within the adult brain, and have roles associated with cognitive and behavioural
phenotypes observed in individuals with FASD.

While these results are

preliminary in nature and require further functional examination to confirm
miRNA/mRNA interactions in given cell types and specific consequences on
cellular function, the findings are interesting and certainly indicate that long -term
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miRNA regulation is altered as a consequence of neurodevelopmental alcohol
exposure. These findings are also consistent with recent literature suggesting that
miRNAs play multiple roles in both the acute and long-term effects of alcohol in
the developing and adult brain (SATHYAN et al. 2007, WANG et al. 2009, BALARAMAN
et al. 2013, IGNACIO et al. 2014, CHEN et al. 2015).

4.3 Caveats to assessing FASD in animal models
4.3.1 Limitations to the use of mice in modeling FASD
There are some limitations to the current study which should be noted. A broad
observation relevant to many studies that utilize any animal model system to
assess neurobehavioural or cognitive disorders is that it cannot be ignored tha t
one is trying to recapitulate a complex human phenotype in an animal model that,
by its nature, will not be able to fully model all aspects of that disorder as it
presents in human patients. In this sense, the validity of the model is reliant on
its ability to effectively map the etiology, behaviour, and biological mechanisms of
human psychopathology. FASD is different from many neurological disorders in
that it has a clear etiology: exposure to alcohol during neurodevelopment. This
known causation provides legitimacy to animal models of FASD in that it is
relatively simple to treat pregnant dams with ethanol, either via voluntary
ingestion, gavage, or injection of known ethanol doses, allowing clear relevance of
the model to human FASD. Animal models must also focus on the presentation of
neurobehavioural phenotypes that are relevant to the disorder they are seeking
to emulate, either cognitive, which in animal models must be inferred, or
behavioural, which is an observable response to a given assay. In this study, I
believed it was important that mice exposed to ethanol during neurodevelopment
displayed a cluster of endophenotypes that were commonly associated with
human FASD, namely developmental delay, activity alterations, anxiety-related
phenotypes, and learning deficits.

A combined behavioural and molecular
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approach may help define genetic contributions to endophenotypes in mental
disorders (GOTTESMAN and GOULD 2003).

The presented model successfully

displayed many endophenotypes that can be compared to human FASD
behavioural phenotypes, and there was a great deal of consistency with the genes
and pathways that were implicated as involved in both neonate and adult mice.
These included pathways that have previously been identified as involved in
alcohol response and fetal alcohol spectrum effects including glutamate
neurotransmission and genes associated with synaptic plasticity, cell cycle control
and stress response, neurotrophic molecules, and genes associated with HPA axis
function.
Humans and mice – while genetically and physiologically similar – are certainly
not identical, and they have different evolutionary histories that cannot be
discounted. The neurodevelopmental timeline of mice and humans have been
well-characterized and well-correlated; however, based on the human
neurodevelopmental timeline, the developmental processes that occur during the
third trimester also occur in the mouse from roughly postnatal days 2 to 14
(DOBBING 1974, DOBBING and SANDS 1979, CLANCY et al. 2001). Thus, to mimic an
ethanol exposure during this neurodevelopmental time, ethanol must be
administered to a neonate pup rather than to an in utero fetus, eliminating
interactions with maternal genotype and maternal ethanol metabolism. This
could be viewed as a potential advantage, given that these maternal confounding
factors can be avoided and the blood alcohol concentration of the animal can be
more easily controlled. In this study, the timing of ethanol exposure also allowed
us to balance the treatment groups such that we were able to pair each ethanoltreated pup with a weight and sex-matched littermate control, eliminating the
potential confounds associated with litter effects. There are certainly other
animal models such as non-human primates, other rodent species, and nonmammalian species (PATTEN et al. 2014), many of which are more precocial at
birth, that have been successfully used to evaluate behavioural, physiological, or
molecular phenotypes associated with FASD. In this study, mice were chosen due
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to their amenability to ethanol effects, range of well-validated behavioural assays,
and broad range of available genetic information and tools. In mice, these
resources have been shown to be useful when evaluating how molecular
processes contribute to changes in brain function in neurological disorders, which
is not possible to assess in humans (CRYAN and HOLMES 2005, NESTLER and HYMAN
2010a).
With regards to the model presented here that sought to interrogate the specific
effects of late-gestational ethanol exposure, it should also be noted that,
epidemiologically, it is certainly uncommon that a pregnant female would ingest
a high dose of alcohol during the third trimester only (GLADSTONE et al. 1997, ETHEN
et al. 2009). Neurodevelopment is a lengthy and complex process, and without
controlled models of exposures of specific times, it is difficult to differentiate the
resulting molecular and, subsequently, the phenotypic effects that result from
exposures at each stage of development. The purpose of this third trimester equivalent exposure paradigm was to evaluate how exposure during the ‘brain
growth spurt’ – a period of rapid neural development and synapse formation –
disrupts certain genes or pathways known to be involved in these processes. Also,
certain regions of the brain that have relevance to FASD-related phenotypes, such
as learning, stress reactivity, hyperactivity and attention, and motor coordination,
show a strong vulnerability to ethanol-induced apoptosis or damage during this
period of neurodevelopment (IKONOMIDOU et al. 2000, OLNEY 2004, DIKRANIAN et al.
2005). Evaluations of third trimester-equivalent models of FASD are becoming
increasingly prevalent in the literature due to the brain’s vulnerability at this
stage. Studies have established that ethanol exposure at P7 results in robust
phenotypic consequences, such as profound learning deficits, altered stressreactivity and altered Circadian rhythm dysfunction (EARNEST et al. 2001, WOZNIAK
et al. 2004, BROCARDO et al. 2012). This is also why we have employed various
treatment paradigms in our research, including ‘binge’-like exposures at distinct
neurodevelopmental times and a moderate chronic exposure paradigm that
exposes the developing pup to ethanol throughout gestation via voluntary
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maternal consumption of a 10% ethanol solution (KLEIBER et al. 2011, MANTHA et
al. 2013). While it is clear that there is no one exposure time that is independently
responsible for the range of behaviours associated with FASD, it is important to
discern the mechanisms that may underlie the subtle differences in behavioural
and molecular phenotypes generated from each treatment paradigm.

4.3.2 Technical considerations
Aside from considerations regarding the model itself, there are other cavea ts to
this research that should be noted that were associated with technical aspects of
the methodology. First, the gene expression changes identified in this study were
evaluated using whole-brain homogenates. It is recognized that the developing
and adult brain are complex tissues with a number of regions that undergo
neurodevelopmental processes at a varying timeframes. While synapse formation
may the predominant process occurring during the first two weeks of postnatal
mouse development (corresponding to the processes occurring during the third
trimester equivalent), there are also a number of other critical processes
occurring at this time depending on region, including neurogenesis, glial
development, apoptotic pruning, and myelination (DOBBING and SANDS 1973). The
results we have generated have relevance to synapse-related processes,
particularly in regions such as the corpus callosum, the limbic system, the HPA
axis, the cerebellum, and the cortices. Coincidentally, these are the regions that
are particularly vulnerable to ethanol-induced neurodegeneration and show
altered developmental trajectories following trimester three-equivalent ethanol
exposure (BONTHIUS and WEST 1990, IKONOMIDOU et al. 2000, OLNEY 2004, DIAZ et
al. 2014a). We hypothesize that the brain regions most vulnerable to ethanol will
be those cells that are actively undergoing developmental processes and are
particularly sensitive to intracellular and extracellular cues, such as ethanol. As
such, the results generated in this study can only be interpreted on a broad scale,
perhaps suggesting that common alterations to neurodevelopmental trajectories
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may happen in some varying brain regions that have a similar developmental
timeline.

Regardless, future studies examining region-specific changes in gene

expression, protein expression, and physiological structure would be extremely
useful and will provide a more detailed perspective of those genes and pathways
that may be affected by ethanol within those regions.
Secondly, experimenters using microarrays as investigative tools have attempted
to achieve a standardization of data quality with the suggestion of requirements,
known as the ‘minimum information about a microarray experiment’ (MIAME)
that may be needed to interpret the results of the experiment and potentially
reproduce its findings (BRAZMA et al. 2001). Currently, many journals and funding
agencies require that microarray experiments adhere to MIAME guidelines,
though there has been criticism (GALBRAITH 2006, SHIELDS 2006). While the array
experiments included in this study have attempted to meet MIAME standards and
the information regarding all experiments have been curated to NCBI’s Gene
Expression Omnibus (GEO) database , I acknowledge that the sample sizes used
by the microarray studies were low, resulting in less than ideal statistical power
to identify low-fold gene expression changes. The use of an FDR-corrected p-value
in the identification of differentially expressed genes certainly assisted in
reducing array noise, though it cannot be discounted that a proportion of the
genes identified were false positives, and equally importantly, a number of genes
affected were likely not identified by this study (false negatives).

It has been

reported that the use of inbred animals, as in this study, reduces the need for a
greater number of array replicates (WEI et al. 2004). Also, I had success in
confirming three of four genes identified by the short-term array, and four of four
genes identified by the long-term analysis, which may speak to the reliability of
the array results using qPCR, though the confirmation of more genes would
certainly add to confidence in the array results. Further, the cost of arrays since
2001 has substantially decreased and continues to decline, allowing current
studies to employ more arrays or even make use of next-generation technology,
such as RNA-seq (MARIONI et al. 2008, MORTAZAVI et al. 2008).
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Lastly, while behavioural analyses used both male and female cohorts, all samples
used for RNA and miRNA expression analysis were derived from male mice. Sex specific differences in certain behaviours, such as activity in a novel open field
arena (Figure 3.2) and anxiety-related behaviours (Figures 3.8, 3.9, 3.10, 3.11)
were identified by this study. As mentioned, these findings are consistent with
other studies suggesting that prenatal alcohol exposure may affect individuals in
a sexually-dimorphic manner, particularly with regard to stress vulnerability,
HPA axis function, serotonin response, and hippocampal function (GABRIEL et al.
2006, HOFMANN et al. 2007, MCMURRAY et al. 2008, HELLEMANS et al. 2010,
PRZYBYCIEN-SZYMANSKA et al. 2010, ZAJAC et al. 2010). It would be prudent to
evaluate sex-specific differences in gene expression, particularly with regar d to
genes that were identified and are critical to HPA axis development and function
such as pro-opiomelanocortin (Pomc) and apolipoprotein E (Apoe), and to further
assess how ethanol affects neurodevelopment in conjunction with sex -specific
hormonal signaling (HELLEMANS et al. 2008, WEINBERG et al. 2008, KUDWA et al.
2014).

4.4 Evaluation of behavioural and gene expression changes
across treatment paradigms
Upon the initiation of this study, there were few models of FASD that were being
utilized to evaluate the molecular effects of prenatal alcohol expo sure in the brain.
These models varied in treatment dose, timing, treatment method, and model
system, making comparisons between them difficult. A major goal of this research
was to develop a comprehensive animal model that evaluated the behavioural and
genetic effects of ethanol exposure during neurodevelopment using controlled
dosage paradigms across multiple trimester equivalents. These studies have
provided a mechanism to compare the behaviours and genes that may be affected
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by alcohol consumption at specific stages of human neurodevelopment (KLEIBER
et al. 2013, MANTHA et al. 2013, KLEIBER et al. 2014b, MANTHA et al. 2014a).

4.4.1 Behavioural changes and timing of exposure
The results included in this thesis focus on findings resulting from a heavy bingelike exposure during early postnatal period, disrupting neurodevelopmental
processes that are roughly equivalent to those occurring in the human brain
during the third trimester. The first goal of this research was to establish a battery
of behavioural assays that was relevant to major behavioural and cognitive
phenotypes observed in human FASD and that could be used to test the
development of these features as they emerged throughout the course of the
maturation from neonate to adult. The behavioural battery, while certainly not
an exhaustive evaluation of all FASD-relevant behaviours, was able to successfully
identify changes to early neuromuscular coordination, activity levels, anxietyrelated traits, and learning ability, strategy, and spatial memory retention
resulting from early postnatal ethanol exposure.
This battery was also able to identify behavioural differences between treatment
paradigms that used an equivalent ethanol dose administered at the trimester
one, trimester two, or trimester three-equivalent (MANTHA et al. 2013). Findings
across treatment paradigms were intriguing, and while similar behaviours were
observed within all models, there were distinctive differences in the subset or
severity of the phenotypes observed. For example, while differences in nocturnal
overnight activity were observed in all paradigms, the pattern varied considerably
with very little difference observed following trimester one-equivalent exposure,
an intermediate phenotype observed following trimester two-equivalent
exposure, and a pronounced difference – specifically during the early period of the
light/dark cycle - following third trimester-equivalent ethanol exposure. Further,
the emergence of anxiety-related traits seemed to be specific to late-gestational
(trimester two and three-equivalents) ethanol exposure. Lastly, the pattern of
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spatial learning was interestingly variable between treatment times, with
trimester one-equivalent-treated mice showing a pronounced difference in
latency to locate the target of the Barnes maze between control and ethanoltreated mice only during the latter testing days. Conversely, trimester two equivalent-treated mice showed differences in latency during the first day of
training, but appeared to ‘catch up’ to their control counterparts – eliminating
differences in latency to locate the target - by testing days two to four.

As

presented within this thesis, ethanol treatment during the third trimester equivalent resulted in the most severe spatial learning deficits as tested by the
Barnes maze, which were more pronounced when postnatal day 7 was included
as a treatment day. These findings suggest that there may be windows of
vulnerability for the later emergence of certain phenotypes that may be
dependent on the sensitivity of certain neural regions that govern these
behaviours. This would also imply that certain behaviours are likely to appear co morbidly given that brain regions interact to influence multiple cognitive
behaviours, such as the hippocampus and its role in learning and memory and the
influence of HPA axis-associated stress reactivity on learning behaviour (MCEWEN
2003, WINGENFELD and WOLF 2014). The sensitivity of particular brain regions to
ethanol at varying neurodevelopmental times also may speak to the phenotypic
heterogeneity of FASD. Its classification as a “spectrum” disorder certainly
reflects the broad range and severity of phenotypes that are associated with
prenatal alcohol exposure, and factors including (though not limited to) timing
and dose of ethanol may contribute to this variability. Finally, as early gestational
exposure has been biologically associated with distinctive craniofacial and other
physiological abnormalities that categorize FAS (SULIK 2005), the appearance of a
subset of abnormal behaviours in an infant, child, or adolescent with prenatal
alcohol exposure may offer a modest estimate of the timing and/or dosage of
ethanol exposure, though this hypothesis certainly would require a much more
thorough evaluation at both the animal model and clinical level given the complex
socio-economic factors that influence outcome in humans.
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4.4.2 Genome-wide gene expression changes as an indicator of altered
neurodevelopmental and adult neural processes
Many studies have examined the ability of ethanol to elicit excitotoxic cell death
in immature brain regions depending on timing and dosage (IKONOMIDOU et al.
2000, GOODLETT and HORN 2001, DIKRANIAN et al. 2005, NOWOSLAWSKI et al. 2005).
Fewer studies, however, have examined the long-term molecular effects of
ethanol exposure – those effects that do not lead to apoptosis but to an
interruption of normal neurodevelopmental processes that causes the cell to
respond, adapt, and continue on a developmental trajectory towards maturation.
Analysis of gene expression changes acutely (4 hours) following ethanol exposure
at P7 suggested that a number of cellular stress-associated mechanisms underlie
the response of developing neural cells to a binge-like ethanol insult.

While a

number of genes associated with apoptotic cell death were upregulated, a number
of biological processes were identified that were consistent with optimizing cell
survival, such as the down-regulation of molecules involved in energetically costly
processes such as ribosome synthesis, cell cycle transition, and a number of
transcription factors involved in developmental processes, and the upregulation
of molecules integral to cell membrane integrity (Table 3.5). These findings are
consistent with results from ethanol treatments administered during the first and
second trimester equivalent, which identified the down-regulation of genes
associated with ribosomal biosynthesis, cell cycle progression, cellular migration,
and neuronal maturation, and the upregulation of genes involved in cellular
integrity and adhesion (GREEN et al. 2007, MANTHA et al. 2014a). What seems to be
integral to ethanol exposure during the third trimester-equivalent is the changes
in expression of a number of genes associated with neurotransmitter systems
such as glutamate, GABA, dopamine and serotonin, as well as steroid hormone
signaling

including

retinoic

acid

and

metabolic

derivatives

of

pro-

opiomelanocortin (Pomc) (Tables 3.5, 3.6, 3.8. 3.9. 3.10). This may be related to
the timing of exposure and the sensitivity of predominant biological processes
that are occurring during this ‘brain growth spurt’ to external molecular cues,
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including the maturation of neural circuitry, maintenance of synaptic connections,
and apoptotic synaptic pruning (COHEN-CORY 2002, LUJAN et al. 2005, AKERMAN and
CLINE 2007). Interestingly, we have found that ethanol exposure during the first
trimester equivalent alters the expression of a number of genes associated with
cellular survival, neurulation, and extracellular matrix remodeling, while
exposure during the second trimester-equivalent disrupts processes associated
with cellular migration and differentiation (KLEIBER et al. 2013, KLEIBER et al.
2014a). This has reinforced our hypothesis that ethanol may target cells that are
particularly sensitive to intra- and extracellular cues, as is the case with cells
undergoing neurodevelopmental processes that rely heavily on cellular
communication, signaling, and appropriate and timely gene expression.
A novel goal of this study was to not only assess the changes to the brain
transcriptome acutely following ethanol exposure, but to also evaluate if
neurodevelopmental ethanol exposure resulted in long-term changes to brain
gene expression that are present in adulthood, potentially driving or at least
contributing to the behavioural phenotypes that emerge and persevere in
individuals with FASD. Given that long-term gene expression changes were
identified regardless of treatment paradigm (KLEIBER et al. 2012, KLEIBER et al.
2013), the question of what may initiate and maintain these gene expression
changes over time naturally arises.

A clear answer to these questions is not

straight-forward and may involve some combination of the primary (acute) and
secondary effects of ethanol exposure.
Factors that instigate these changes in gene expression may include ethanolinduced apoptosis of susceptible cell types, leading to an overall change in the
cellular composition of the brain and, subsequently, the overall pattern of brain
gene expression (IKONOMIDOU et al. 2000, OLNEY et al. 2002a). Given that this study
utilized whole brain tissue as a source of RNA, this may certainly contribute to
some of the gene expression changes identified. Another contributing mechanism
may be the ability of ethanol to disrupt developmental processes that are highly
reliant on external cues such as cell proliferation, migration, differentiation, and
183

Chapter 4. Discussion

communication (GUERRI 1998, RICE and BARONE 2000, CAMARILLO and MIRANDA
2008). The disruption of these processes would represent residual effects of the
ability of alcohol to alter cellular identity, structure, or connectivity in a way that
alters the physiology of the brain such that the appropriate balance of adult gene
expression is not maintained. This hypothesis has been suggested for a number
of spectrum disorders, and has been referred to as a neurodevelopmental
“footprint” of teratogen exposure (DEMJAHA et al. 2011, DUFOUR-RAINFRAY et al.
2011, KLEIBER et al. 2012). We have observed distinct (though related) patterns
of altered gene expression depending on timing and dose of ethanol exposure,
supporting that neurodevelopmental ethanol exposure may leave a ‘molecular
footprint’ that is somewhat specific to the timing of exposure and involves altered
gene expression and epigenetic patterning (KLEIBER et al. 2012, KLEIBER et al. 2013,
LAUFER et al. 2013).
There is increasing evidence that developmental ethanol exposure ca n affect
epigenetic patterning including DNA methylation, histone modifications, and
microRNA expression, which can produce long-term and relatively stable changes
to the expression of a number of genes (SATHYAN et al. 2007, WANG et al. 2008, LIU
et al. 2009, KAMINEN-AHOLA et al. 2010, MIRANDA 2011). Results presented within
this thesis support research reporting ethanol’s ability to alter the expression of
proteins involved in histone modifications (ie, HDACs), proteins involved in onecarbon metabolism and DNA methylation, and a number of microRNAs,
suggesting that ethanol exposure during the third trimester equivalent is able to
interfere with

processes that establish

appropriate neural epigenetic

programming. This is consistent with results from other treatment paradigms
used within our lab; indeed, all treatment methods (binge or voluntary maternal
consumption) that we have utilized have been associated with changes to
epigenetic programming (LAUFER et al. 2013, KLEIBER et al. 2014b, MANTHA et al.
2014b). This avenue of fetal alcohol research is relatively new but gaining in
attention given that it has implications towards the persistence of FASD
phenotypes throughout the lifetime of an individual.
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established epigenetic programming can often be rendered extremely stable (REIK
et al. 2001, HAYCOCK 2009, O'SULLIVAN et al. 2012); however, reprogramming can
take place at several points throughout the lifespan in response to changes in
environmental conditions, suggesting that if epigenetic factors strongly underlie
the behavioural and cognitive consequences of fetal alcohol exposure, they may
be amenable to treatment by environmental interventions.

4.4.3 Future directions: understanding FASD etiology and potential for
developing diagnostic and treatment strategies
The ultimate goal of any animal model of a human genetic disorder is the
utilization of that model to understand the pathogenesis of the disease and assess
potential treatment strategies. The mouse model developed in this study, along
with other models developed by our lab, interrogate the effects of ethanol dosage
and timing on behaviour, brain gene expression, and epigenetic patterning
(KLEIBER et al. 2012, KLEIBER et al. 2013, LAUFER et al. 2013, MANTHA et al. 2013,
KLEIBER et al. 2014b). Given that the ultimate purpose of these models is to
examine the biological underpinnings of human FASD, future studies examining
how the findings from this study may translate diagnostically or prognostically to
humans would be useful and, importantly, evaluate if similar mechanisms, either
genetic or epigenetic, contribute to the development of this disorder in humans.
The results submitted as part of this thesis are hopefully an initial step to facilitate
these studies and there are some findings included that may direct future research
with these goals in mind. As with other array studies involving complex traits and
disorders, a large number of gene transcripts – both mRNA and miRNA – were
identified including those affected acutely following ethanol exposure (short-term
effects) and those that remain altered in the adult brain (long-term effects). This
indicates that multiple mechanisms and pathways are involved, and certainly,
many have been implicated in FASD not only by this study but also within the
expanding FASD-associated literature. This raises the question of how to reduce
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this biological complexity and how to most effectively identify candidate target
molecules or processes that may aid in diagnosis or treatment.
To explore the molecular relationships between the genes identified within this
study and to identify core molecules that could unify the somewhat distinct
biological processes associated with them, the transcripts were organized into
interconnected gene networks. This approach is a key feature of ‘network
medicine’ that has been applied to the analysis of other complex diseases and is a
promising approach to identify potential diagnostic and prognostic biomarkers or
pharmaceutical targets from large array-based studies (BENSON and BREITLING
2006, BARABASI et al. 2011). Indeed, the results from this study and other research
investigating the molecular consequences of neurodevelopmental alcohol
exposure demonstrate that while various genes or gene sets may be identified
depending on factors such as timing of exposure or ethanol dosage administered,
there is some consistency with regard to the biological pathways and ‘hub’
molecules that appear following network analyses associated with those gene sets
(KLEIBER et al. 2013). Evaluating the role of these specific genes in the developing
and adult brain with regard to the influence of alcohol on their expression or
function may be a promising initial step to unravelling the complexity of FASD associated neural dysfunction.
In addition to identifying core molecules that may be key biological effectors of
FASD, it is also important to consider that FASDs do not occur in isolation of social,
economic, and other environmental factors.

FASD prevalence is often

considerably higher in populations with low socioeconomic and educational
status, increasing the likelihood of factors that exacerbate the severity of FASD
phenotypes both prenatally and postnatally, including nutritional deficiencies,
comorbid exposure to other teratogenic substances, and a suboptimal early-life
environment (LIEBER 2003, SECKL and MEANEY 2004, STREISSGUTH et al. 2004,
DWYER et al. 2009, ESPER and FURTADO 2014). While these factors contribute to
how FASD phenotypes may present, they are also potential targets to mitigate the
effects of prenatal alcohol exposure. Improving the nature of early postnatal care
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has been shown to improve a number of phenotypic impairments associated with
prenatal alcohol exposure (CHIODO et al. 2009, ORNOY and ERGAZ 2010). Children
that have a strong, interdisciplinary support system including parents, teachers,
and health care professionals show improved social and learning skills (KALBERG
and BUCKLEY 2007). Additionally, these improvements may have a molecular basis
including epigenetic reprogramming of genes associated with cognition and
stress reactivity (WEAVER et al. 2004). Given that epigenetic alterations appear to
be a prominent consequence of prenatal alcohol exposure, the malleability of
these features by postnatal environment suggests that positive and enriched early
life experiences may ameliorate some prenatal alcohol effects in a stable and long term manner. There are also pharmaceutical epigenetic treatment opportunities
that have proven successful for enhancing learning and memory following
traumatic brain injury and within some models of neurodegenerative conditions
(HOCKLY et al. 2003, CHEN et al. 2006b, DASH et al. 2009), though the transient
effects and non-specific alterations to the epigenome limit this avenue.
Technologies such as CRISPR-Cas9-mediated alteration of epigenetic marks are
promising in that they may be able to specifically target and alter acetylation or
methylation at specific locations throughout the genome (DOUDNA and
CHARPENTIER 2014, HILTON et al. 2015). This technology is still being developed,
but it has proven effective and may, in the future, facilitate new treatments to
improve some phenotypes associated with neurodevelopmental disorders such
as FASD.
Finally, while mouse models can be extremely useful in identifying molecular
pathways that underlie neurodevelopmental disorders, it must be confirmed that
those models reliably and consistently reflect the processes that occur during
human neurodevelopment and contribute to the manifestation of any
neurological disorder.

As an initial step towards translating this research to

human FASD, our lab has performed some investigative studies examining if the
altered epigenetic patterning that we observed in mice following prenatal alcohol
exposure may be present in peripheral human tissues and may be used as a
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diagnostic measure in children. Indeed, similar to results obtained from mouse
brain tissue, we have observed a great deal of consistency between the
methylation patterns of buccal DNA obtained from children with FASD that were
distinct from non-exposed children, suggesting that analysis of DNA methylation
or other epigenetic marks may provide a novel diagnostic strategy (LAUFER et al.
2015).

4.5 Conclusions
4.5.1 Contributions to FASD research
Neurodevelopmental ethanol exposure results in a complex array of behavioural,
genetic and epigenetic changes in the brain. It is remarkable that so little attention
was given to such a detrimental, prevalent, and entirely preventable set of
disorders by the scientific and medical community until the early 1970s (LEMOINE
et al. 1968, JONES and SMITH 1973). Since its recognition, however, literature
examining the behavioural, cognitive, physiological, cellular, and genetic effects
on the developing brain has steadily grown. The results from these studies are
varied as are the strategies used by researchers, but consistent themes are
emerging. The results included in this thesis present several contributions to
extant FASD literature that, along with other research I have previously published,
have hopefully progressed our understanding of the biological mechanisms that
contribute to these disorders.
First, a goal of this research was to generate a mouse model that recapitulated a
number of phenotypes consistent with FASD that could be assessed at throughout
the maturation of the mouse from neonate to adult. To assess this, I developed a
behavioural battery designed to follow the maturation of the mouse from neonate
to adult to somewhat parallel the emergence of behaviours in children and young
adults affected by prenatal alcohol exposure. Further, the battery could be used
on cohorts of mice exposed to alcohol using varying treatment paradigms. While
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this thesis focuses on a third trimester-equivalent ‘binge’-like exposure, we have
also used the same battery on mice treated with binge doses at other trimester
equivalents as well as by voluntary maternal consumption throughout gestation.
This has allowed for the validation of these models in that they do show FASDrelevant behavioural and cognitive phenotypes but also allowed for the
comparison of the effects of ethanol exposure at different developmental times
and doses. The results from these studies have suggested that there are temporal
windows during neurodevelopment that affect the presence or severity of certain
behaviours as they appear later in life. The results also suggest that the third
trimester-equivalent is an extremely sensitive period for the disruption of brain
regions or pathways associated with spatial learning and stress reactivity. These
data are consistent with FASD as a ‘spectrum’ disorder and support that alcohol
timing and dose are key factors that contribute to the range of neurobehavioural
phenotypes associated with prenatal alcohol exposure.
Second, this study is the first to examine genome-wide changes in gene expression
resulting from ethanol exposure during synaptogenesis. Gene expression was
examined at two time points: acutely (4 hours) following ethanol exposure to gain
insight into how ethanol may alter neurodevelopmental processes, and during
adulthood (postnatal day 60) to evaluate how neurodevelopmental alcohol
exposure may cause long-lasting changes within the adult brain and how these
changes relate to the persistent FASD-associated phenotypes. The acute response
was characterized by cellular stress response and the down-regulation of
energetically costly cellular processes, consistent with the current literature;
however, there were a subset of genes identified associated with glutamate
neurotransmission and synaptic formation that were not over -represented in
other treatment paradigms. This ability to compare altered gene sets across
different treatments has been informative, and has led to our hypothesis that
ethanol may most effectively disrupt neurodevelopmental processes that are
active at the time of exposure, perhaps due to their sensitivity to environmental
cues. Also, while few transcripts were identified as altered in both the sh ort-term
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and long-term analyses, there was considerable consistency between the
biological processes and pathway associated with them including synaptic
plasticity, neurotransmission, and HPA axis function. These processes were
consistent with the learning and anxiety-related phenotypes I observed in these
animals, particularly with regard to their severity compared to animals treated
using other paradigms.
Finally, given that epigenetic mechanisms have been implicated in maintaining
the long-term effects of prenatal alcohol exposure, miRNA expression in the adult
brain was analyzed to evaluate any correlations between altered miRNA levels
and the expression of their putative mRNA targets. A number of miRNAs were
identified and showed an inverse direction of expression change as compared to
their mRNA target(s). While this analysis requires further confirmation, the
processes associated with the mRNA targets again showed an over representation of a number of processes identified by both mRNA array
experiments.
It is important to note that all of these analyses are exploratory and designed
toward establishing and testing the utility of a novel animal model strategy in
assessing the molecular changes in the brain associated with FASD. The model
has proven effective in identifying molecular features of ethanol exposure at
different developmental times, and comparing those changes with differences in
observed behaviours. Also, there is consistency and a logical agreement between
the results from multiple lines of analyses including behaviour, biological
functions associated with the short and long-term transcript changes, and miRNA
target processes that may point to lucrative avenues for future investigation. This
process, while essential and valuable, is an initial step towards understanding the
complexity associated with how ethanol can affect the developing brain and lead
to a lifetime of behavioural and cognitive changes. These studies leave many more
questions regarding the role of these genes in altering the function of cells, brain
regions, and the neural interactions that ultimately dictate behaviour, as well as
which mechanisms may be effective diagnostic or therapeutic targets. There
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likely will be no ‘smoking gun’ mechanism or course of obvious treatment;
however, this research has facilitated ongoing studies that use the models and
findings established within this thesis to more deeply explore biological
mechanisms that contribute to FASD including epigenetic alterations such as the
involvement of DNA methylation and histone modification, how alcohol exposure
may interact with postnatal environment to affect behaviour, and translational
work involving potential diagnostic strategies in humans.

4.5.2 A working model of FASD
This study was initiated to provide a holistic investigation into the effects of
ethanol exposure during neurodevelopment on behaviour, gene expression, and
epigenetic patterning. The model allows for the proposal of FASD as a continuum
of molecular events that ultimately manifests as long-term cognitive and
behavioural phenotypes (Figure 4.1).

Ethanol exposure represents an

interruption in normal neurodevelopmental processes. Depending on the timing
of exposure, certain populations of cells will succumb to cellular stress response
and undergo apoptosis, while surviving cells must suspend their normal
developmental trajectories and utilize molecular adaptations that include
changes in gene expression and epigenetic patterning.

These epigenetic

alterations likely involve the interaction of DNA methylation, histone
modification, and ncRNA regulation. Many of these epigenetic changes are
expected

to

be

stably

inherited

following

subsequent neurogenesis,

differentiation, and maturation, resulting in not only altered brain str ucture and
neuronal connectivity but also a distinctive pattern of altered gene expression in
the mature brain. These transcriptomic and epigenetic changes represent an
enduring molecular “footprint” that reflects the timing, dose, and pattern of
alcohol exposure as well as their interactions with maternal and fetal genotype
and the prenatal environment. This reprogramming of neurogenomic patterning
may be further compounded by subsequent ontogenetic factors such as postnatal
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environment, which may further exacerbate or ameliorate epigenetic signatures
and subsequent gene expression. Postnatal environment is therefore a potential
avenue for early-life mitigation of FASD phenotypes. Also, these epigenetic
signatures may—if shared by peripheral tissue sources—offer a source of early
diagnosis of prenatal alcohol exposure. Given the unlikelihood of total abstinence
from alcohol consumption during pregnancy, particularly within Western
cultures, evidence that the effects of prenatal alcohol exposure may be amended
or reversed at the molecular and, subsequently, at the phenotypic level would
represent a significant step towards improving the prognosis of individuals with
FASD.
Not even half a century after the recognition that alcohol consumption during
pregnancy leads to a set of characteristic physiological and cognitive phenotypes
that led Jones and Smith to coin the term ‘fetal alcohol syndrome’ (JONES et al.
1973), we are making leaps in our understanding of the myriad of effects of
alcohol on neurodevelopment, including its eventual manifestation as increased
risk for behavioural and cognitive phenotypes that ultimately impair the ability of
an ethanol-exposed child to thrive.

In addition to contributing to our

understanding of the biological etiology of FASD, it is hoped that this work
facilitates the development of novel therapeutic and treatment approaches to
improve the outcome of individuals with this pervasive and costly disorder. Given
the increase in prevalence of disorders of neurodevelopmental origin, this work
also provides a model to assist in our understanding of how adverse prenatal
environments, including exposure to teratogens such as alcohol, can lead to
adverse effects on brain development that contributes to the emergence of later life psychopathologies.
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FIGURE 4.1. A working model of FASD as a continuum of genetic and epigenetic events. (A) Ethanol exposure results in cellular
stress response leading to the apoptosis of vulnerable cell types. (B) These changes are followed by molecular adaptation in
surviving cells that include changes to gene expression, driven in part by changes to epigenetic programming including altered DNA
methylation, histone modifications, and ncRNA regulation. (C) These changes may be inherited and maintained throughout further
developmental processes such as cellular differentiation and maturation. Additionally, following parturition, epigenetic control of
gene expression is vulnerable to exacerbation or amelioration by postnatal environmental experiences. (D) Adverse (red) or
positive (green) outcomes likely depend on the interaction of these factors and contribute to the ontogeny of FASD phenotypes.
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Appendix A. mRNA transcripts identified as altered in the brain of neonate mice (postnatal day 7) four hours following ethanol
treatment (fold cutoff ≥ ±1.2, FDR-corrected p-value < 0.05). Genes are listed alphabetically by gene symbol.
Transcript
ID
10539766

Gene
symbol
Aak1

10392484

Chra

Fold change

p-value b

6

1.22

0.012

NM_013851

11

1.36

0.009

ATP-binding cassette, sub-family G (WHITE), member 1

NM_009593

17

1.21

0.024

Accs

1-aminocyclopropane-1-carboxylate synthase (non-functional)

NM_183220

2

1.36

0.002

10505779

Acer2

alkaline ceramidase 2

NM_139306

4

1.31

0.003

10397172

Acot6

acyl-CoA thioesterase 6

NM_172580

12

1.25

0.005

10554074

Adamts17

NM_001033877

7

1.21

0.007

10531195

Adamts3

NM_177872

5

1.20

0.038

10351551

Adamts4

NM_172845

1

1.21

0.002

10447502

Adcyap1

a disintegrin-like and metallopeptidase (reprolysin type) with
thrombospondin type 1 motif, 17
a disintegrin-like and metallopeptidase (reprolysin type) with
thrombospondin type 1 motif, 3
a disintegrin-like and metallopeptidase (reprolysin type) with
thrombospondin type 1 motif, 4
adenylate cyclase activating polypeptide 1

NM_009625

17

-1.31

0.014

10479351

Adrm1

adhesion regulating molecule 1

NM_019822

2

-1.21

0.012

10523647

Aff1

AF4/FMR2 family, member 1

NM_001080798

5

1.22

0.005

10534889

Agfg2

ArfGAP with FG repeats 2

NM_178162

5

-1.21

0.009

10582658

Agt

angiotensinogen (serpin peptidase inhibitor, clade A, member 8)

NM_007428

8

1.23

0.038

10472923

Ak4

adenylate kinase 4

NM_001177602

4

-1.22

0.024

10446214

Alkbh7

alkB, alkylation repair homolog 7 (E. coli)

NM_025538

17

-1.25

0.049

10459389

Amd1

S-adenosylmethionine decarboxylase 1

NM_009665

10

-1.21

0.014

10595668

Ankrd34c

ankyrin repeat domain 34C

NM_207260

9

-1.40

0.022

10583834

Anln

anillin, actin binding protein

NM_028390

9

1.23

0.010

10594631

Aph1b

anterior pharynx defective 1b homolog (C. elegans)

NM_177583

9

1.22

0.003

10604375

Apln

apelin

NM_013912

X

-1.29

0.042

10450796

Armcx5

armadillo repeat containing, X-linked 5

NM_001009575

X

1.40

0.037

Gene name

RefSeq ID

AP2 associated kinase 1

NM_001040106

Abca8b

ATP-binding cassette, sub-family A (ABC1), member 8b

10443730

Abcg1

10485241

223

10406407

Arrdc3

arrestin domain containing 3

NM_001042591

13

2.22

0.000

10564507

Arrdc4

arrestin domain containing 4

NM_001042592

7

1.65

0.001

10499666

Atp8b2

ATPase, class I, type 8B, member 2

NM_001081182

3

1.29

0.029

10490104

Aurka

aurora kinase A

NM_011497

2

-1.24

0.007

10406456

AY512938

cDNA sequence AY512938

AY512938

UN

1.25

0.003

10437191

B3galt5

UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5

NM_033149

16

1.31

0.008

10434291

B3gnt5

UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5

NM_001159407

16

1.23

0.040

10439854

Bbx

bobby sox homolog (Drosophila)

NM_027444

16

1.23

0.001

10587085

BC031353

family with sequence similarity 214, member A

NM_001113283

9

1.21

0.019

10439409

BC031361

cDNA sequence BC031361

NR_033221

16

1.20

0.042

10475866

Bcl2l11

BCL2-like 11 (apoptosis facilitator)

NM_207680

2

1.46

0.002

10357875

Btg2

B cell translocation gene 2, anti-proliferative

NM_007570

1

1.48

0.001

10440419

Btg3

B cell translocation gene 3

NM_009770

16

1.25

0.004

10515026

Cc2d1b

coiled-coil and C2 domain containing 1B

NM_177045

4

1.23

0.011

10578557

Ccdc111

primase and polymerase (DNA-directed)

NM_001001184

8

1.29

0.025

10368083

Ccdc28a

coiled-coil domain containing 28A

NM_144820

10

1.30

0.021

10569646

Ccnd1

cyclin D1

NM_007631

7

-1.34

0.003

10349442

Ccnt2

cyclin T2

NM_028399

1

-1.20

0.024

10474229

Cd59a

CD59a antigen

NM_001111060

2

1.24

0.037

10564573

Chd2

chromodomain helicase DNA binding protein 2

NM_001081345

7

1.34

0.006

10583347

Chordc1

NM_025844

9

-1.28

0.008

10507726

Cited4

NM_019563

4

-1.26

0.013

10438769

Cldn1

cysteine and histidine-rich domain (CHORD)-containing, zinc-binding
protein 1
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal
domain, 4
claudin 1

NM_016674

16

1.29

0.018

10547674

Clec4e

C-type lectin domain family 4, member e

AB024717

6

1.20

0.007

10597564

Cmc1

COX assembly mitochondrial protein 1

NM_026442

9

-1.20

0.028

10364593

Cnn2

calponin 2

NM_007725

10

-1.21

0.010

224

10346298

Coq10b

coenzyme Q10 homolog B (S. cerevisiae)

NM_001039710

1

-1.26

0.014

10565089

Cpeb1

cytoplasmic polyadenylation element binding protein 1

NM_007755

7

1.31

0.011

10388996

Crlf3

cytokine receptor-like factor 3

NM_018776

11

1.21

0.024

10371400

Cry1

cryptochrome 1 (photolyase-like)

NM_007771

10

-1.24

0.001

10428453

Csmd3

CUB and Sushi multiple domains 3

NM_001081391

15

1.21

0.007

10472408

Csrnp3

cysteine-serine-rich nuclear protein 3

NM_153409

2

1.25

0.012

10485580

Cstf3

cleavage stimulation factor, 3' pre-RNA, subunit 3

NM_145529

2

1.31

0.011

10515943

Ctps

cytidine 5'-triphosphate synthase

NM_016748

4

-1.22

0.003

10453057

Cyp1b1

cytochrome P450, family 1, subfamily b, polypeptide 1

NM_009994

17

1.25

0.011

10514520

Cyp2j9

cytochrome P450, family 2, subfamily j, polypeptide 9

NM_028979

4

1.29

0.001

10489498

Dbndd2

dysbindin (dystrobrevin binding protein 1) domain containing 2

NM_001048227

2

-1.22

0.041

10369290

Ddit4

DNA-damage-inducible transcript 4

NM_029083

10

1.24

0.023

10369630

Ddx21

DEAD (Asp-Glu-Ala-Asp) box polypeptide 21

NM_019553

10

-1.27

0.001

10470628

Ddx31

DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 31

NM_001033294

2

-1.20

0.004

10525751

Ddx55

DEAD (Asp-Glu-Ala-Asp) box polypeptide 55

NM_026409

5

-1.21

0.036

10437664

Dexi

dexamethasone-induced transcript

NM_021428

16

1.21

0.011

10401841

Dio2

deiodinase, iodothyronine, type II

NM_010050

12

-1.21

0.023

10449284

Dusp1

dual specificity phosphatase 1

NM_013642

17

1.65

0.001

10548735

Dusp16

dual specificity phosphatase 16

NM_130447

6

1.27

0.004

10571312

Dusp4

dual specificity phosphatase 4

NM_176933

8

-1.35

0.035

10366043

Dusp6

dual specificity phosphatase 6

NM_026268

10

-1.73

0.000

10588495

Dusp7

dual specificity phosphatase 7

NM_153459

9

-1.21

0.002

10569280

Dusp8

dual specificity phosphatase 8

NM_008748

7

1.21

0.011

10574682

E2f4

E2F transcription factor 4

NM_148952

8

-1.29

0.046

10404783

Edn1

endothelin 1

NM_010104

13

1.29

0.019

10603768

Efhc2

EF-hand domain (C-terminal) containing 2

NM_028916

X

1.23

0.007

10518069

Efhd2

EF hand domain containing 2

NM_025994

4

-1.28

0.007
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10416251

Egr3

early growth response 3

NM_018781

14

-1.26

0.003

10545859

Egr4

early growth response 4

NM_020596

6

-1.25

0.040

10368317

Enpp3

ectonucleotide pyrophosphatase/phosphodiesterase 3

NM_134005

10

1.22

0.047

10357164

Epb41l5

erythrocyte membrane protein band 4.1 like 5

NM_145506

1

-1.20

0.027

10391490

Etv4

ets variant 4

NM_008815

11

-1.27

0.016

10438626

Etv5

ets variant 5

NM_023794

16

-1.73

0.000

10545045

Fam13a

family with sequence similarity 13, member A

NM_153574

6

1.30

0.004

10368638

Fam26e

family with sequence similarity 26, member E

NM_178908

10

1.31

0.018

10597088

Fbxw26

F-box and WD-40 domain protein 26

NM_198674

9

1.22

0.049

10524052

Fgfrl1

fibroblast growth factor receptor-like 1

NM_054071

5

-1.26

0.013

10505044

Fktn

fukutin

NM_139309

4

1.25

0.005

10565401

Folh1

folate hydrolase 1

NM_016770

7

1.44

0.003

10368886

Foxo3

forkhead box O3

10

1.27

0.000

10553769

Gabra5

gamma-aminobutyric acid (GABA) A receptor, subunit alpha 5

ENSMUST00000
105502
NM_176942

7

-1.23

0.024

10404702

Gcnt2

glucosaminyl (N-acetyl) transferase 2, I-branching enzyme

NM_023887

13

1.22

0.014

10418480

Gnl3

guanine nucleotide binding protein-like 3 (nucleolar)

NM_153547

14

-1.21

0.002

10493120

Gpatch4

G patch domain containing 4

NM_025663

3

-1.23

0.014

10414278

Gpr137c

G protein-coupled receptor 137C

NM_027518

14

1.32

0.000

10567361

Gpr139

G protein-coupled receptor 139

NM_001024138

7

1.30

0.002

10368780

Gpr6

G protein-coupled receptor 6

NM_199058

10

1.40

0.007

10433101

Gpr84

G protein-coupled receptor 84

NM_030720

15

-1.22

0.029

10437629

Grin2a

glutamate receptor, ionotropic, NMDA2A (epsilon 1)

NM_008170

16

1.25

0.049

10548791

Grin2b

glutamate receptor, ionotropic, NMDA2B (epsilon 2)

NM_008171

6

1.25

0.018

10407543

Gtpbp4

GTP binding protein 4

NM_027000

13

-1.27

0.002

10444802

H2-Q2

histocompatibility 2, Q region locus 2

NM_010392

17

-1.23

0.037

10447004

Hdac1

histone deacetylase 1

NM_008228

4

-1.25

0.000

10399973

Hdac9

histone deacetylase 9

NM_024124

12

-1.22

0.008
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10403511

Heatr1

HEAT repeat containing 1

NM_144835

13

-1.31

0.001

10560329

Hif3a

hypoxia inducible factor 3, alpha subunit

NM_001162950

7

1.23

0.003

10358609

Hmcn1

hemicentin 1

NM_001024720

1

-1.20

0.039

10435443

Hspbap1

Hspb associated protein 1

NM_175111

16

-1.23

0.004

10509238

Htr1d

5-hydroxytryptamine (serotonin) receptor 1D

NM_008309

4

1.23

0.038

10520355

Htr5a

5-hydroxytryptamine (serotonin) receptor 5A

NM_008314

5

1.22

0.009

10400095

Ifrd1

interferon-related developmental regulator 1

NM_013562

12

-1.29

0.035

10554094

Igf1r

insulin-like growth factor I receptor

NM_010513

7

1.21

0.043

10384223

Igfbp3

insulin-like growth factor binding protein 3

NM_008343

11

1.26

0.013

10498386

Igsf10

immunoglobulin superfamily, member 10

NM_001162884

3

1.34

0.002

10579958

Il15

interleukin 15

NM_008357

8

-1.23

0.005

10413398

Il17rd

interleukin 17 receptor D

NM_134437

14

-1.21

0.043

10465861

Incenp

inner centromere protein

NM_016692

19

-1.21

0.040

10403743

Inhba

inhibin beta-A

NM_008380

13

-1.23

0.006

10389421

Ints2

integrator complex subunit 2

NM_027421

11

1.26

0.013

10557925

Itgad

integrin, alpha D

7

-1.25

0.039

10567297

Itpripl2

inositol 1,4,5-triphosphate receptor interacting protein-like 2

ENSMUST00000
106237
NM_001033380

7

1.24

0.025

10544148

Jhdm1d

lysine (K)-specific demethylase 7A

NM_001033430

6

1.24

0.043

10411126

Jmy

junction-mediating and regulatory protein

NM_021310

13

1.25

0.006

10514466

Jun

jun proto-oncogene

NM_010591

4

2.60

0.000

10382321

Kcnj2

potassium inwardly-rectifying channel, subfamily J, member 2

NM_008425

11

-1.40

0.008

10561702

Kcnk6

potassium inwardly-rectifying channel, subfamily K, member 6

NM_001033525

7

1.36

0.043

10412650

Kctd6

potassium channel tetramerisation domain containing 6

NM_027782

14

1.27

0.035

10403352

Klf6

Kruppel-like factor 6

NM_011803

13

-1.26

0.011

10396079

Klhdc1

kelch domain containing 1

NM_178253

12

1.25

0.012

10434302

Klhl24

kelch-like 24

NM_029436

16

1.28

0.024

10400572

Klhl28

kelch-like 28

NM_025707

12

1.21

0.025
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10519392

Krit1

KRIT1, ankyrin repeat containing

NR_033173

5

-1.21

0.036

10603254

Larp4

La ribonucleoprotein domain family, member 4

NM_001024526

15

-1.31

0.015

10583732

Ldlr

low density lipoprotein receptor

NM_010700

9

-1.26

0.020

10422822

Lifr

leukemia inhibitory factor receptor

NM_013584

15

1.23

0.025

10467139

Lipa

lysosomal acid lipase A

NM_021460

19

1.25

0.024

10578207

Lonrf1

LON peptidase N-terminal domain and ring finger 1

NM_001081150

8

-1.22

0.035

10367931

Ltv1

LTV1 homolog (S. cerevisiae)

NM_181470

10

-1.48

0.005

10521555

Lyar

Ly1 antibody reactive clone

NM_025281

5

-1.28

0.023

10510464

Lzic

leucine zipper and CTNNBIP1 domain containing

NM_026963

4

-1.28

0.032

10465244

Malat1

NR_002847

19

1.53

0.004

10568780

Mapk1ip1

metastasis associated lung adenocarcinoma transcript 1 (non-coding
RNA)
mitogen-activated protein kinase 1 interacting protein 1

7

1.20

0.001

10425507

Mchr1

melanin-concentrating hormone receptor 1

NM_145132

15

1.37

0.006

10546163

Mcm2

minichromosome maintenance deficient 2 mitotin (S. cerevisiae)

NM_008564

6

-1.22

0.011

10470696

Med27

mediator complex subunit 27

NM_026896

2

-1.26

0.027

10455826

Megf10

multiple EGF-like-domains 10

NM_001001979

18

1.22

0.020

10475890

Mertk

c-mer proto-oncogene tyrosine kinase

NM_008587

2

1.56

0.001

10382852

Mfsd11

major facilitator superfamily domain containing 11

NM_178620

11

1.23

0.044

10378568

Mir22

microRNA 22

NR_029739

11

-1.36

0.006

10398442

Mir410

microRNA 410

NR_029914

12

-1.47

0.003

10398394

Mir494

microRNA 494

NR_030269

12

-1.22

0.041

10469239

Mir669c

microRNA 669c

NR_030473

2

-1.33

0.029

10433656

Mkl2

MKL/myocardin-like 2

NM_153588

16

1.28

0.029

10401616

Mlh3

mutL homolog 3 (E coli)

NM_175337

12

1.24

0.034

10564313

Mphosph10

M-phase phosphoprotein 10 (U3 small nucleolar ribonucleoprotein)

NM_026483

7

-1.34

0.030

10566514

Mrps36

mitochondrial ribosomal protein S36

NM_025369

13

-1.22

0.043

10574027

Mt1

metallothionein 1

NM_013602

8

1.25

0.004

10574023

Mt2

metallothionein 2

NM_008630

8

1.37

0.015

228

NM_001045483

10605421

Mtcp1

mature T cell proliferation 1

NM_001039373

X

1.27

0.000

10545672

Mthfd2

methylenetetrahydrofolate dehydrogenase (NAD+ dependent),
methenyltetrahydrofolate cyclohydrolase

NM_008638

6

-1.27

0.012

10361366

Mtrf1l

mitochondrial translational release factor 1-like

NM_175374

10

-1.20

0.022

10601980

Mum1l1

melanoma associated antigen (mutated) 1-like 1

NM_001164630

X

1.25

0.011

10503643

Ndufaf4

NM_026742

4

-1.29

0.005

10488771

Necab3

NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor
4
N-terminal EF-hand calcium binding protein 3

2

-1.20

0.015

10408850

Nedd9

neural precursor cell expressed, developmentally down-regulated gene 9

NM_001111324

13

1.20

0.018

10577492

Nek3

NIMA (never in mitosis gene a)-related expressed kinase 3

NM_001162947

8

1.21

0.046

10493114

Nes

nestin

NM_016701

3

-1.22

0.032

10492598

Nmd3

NMD3 homolog (S. cerevisiae)

NM_133787

3

-1.26

0.003

10404827

Nol7

nucleolar protein 7

NM_023554

13

-1.20

0.035

10463535

Nolc1

nucleolar and coiled-body phosphoprotein 1

NM_053086

19

-1.26

0.018

10541845

Nop2

NOP2 nucleolar protein

NM_138747

6

-1.21

0.002

10600707

Nr0b1

nuclear receptor subfamily 0, group B, member 1

NM_007430

X

-1.30

0.025

10427035

Nr4a1

nuclear receptor subfamily 4, group A, member 1

NM_010444

15

-1.40

0.015

10522192

Nsun7

NOL1/NOP2/Sun domain family, member 7

NM_027602

5

1.20

0.032

10479397

Ntsr1

neurotensin receptor 1

NM_018766

2

1.21

0.012

10598236

Nudt11

nudix (nucleoside diphosphate linked moiety X)-type motif 11

NM_021431

X

1.33

0.004

10416510

Nufip1

nuclear fragile X mental retardation protein interacting protein 1

NM_013745

14

-1.22

0.009

10361651

Nup43

nucleoporin 43

NM_145706

10

-1.21

0.014

10466268

Olfr1418

olfactory receptor 1418

NM_001011524

19

-1.24

0.017

10436823

Olig2

oligodendrocyte transcription factor 2

NM_016967

16

-1.30

0.009

10360454

Opn3

opsin 3

NM_010098

1

-1.21

0.035

10346260

Osgepl1

O-sialoglycoprotein endopeptidase-like 1

NM_028091

1

1.29

0.008

10427471

Osmr

oncostatin M receptor

NM_011019

15

1.23

0.033

10498367

P2ry13

purinergic receptor P2Y, G-protein coupled 13

NM_028808

3

-1.20

0.012
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NM_021546

10363350

P4ha1

NM_011030

10

-1.26

0.017

Parp16

procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4hydroxylase), alpha 1 polypeptide
poly (ADP-ribose) polymerase family, member 16

10586347

NM_177460

9

1.21

0.035

10455118

Pcdhb18

protocadherin beta 18

NM_053143

18

1.21

0.018

10455135

Pcdhb21

protocadherin beta 21

NM_053146

18

1.22

0.015

10479726

Pcmtd2

NM_153594

2

1.30

0.005

10414417

Peli2

protein-L-isoaspartate (D-aspartate) O-methyltransferase domain
containing 2
pellino 2

NM_033602

14

1.21

0.023

10377439

Per1

period circadian clock 1

NM_001159367

11

1.20

0.000

10356601

Per2

period circadian clock 2

NM_011066

1

-1.26

0.037

10361887

Perp

PERP, TP53 apoptosis effector

NM_022032

10

1.25

0.030

10470959

Phyhd1

phytanoyl-CoA dioxygenase domain containing 1

NM_172267

2

1.22

0.033

10351788

Pigm

phosphatidylinositol glycan anchor biosynthesis, class M

NM_026234

1

1.25

0.040

10441055

Pigp

phosphatidylinositol glycan anchor biosynthesis, class P

NM_001159617

16

-1.21

0.041

10517083

Pigv

phosphatidylinositol glycan anchor biosynthesis, class V

NM_178698

4

1.21

0.008

10373740

Pik3ip1

phosphoinositide-3-kinase interacting protein 1

NM_178149

11

1.51

0.002

10411782

Pik3r1

NM_001077495

13

1.21

0.005

10515399

Plk3

phosphatidylinositol 3-kinase, regulatory subunit, polypeptide 1 (p85
alpha)
polo-like kinase 3

NM_013807

4

-1.23

0.006

10499366

Pmf1

polyamine-modulated factor 1

NM_025928

3

-1.21

0.033

10384474

Pno1

partner of NOB1 homolog (S. cerevisiae)

NM_025443

11

-1.28

0.037

10421351

Polr3d

polymerase (RNA) III (DNA directed) polypeptide D

NM_025945

14

-1.27

0.018

10394240

Pomc

pro-opiomelanocortin-alpha

NM_008895

12

-1.21

0.013

10543471

Pot1a

protection of telomeres 1A

NM_133931

6

1.24

0.000

10545001

Ppm1k

protein phosphatase 1K (PP2C domain containing)

NM_175523

6

1.30

0.020

10525374

Pptc7

PTC7 protein phosphatase homolog (S. cerevisiae)

NM_177242

5

-1.20

0.013

10485624

Prrg4

proline rich Gla (G-carboxyglutamic acid) 4 (transmembrane)

NM_178695

2

1.27

0.006

10587616

Prss35

protease, serine 35

NM_178738

9

1.41

0.010

10578986

Psd3

pleckstrin and Sec7 domain containing 3

NM_030263

8

1.28

0.021
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10535637

Ptcd1

pentatricopeptide repeat domain 1

NM_133735

5

1.20

0.026

10357191

Ptpn4

protein tyrosine phosphatase, non-receptor type 4

NM_019933

1

1.23

0.010

10376163

Rapgef6

Rap guanine nucleotide exchange factor (GEF) 6

NM_175258

11

1.66

0.000

10522467

Rasl11b

RAS-like, family 11, member B

NM_026878

5

1.45

0.003

10558840

Rassf7

Ras association (RalGDS/AF-6) domain family (N-terminal) member 7

NM_025886

7

-1.21

0.025

10453867

Rbbp8

retinoblastoma binding protein 8

NM_001081223

18

-1.32

0.001

10410709

Rfesd

Rieske (Fe-S) domain containing

NM_178916

13

1.23

0.003

10359908

Rgs4

regulator of G-protein signaling 4

NM_009062

1

-1.30

0.000

10466935

Rln1

relaxin 1

NM_011272

19

1.22

0.027

10350742

Rnasel

ribonuclease L (2', 5'-oligoisoadenylate synthetase-dependent)

NM_011882

1

1.28

0.003

10404965

Rnf144b

ring finger protein 144B

NM_146042

13

1.30

0.009

10565852

Rnf169

ring finger protein 169

NM_175388

7

1.20

0.020

10381395

Rundc1

RUN domain containing 1

NM_172566

11

-1.22

0.043

10351430

Rxrg

retinoid X receptor gamma

NM_009107

1

-1.24

0.022

10402512

Scarna13

small Cajal body-specific RNA 1

NR_028576

12

1.27

0.012

10514219

Scarna8

small Cajal body-specific RNA 8

NR_028545

4

1.21

0.015

10483326

Scn9a

sodium channel, voltage-gated, type IX, alpha

NM_018852

2

1.29

0.012

10489484

Sdc4

syndecan 4

NM_011521

2

1.31

0.004

10357072

Serpinb3a

serine (or cysteine) peptidase inhibitor, clade B (ovalbumin), member 3A

NM_009126

1

1.20

0.041

10362811

Sesn1

sestrin 1

NM_001162908

10

1.29

0.001

10469167

Sfmbt2

Scm-like with four mbt domains 2

NM_177386

2

1.29

0.033

10457959

Sft2d3

SFT2 domain containing 3

NM_026006

18

-1.23

0.009

10471505

Sh2d3c

SH2 domain containing 3C

NM_013781

2

1.39

0.000

10393866

Sirt7

sirtuin 7

NM_153056

11

-1.33

0.021

10356240

Slc16a14

solute carrier family 16 (monocarboxylic acid transporters), member 14

NM_027921

1

1.33

0.003

10392440

Slc16a6

solute carrier family 16 (monocarboxylic acid transporters), member 6

NM_001029842

11

1.35

0.006

10363860

Slc16a9

solute carrier family 16 (monocarboxylic acid transporters), member 9

NM_025807

10

1.36

0.010
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10397835

Slc24a4

solute carrier family 24 (sodium/potassium/calcium exchanger), member 4

NM_172152

12

1.34

0.000

10495405

Slc25a24

NM_172685

3

1.28

0.015

10507594

Slc2a1

solute carrier family 25 (mitochondrial carrier, phosphate carrier), member
24
solute carrier family 2 (facilitated glucose transporter), member 1

NM_011400

4

1.30

0.003

10378649

Slc43a2

solute carrier family 43, member 2

NM_173388

11

1.28

0.001

10496975

Slc44a5

solute carrier family 44, member 5

NM_001081263

3

1.41

0.002

10386683

Slc47a1

solute carrier family 47, member 1

NM_026183

11

-1.23

0.020

10605986

Slc7a3

NM_007515

X

1.21

0.049

10396936

Smoc1

solute carrier family 7 (cationic amino acid transporter, y+ system),
member 3
SPARC related modular calcium binding 1

NM_001146217

12

1.21

0.010

10383731

Smtn

smoothelin

NM_001159284

11

-1.22

0.030

10396442

Snapc1

small nuclear RNA activating complex, polypeptide 1

NM_178392

12

-1.22

0.047

10576216

Snord68

small nucleolar RNA, C/D box 68

NR_028128

8

-1.21

0.010

10582874

Sp110

Sp110 nuclear body protein

NM_175397

1

1.23

0.018

10347933

Sp140

Sp140 nuclear body protein

NM_001013817

1

-1.21

0.046

10387936

Spag7

sperm associated antigen 7

NM_172561

11

-1.22

0.025

10561673

Spred3

sprouty-related, EVH1 domain containing 3

NM_182927

7

-1.35

0.008

10458555

Spry4

sprouty homolog 4 (Drosophila)

NM_011898

18

-1.69

0.001

10393395

Srsf2

serine/arginine-rich splicing factor 2

NM_011358

11

-1.21

0.000

10453102

Srsf7

serine/arginine-rich splicing factor 7

NR_036615

17

-1.20

0.013

10434758

St6gal1

beta galactoside alpha 2,6 sialyltransferase 1

NM_145933

16

1.21

0.020

10549162

St8sia1

ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1

NM_011374

6

1.22

0.013

10519484

Steap2

six transmembrane epithelial antigen of prostate 2

AK141701

5

1.56

0.004

10554863

Sytl2

synaptotagmin-like 2

NM_001040085

7

1.25

0.040

10515706

Szt2

seizure threshold 2

NM_198170

4

-1.22

0.047

10448707

Tbl3

transducin (beta)-like 3

NM_145396

17

-1.21

0.025

10365098

Tbxa2r

thromboxane A2 receptor

NM_009325

10

-1.23

0.022

10365344

Tcp11l2

t-complex 11 (mouse) like 2

NM_146008

10

1.22

0.047

10369688

Tet1

tet methylcytosine dioxygenase 1

NM_027384

10

1.22

0.041
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10401673

Tgfb3

transforming growth factor, beta 3

NM_009368

12

1.32

0.000

10567316

Tmc7

transmembrane channel-like gene family 7

NM_172476

7

1.25

0.000

10572318

Tmem161a

transmembrane protein 161A

NM_145597

8

-1.24

0.045

10458314

Tmem173

transmembrane protein 173

NM_028261

18

-1.23

0.039

10346224

Tmem194b

transmembrane protein 194B

NM_001142647

1

1.23

0.026

10461214

Tmem223

transmembrane protein 223

NM_025791

19

-1.20

0.040

10572747

Tpm4

tropomyosin 4

NM_001001491

8

-1.20

0.004

10438621

Tra2b

transformer 2 beta homolog (Drosophila)

NM_009186

16

-1.30

0.020

10503259

Trp53inp1

transformation related protein 53 inducible nuclear protein 1

NM_021897

4

1.32

0.001

10353221

Trpa1

transient receptor potential cation channel, subfamily A, member 1

NM_177781

1

-1.20

0.017

10428534

Trps1

trichorhinophalangeal syndrome I (human)

NM_032000

15

1.31

0.011

10483819

Ttc30b

tetratricopeptide repeat domain 30B

NM_028235

2

1.27

0.000

10456400

Tubb6

tubulin, beta 6 class V

NM_026473

18

-1.26

0.009

10494428

Txnip

thioredoxin interacting protein

NM_001009935

3

2.63

0.000

10599222

Ube2a

ubiquitin-conjugating enzyme E2A

NM_019668

X

-1.27

0.046

10416793

Uchl3

ubiquitin carboxyl-terminal esterase L3 (ubiquitin thiolesterase)

NM_016723

14

-1.22

0.039

10469083

Upf2

UPF2 regulator of nonsense transcripts homolog (yeast)

NM_001081132

2

1.32

0.004

10440800

Urb1

URB1 ribosome biogenesis 1 homolog (S. cerevisiae)

NM_029497

16

-1.26

0.011

10516229

Utp11l

UTP11-like, U3 small nucleolar ribonucleoprotein, (yeast)

NM_026031

4

-1.27

0.004

10389842

Utp18

UTP18, small subunit (SSU) processome component, homolog (yeast)

NM_001013375

11

-1.27

0.010

10451198

Vegfa

vascular endothelial growth factor A

NM_001025250

17

-1.24

0.000

10547682

Vmn2r22

vomeronasal 2, receptor 22

NM_001104637

6

1.20

0.007

10559880

Vmn2r33

vomeronasal 2, receptor 33

NM_001105065

7

1.29

0.045

10549904

Vmn2r37

vomeronasal 2, receptor 37

NM_009489

7

1.24

0.034

10559890

Vmn2r43

vomeronasal 2, receptor 43

NM_198961

7

1.28

0.011

10405879

Vmn2r85

vomeronasal 2, receptor 85

NM_001102602

10

1.24

0.026

10552425

Vsig10l

V-set and immunoglobulin domain containing 10 like

BC112410

7

-1.21

0.045
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10444098

Wdr46

WD repeat domain 46

NM_020603

17

-1.21

0.005

10346074

Wdr75

WD repeat domain 75

NM_028599

1

-1.21

0.004

10373000

Xrcc6bp1

XRCC6 binding protein 1

NM_026858

10

-1.20

0.020

10433904

Yars2

tyrosyl-tRNA synthetase 2 (mitochondrial)

NM_198246

16

-1.20

0.048

10473349

Ypel4

yippee-like 4 (Drosophila)

NM_001005342

2

1.49

0.018

10446756

Ypel5

yippee-like 5 (Drosophila)

NM_027166

17

1.23

0.006

10406733

Zbed3

zinc finger, BED type containing 3

NM_028106

13

1.30

0.003

10490826

Zbtb10

zinc finger and BTB domain containing 10

NM_177660

3

1.38

0.002

10509998

Zbtb17

zinc finger and BTB domain containing 17

NM_009541

4

-1.25

0.010

10480027

Zbtb2

zinc finger and BTB domain containing 2

NM_001033466

10

-1.28

0.043

10359377

Zbtb37

zinc finger and BTB domain containing 37

NM_173424

1

1.22

0.001

10475946

Zc3h6

zinc finger CCCH type containing 6

NM_178404

2

1.24

0.016

10550029

Zfp110

zinc finger protein 110

NM_022981

7

1.24

0.004

10556246

Zfp143

zinc finger protein 143

NM_009281

7

-1.23

0.015

10591161

Zfp558

zinc finger protein 558

NM_028935

9

1.47

0.006

10547282

Zfp9

zinc finger protein 9

NM_011763

6

1.25

0.008

Chromosomal location of transcript-encoding gene
p-values < 0.001 are shown as 0.000
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APPENDIX B. mRNA transcripts identified as altered in the adult brain (P60) of mice exposed to ethanol during synaptogenesis (P4+7)
(fold cutoff ≥ ±1.2, FDR-corrected p-value < 0.05). Genes are listed alphabetically by gene symbol.
Transcript
ID

Gene symbol

Gene name

RefSeq

10389269

Aatf

apoptosis antagonizing transcription factor

10546432

Adamts9

10496438

Chra

Fold-change

p-value b

NM_019816

11

-1.32

0.001

NM_175314

6

-1.23

0.000

Adh1

a disintegrin-like and metallopeptidase (reprolysin type) with
thrombospondin type 1 motif, 9
alcohol dehydrogenase 1 (class I)

NM_007409

3

-1.35

0.000

10532630

Adrbk2

adrenergic receptor kinase, beta 2

NM_177078

5

-1.28

0.000

10554233

Aen

apoptosis enhancing nuclease

NM_026531

7

-1.35

0.000

10371332

Aldh1l2

aldehyde dehydrogenase 1 family, member L2

NM_153543

10

-1.32

0.000

10452734

Alk

anaplastic lymphoma kinase

NM_007439

17

-1.37

0.000

10586744

Anxa2

annexin A2

NM_007585

9

-1.42

0.000

10419977

Ap1g2

adaptor protein complex AP-1, gamma 2 subunit

NM_007455

14

-1.36

0.000

10462113

Apba1

amyloid beta (A4) precursor protein binding, family A, member 1

NM_177034

19

-1.25

0.000

10560624

Apoe

apolipoprotein E

NM_009696

7

-1.26

0.000

10430190

Apol10b

apolipoprotein L 10B

NM_177820

15

-1.27

0.000

10490221

Atp5e

NM_025983

2

-1.35

0.000

10587892

Atr

ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon
subunit
ataxia telangiectasia and Rad3 related

NM_019864

9

-1.37

0.000

10402249

Atxn3

ataxin 3

NM_029705

12

-1.34

0.001

10485700

Bbox1

NM_130452

2

-1.42

0.000

10400030

Bzw2

butyrobetaine (gamma), 2-oxoglutarate dioxygenase 1 (gammabutyrobetaine hydroxylase)
basic leucine zipper and W2 domains 2

NM_025840

12

-1.24

0.000

10547322

Cacna1c

calcium channel, voltage-dependent, L type, alpha 1C subunit

NM_001159533

6

-1.24

0.000

10579691

Calr3

calreticulin 3

NM_028500

8

-1.27

0.000

10475144

Capn3

calpain 3

NM_007601

2

-1.25

0.000

10571696

Casp3

caspase 3

NM_009810

8

-1.31

0.001

10457106

Cbln2

cerebellin 2 precursor protein

NM_172633

18

-1.27

0.001

10348999

Cdh20

cadherin 20

NM_011800

1

-1.31

0.000
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10513824

Cdk5rap2

CDK5 regulatory subunit associated protein 2

NM_145990

4

-1.26

0.000

10468974

Cdnf

cerebral dopamine neurotrophic factor

NM_177647

2

-1.55

0.000

10466423

Cep78

centrosomal protein 78

NM_198019

19

-1.37

0.000

10470775

Cercam

cerebral endothelial cell adhesion molecule

NM_207298

2

-1.41

0.001

10560063

Chmp2a

charged multivesicular body protein 2A

NM_026885

7

-1.27

0.000

10461143

Chrm1

cholinergic receptor, muscarinic 1, CNS

NM_001112697

19

-1.24

0.000

10542129

Clec2g

C-type lectin domain family 2, member g

NM_027562

6

-1.24

0.000

10402473

Clmn

calmin

NM_053155

12

-1.49

0.000

10416843

Cln5

ceroid-lipofuscinosis, neuronal 5

NM_001033242

14

-1.36

0.001

10484457

Clp1

CLP1, cleavage and polyadenylation factor I subunit

NM_133840

2

-1.20

0.000

10545874

Cml5

camello-like 5

NM_023493

6

-1.47

0.001

10581049

Cmtm2a

CKLF-like MARVEL transmembrane domain containing 2A

NM_027022

8

-1.36

0.000

10503902

Cnr1

cannabinoid receptor 1 (brain)

NM_007726

4

-1.30

0.000

10467216

Cpeb3

cytoplasmic polyadenylation element binding protein 3

NM_198300

19

-1.37

0.000

10437330

Crebbp

CREB binding protein

16

-1.25

0.000

10526931

Cyp2w1

cytochrome P450, family 2, subfamily w, polypeptide 1

ENSMUST00000
100216
NM_001160265

5

-1.27

0.000

10399732

Dcdc2c

doublecortin domain containing 2C

NM_001177964

12

-1.38

0.000

10560983

Dedd2

death effector domain-containing DNA binding protein 2

NM_207677

7

-1.39

0.000

10577441

Defb9

defensin beta 9

NM_139219

8

-1.41

0.000

10438245

Dgcr14

DiGeorge syndrome critical region gene 14

NM_022408

16

-1.24

0.000

10515481

Dmap1

DNA methyltransferase 1-associated protein 1

NM_023178

4

-1.38

0.001

10600604

Dmd

dystrophin, muscular dystrophy

NM_007868

X

-1.30

0.000

10596231

Dnajc13

DnaJ (Hsp40) homolog, subfamily C, member 13

NM_001163026

9

-1.21

0.001

10417034

Dnajc3

DnaJ (Hsp40) homolog, subfamily C, member 3

NM_008929

14

-1.38

0.000

10345241

Dst

dystonin

NM_134448

1

-1.24

0.000

10506170

Efcab7

EF-hand calcium binding domain 7

NM_145549

4

-1.43

0.000

10452419

Efna5

ephrin A5

NM_207654

17

-1.33

0.000

10576911

Efnb2

ephrin B2

NM_010111

8

-1.30

0.000
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10374366

Egfr

epidermal growth factor receptor

NM_207655

11

-1.27

0.000

10400304

Egln3

egl-9 family hypoxia-inducible factor 3

NM_028133

12

1.41

0.001

10349752

Elk4

ELK4, member of ETS oncogene family

NM_007923

1

-1.31

0.000

10596115

Ephb1

Eph receptor B1

AK082061

9

-1.49

0.000

10389990

Epn3

epsin 3

NM_027984

11

-1.41

0.000

10562064

Etv2

ets variant 2

NM_007959

7

-1.23

0.000

10569611

Fadd

Fas (TNFRSF6)-associated via death domain

NM_010175

7

-1.24

0.001

10470298

Fam69b

family with sequence similarity 69, member B

NM_019833

2

-1.28

0.000

10460726

Fau

NM_007990

19

-1.24

0.001

10540085

Fbln2

Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously
expressed (fox derived)
fibulin 2

NM_007992

6

-1.33

0.000

10557742

Fbxl19

F-box and leucine-rich repeat protein 19

NM_172748

7

-1.38

0.000

10492755

Fga

fibrinogen alpha chain

NM_001111048

3

-1.23

0.000

10415651

Fgf9

fibroblast growth factor 9

NM_013518

14

-1.30

0.000

10481566

Fibcd1

fibrinogen C domain containing 1

NM_178887

2

-1.28

0.000

10603099

Figf

c-fos induced growth factor

NM_010216

X

-1.23

0.001

10565401

Folh1

folate hydrolase 1

NM_016770

7

-1.28

0.000

10576046

Foxf1a

forkhead box F1

NM_010426

8

-1.36

0.000

10504534

Frmpd1

FERM and PDZ domain containing 1

NM_001081172

4

-1.65

0.000

10495596

Frrs1

ferric-chelate reductase 1

NM_001113478

3

-1.24

0.000

10445710

Frs3

fibroblast growth factor receptor substrate 3

NM_144939

17

-1.41

0.000

10530563

Fryl

furry homolog-like (Drosophila)

NM_028194

5

-1.28

0.000

10552964

Ftl1

ferritin light chain 1

NM_010240

7

-1.51

0.000

10581702

Fuk

fucokinase

NM_172283

8

-1.49

0.001

10571233

Fut10

fucosyltransferase 10

NM_134161

8

-1.58

0.000

10376230

G3bp1

GTPase activating protein (SH3 domain) binding protein 1

NM_013716

11

-1.33

0.001

10575616

Gabarapl2

-1.51

0.043

Gabrr3

ENSMUST00000
034428
NM_001081190

8

10436416

gamma-aminobutyric acid (GABA) A receptor-associated protein-like
2
gamma-aminobutyric acid (GABA) receptor, rho 3

16

-1.21

0.012

10487190

Galk2

galactokinase 2

NM_175154

2

-1.32

0.000

237

10578786

Galntl6

UDP-N-acetyl-alpha-D-galactosamine:polypeptide Nacetylgalactosaminyltransferase-like 6
glioblastoma amplified sequence

NM_175032

8

1.29

0.001

10526055

Gbas

10406777

Gcnt4
Gfpt2

glucosaminyl (N-acetyl) transferase 4, core 2 (beta-1,6-Nacetylglucosaminyltransferase)
glutamine fructose-6-phosphate transaminase 2

NM_008095

5

-1.32

0.001

NM_001166065

13

-1.44

0.001

10375614

NM_013529

11

-1.26

0.000

10544588

Gimap3

GTPase, IMAP family member 3

NM_031247

6

-1.23

0.001

10372410

Glipr1

GLI pathogenesis-related 1 (glioma)

NM_028608

10

-1.26

0.000

10558454

Glrx3

glutaredoxin 3

NM_023140

7

-1.87

0.000

10560202

Gltscr1

glioma tumor suppressor candidate region gene 1

NM_001081418

7

-1.30

0.000

10560181

Gltscr2

glioma tumor suppressor candidate region gene 2

NM_133831

7

-1.30

0.001

10490653

Gmeb2

glucocorticoid modulatory element binding protein 2

NM_198169

2

-1.31

0.000

10547858

Gnb3

guanine nucleotide binding protein (G protein), beta 3

NM_013530

6

-1.41

0.000

10458547

Gnpda1

glucosamine-6-phosphate deaminase 1

NM_011937

18

-1.48

0.000

10419216

Gnpnat1

glucosamine-phosphate N-acetyltransferase 1

NM_019425

14

-1.25

0.000

10526838

Got2

glutamatic-oxaloacetic transaminase 2, mitochondrial

NM_010325

8

-1.34

0.000

10598381

Gpkow

G patch domain and KOW motifs

NM_173747

X

1.35

0.000

10560237

Gpr77

G protein-coupled receptor 77

NM_176912

7

-1.28

0.001

10414137

Grid1

glutamate receptor, ionotropic, delta 1

NM_008166

14

-1.31

0.001

10508052

Grik3

glutamate receptor, ionotropic, kainate 3

NM_001081097

4

-1.29

0.002

10548791

Grin2b

glutamate receptor, ionotropic, NMDA2B (epsilon 2)

NM_008171

6

-1.27

0.000

10392863

Grin2c

glutamate receptor, ionotropic, NMDA2C (epsilon 3)

NM_010350

11

-1.26

0.002

10563421

Grin2d

glutamate receptor, ionotropic, NMDA2D (epsilon 4)

NM_008172

7

-1.54

0.000

10364583

Grin3b

glutamate receptor, ionotropic, NMDA3B

NM_130455

10

-1.31

0.001

10449343

Grm4

glutamate receptor, metabotropic 4

NM_001013385

17

-1.38

0.004

10521461

Grpel1

GrpE-like 1, mitochondrial

NM_024478

5

-1.38

0.000

10527562

Gsx1

GS homeobox 1

NM_008178

5

-1.37

0.000

10420268

Gzme

granzyme E

NM_010373

14

-1.21

0.027

10391084

Hap1

huntingtin-associated protein 1

NM_010404

11

1.50

0.000

10514201

Haus6

HAUS augmin-like complex, subunit 6

NM_173400

4

-1.42

0.000
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10585851

Hcn4

hyperpolarization-activated, cyclic nucleotide-gated K+ 4

NM_001081192

9

-1.53

0.000

10431371

Hdac10

histone deacetylase 10

NM_199198

15

-1.25

0.001

10606088

Hdac8

histone deacetylase 8

NM_027382

X

-1.38

0.000

10403511

Heatr1

HEAT repeat containing 1

NM_144835

13

-1.33

0.001

10507394

Hectd3

HECT domain containing 3

NM_175244

4

-1.32

0.000

10435266

Heg1

HEG homolog 1 (zebrafish)

NM_175256

16

-1.55

0.000

10382152

Helz

helicase with zinc finger domain

NM_198298

11

-1.26

0.000

10542917

Hepacam2

HEPACAM family member 2

NM_178899

6

-1.32

0.000

10585874

Hexa

hexosaminidase A

NM_010421

9

-1.39

0.000

10408210

Hist1h2bf

histone cluster 1, H2bf

NM_178195

13

-1.33

0.000

10403943

Hist1h2bm

histone cluster 1, H2bm

NM_178200

13

-1.53

0.001

10408239

Hist1h3c

histone cluster 1, H3c

NM_175653

13

-1.30

0.001

10404051

Hist1h4d

histone cluster 1, H4d

NM_175654

13

-1.26

0.000

10500333

Hist2h4

histone cluster 2, H4

NM_033596

3

-1.27

0.000

10491014

Hltf

helicase-like transcription factor

NM_009210

3

-1.33

0.000

10358557

Hmcn1

hemicentin 1

NM_001024720

1

-1.28

0.001

10424909

Hsf1

heat shock factor 1

NM_008296

15

-1.22

0.013

10407034

Htr1a

5-hydroxytryptamine (serotonin) receptor 1A

NM_008308

13

-1.25

0.001

10509238

Htr1d

5-hydroxytryptamine (serotonin) receptor 1D

NM_008309

4

-1.28

0.009

10357288

Htr5b

5-hydroxytryptamine (serotonin) receptor 5B

NM_010483

1

1.30

0.012

10521261

Htt

huntingtin

NM_010414

5

-1.23

0.001

10569014

Ifitm2

interferon induced transmembrane protein 2

NM_030694

7

-1.43

0.000

10588707

Ifrd2

interferon-related developmental regulator 2

NM_025903

9

-1.21

0.000

10390209

Igf2bp1

insulin-like growth factor 2 mRNA binding protein 1

NM_009951

11

-1.56

0.000

10540679

Il17re

interleukin 17 receptor E

NM_145826

6

-1.28

0.000

10581664

Il34

interleukin 34

NM_029646

8

-1.44

0.000

10372730

Iltifb

interleukin 10-related T cell-derived inducible factor beta

NM_054079

10

-2.20

0.000

10555574

Inppl1

inositol polyphosphate phosphatase-like 1

NM_010567

7

-1.27

0.000
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10576696

Insr

insulin receptor

NM_010568

8

-1.30

0.000

10535247

Iqce

IQ motif containing E

NM_028833

5

-1.34

0.000

10385870

Irf1

interferon regulatory factor 1

NM_008390

11

-1.25

0.001

10536898

Irf5

interferon regulatory factor 5

NM_012057

6

-1.25

0.000

10573910

Irx5

Iroquois related homeobox 5 (Drosophila)

NM_018826

8

-1.54

0.000

10554240

Isg20

interferon-stimulated protein

NM_020583

7

-1.51

0.001

10557862

Itgam

integrin alpha M

NM_001082960

7

-1.29

0.001

10435305

Itgb5

integrin beta 5

NM_001145884

16

1.37

0.001

10485340

Itpa

inosine triphosphatase (nucleoside triphosphate pyrophosphatase)

NM_025922

2

-1.25

0.001

10436892

Itsn1

intersectin 1 (SH3 domain protein 1A)

NM_010587

16

-1.23

0.000

10352798

Kcnh1

NM_010600

1

-1.27

0.000

10401987

Kcnk10

potassium voltage-gated channel, subfamily H (eag-related), member
1
potassium channel, subfamily K, member 10

NM_029911

12

-1.32

0.000

10541216

Kdm5a

lysine (K)-specific demethylase 5A

NM_145997

6

-1.34

0.000

10377547

Kdm6b

KDM1 lysine (K)-specific demethylase 6B

NM_001017426

11

-1.35

0.000

10594251

Kif23

kinesin family member 23

NM_024245

9

-1.41

0.000

10398814

Kif26a

kinesin family member 26A

NM_001097621

12

-1.22

0.000

10561942

Kirrel2

kin of IRRE like 2 (Drosophila)

NM_172898

7

-1.41

0.000

10366052

Kitl

kit ligand

NM_013598

10

1.33

0.000

10514319

Klhl9

kelch-like 9

NM_172871

4

-1.31

0.000

10552594

Klk1b22

kallikrein 1-related peptidase b22

NM_010114

7

-1.26

0.000

10548450

Klra5

killer cell lectin-like receptor, subfamily A, member 5

NM_008463

6

-1.28

0.001

10379260

Ksr1

kinase suppressor of ras 1

NM_013571

11

-1.26

0.000

10565479

l7Rn6

lethal, Chr 7, Rinchik 6

NM_026304

7

1.32

0.000

10362538

Lama4

laminin, alpha 4

NM_010681

10

-1.25

0.000

10571005

Letm2

leucine zipper-EF-hand containing transmembrane protein 2

NM_173012

8

-1.28

0.000

10502774

Lphn2

latrophilin 2

NM_001081298

3

-1.32

0.000

10445816

Lrfn2

leucine rich repeat and fibronectin type III domain containing 2

NM_027452

17

-1.23

0.001

10537123

Lrguk

leucine-rich repeats and guanylate kinase domain containing

NM_028886

6

-1.32

0.000
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10396314

Lrrc9

leucine rich repeat containing 9

NM_001142728

12

-1.41

0.000

10463457

Lzts2

leucine zipper, putative tumor suppressor 2

NM_145503

19

-1.44

0.000

10581992

Maf

NM_001025577

8

-1.30

0.000

10412100

Map3k1

avian musculoaponeurotic fibrosarcoma (v-maf) AS42 oncogene
homolog
mitogen-activated protein kinase kinase kinase 1

NM_011945

13

-1.50

0.000

10561323

Map3k10

mitogen-activated protein kinase kinase kinase 10

NM_001081292

7

-1.25

0.001

10551666

Map4k1

mitogen-activated protein kinase kinase kinase kinase 1

NM_008279

7

-1.21

0.000

10346328

Mars2

methionine-tRNA synthetase 2 (mitochondrial)

BC132343

1

-1.62

0.000

10480432

Mastl

microtubule associated serine/threonine kinase-like

NM_025979

2

-1.43

0.000

10370824

Mbd3

methyl-CpG binding domain protein 3

NM_013595

10

-1.41

0.000

10536472

Mdfic

MyoD family inhibitor domain containing

NM_175088

6

-1.48

0.000

10503723

Mdn1

midasin homolog (yeast)

NM_001081392

4

-1.38

0.000

10420080

Mdp1

magnesium-dependent phosphatase 1

NM_023397

14

-1.37

0.000

10554819

Me3

malic enzyme 3, NADP(+)-dependent, mitochondrial

NM_181407

7

-1.33

0.000

10508686

Mecr

mitochondrial trans-2-enoyl-CoA reductase

NM_025297

4

-1.39

0.000

10493189

Mef2d

myocyte enhancer factor 2D

3

-1.26

0.000

10398326

Meg3

maternally expressed 3

ENSMUST00000
001455
NR_003633

12

-1.22

0.001

10378482

Mett10d

methyltransferase like 16

NM_026197

11

-1.34

0.000

10584589

Mir100

microRNA 100

NR_029790

9

-1.37

0.000

10472982

Mir10b

microRNA 10b

NR_029566

2

-1.42

0.000

10470296

Mir126

microRNA 126a

NR_029541

2

-1.24

0.000

10543680

Mir182

microRNA 182

NR_029569

6

-1.26

0.000

10352499

Mir194-1

microRNA 194-1

NR_029580

1

1.50

0.000

10398812

Mir203

microRNA 203

NR_029590

12

-1.32

0.000

10345028

Mir206

microRNA 206

NR_029593

1

-1.41

0.001

10375214

Mir218-2

microRNA 218-2

NR_029799

11

-1.22

0.000

10603807

Mir222

microRNA 222

NR_029807

X

-1.35

0.000

10398382

Mir379

microRNA 379

NR_029880

12

-1.58

0.000

10379028

Mir451

microRNA 451a

NR_029971

11

-1.33

0.001
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10604585

Mir717

microRNA 717

NR_030497

X

-1.26

0.000

10507218

Mknk1

MAP kinase-interacting serine/threonine kinase 1

NM_021461

4

-1.21

0.001

10492469

Mlf1

myeloid leukemia factor 1

NM_001039543

3

-1.54

0.000

10515363

Mmachc

methylmalonic aciduria cblC type, with homocystinuria

NM_025962

4

-1.22

0.000

10482486

Mmadhc

NM_133839

2

-1.27

0.000

10590781

Mmp1b

methylmalonic aciduria (cobalamin deficiency) cblD type, with
homocystinuria
matrix metallopeptidase 1b (interstitial collagenase)

NM_032007

9

-1.24

0.001

10573924

Mmp2

matrix metallopeptidase 2

NM_008610

8

-1.30

0.001

10553330

Mrgprb13

MAS-related GPR, member B13

XM_003086592

7

-1.62

0.000

10563760

Mrgprb2

MAS-related GPR, member B2

NM_175531

7

-1.43

0.000

10523161

Mthfd2l

methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2-like

NM_026788

5

-1.47

0.001

10587695

Mthfs

5, 10-methenyltetrahydrofolate synthetase

NM_026829

9

-1.37

0.000

10407709

Mtr

5-methyltetrahydrofolate-homocysteine methyltransferase

NM_001081128

13

-1.29

0.001

10399421

Mycn

NM_008709

12

-1.35

0.000

10557831

Myst1

v-myc myelocytomatosis viral related oncogene, neuroblastoma
derived (avian)
MYST histone acetyltransferase 1

NM_026370

7

-1.36

0.001

10395074

Myt1l

myelin transcription factor 1-like

NM_001093775

12

-1.27

0.000

10480901

Nacc2

NM_001037098

2

-1.24

0.000

10411595

Naip2

nucleus accumbens associated 2, BEN and BTB (POZ) domain
containing
NLR family, apoptosis inhibitory protein 2

NM_010872

13

-1.45

0.000

10545041

Nap1l5

nucleosome assembly protein 1-like 5

NM_021432

6

-1.21

0.000

10517677

Nbl1

neuroblastoma, suppression of tumorigenicity 1

NM_008675

4

-1.47

0.000

10503431

Nbn

nibrin

NM_013752

4

-1.33

0.000

10480652

Ndor1

NADPH dependent diflavin oxidoreductase 1

NM_001082476

2

-1.44

0.000

10456254

Nedd4l

NM_001114386

18

-1.20

0.000

10407420

Net1

neural precursor cell expressed, developmentally down-regulated
gene 4-like
neuroepithelial cell transforming gene 1

NM_019671

13

-1.52

0.000

10459944

Nfatc1

NM_001164109

18

-1.26

0.000

10553635

Nipa1

NM_153578

7

-1.22

0.000

10599232

Nkap

nuclear factor of activated T cells, cytoplasmic, calcineurin dependent
1
non imprinted in Prader-Willi/Angelman syndrome 1 homolog
(human)
NFKB activating protein

NM_025937

X

-1.21

0.001
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10408037

Nkapl

NFKB activating protein-like

NM_025719

13

-1.43

0.001

10491066

Nlgn1

neuroligin 1

NM_138666

3

-1.26

0.000

10494595

Notch2

notch 2

NM_010928

3

-1.24

0.000

10395719

Npas3

neuronal PAS domain protein 3

NM_013780

12

-1.32

0.000

10401519

Npc2

Niemann-Pick type C2

NM_023409

12

-1.27

0.000

10363492

Npffr1

neuropeptide FF receptor 1

NM_001177511

10

-1.30

0.000

10548038

Ntf3

neurotrophin 3

NM_001164035

6

-1.58

0.000

10481349

Ntng2

netrin G2

NM_133501

2

-1.25

0.000

10520111

Nupl2

nucleoporin like 2

NM_153092

5

-1.36

0.000

10351491

Olfml2b

olfactomedin-like 2B

NM_177068

1

-1.26

0.000

10592391

Olfr937

olfactory receptor 937

NM_146439

9

-1.34

0.000

10484514

Olfr993

olfactory receptor 993

NM_146435

2

-1.41

0.000

10479833

Optn

optineurin

NM_181848

2

-1.46

0.000

10484486

P2rx3

purinergic receptor P2X, ligand-gated ion channel, 3

NM_145526.2

2

-1.28

0.000

10378319

P2rx5

purinergic receptor P2X, ligand-gated ion channel, 5

NM_033321

11

-1.29

0.000

10492330

P2ry1

purinergic receptor P2Y, G-protein coupled 1

NM_008772

3

-1.37

0.000

10590983

Panx1

pannexin 1

NM_019482

9

-1.39

0.000

10592355

Panx3

pannexin 3

NM_172454

9

-1.24

0.000

10587871

Paqr9

progestin and adipoQ receptor family member IX

NM_198414

9

-1.40

0.001

10355916

Pax3

paired box 3

NM_008781

1

-1.24

0.000

10363921

Pcdh15

protocadherin 15

NM_023115

10

-1.32

0.000

10455088

Pcdhb11

protocadherin beta 11

NM_053136

18

-1.34

0.000

10455108

Pcdhb16

protocadherin beta 16

NM_053141

18

-1.30

0.000

10455118

Pcdhb18

protocadherin beta 18

NM_053143

18

-1.43

0.000

10455071

Pcdhb7

protocadherin beta 7

NM_053132

18

-1.47

0.000

10418247

Pde12

phosphodiesterase 12

NM_178668

14

1.25

0.000

10497713

Pex5l

peroxisomal biogenesis factor 5-like

NM_021483

3

-1.30

0.000

10445607

Pex6

peroxisomal biogenesis factor 6

NM_145488

17

-1.49

0.000

243

10550509

Pglyrp1

peptidoglycan recognition protein 1

NM_009402

7

-1.31

0.000

10439710

Phldb2

pleckstrin homology-like domain, family B, member 2

NM_153412

16

-1.26

0.001

10452030

Plin3

perilipin 3

NM_025836

17

-1.23

0.000

10497253

Pmp2

peripheral myelin protein 2

NM_001030305

3

-1.30

0.000

10454478

Polr2d

polymerase (RNA) II (DNA directed) polypeptide D

NM_027002

18

-1.57

0.000

10394240

Pomc

pro-opiomelanocortin-alpha

NM_008895

12

-1.57

0.000

10542983

Pon1

paraoxonase 1

NM_011134

6

-1.25

0.000

10357948

Ppp1r12b

protein phosphatase 1, regulatory (inhibitor) subunit 12B

NM_001081307

1

-1.29

0.001

10607475

Prdx4

peroxiredoxin 4

NM_016764

X

-1.39

0.000

10408412

Prl7b1

prolactin family 7, subfamily b, member 1

NM_029355

13

-1.28

0.000

10408436

Prl7d1

prolactin family 7, subfamily d, member 1

NM_011120

13

-1.22

0.000

10423049

Prlr

prolactin receptor

NM_011169

15

-1.57

0.000

10542239

Prp2

proline rich protein 2

NM_031499

6

3.30

0.000

10407390

Ptbp1

polypyrimidine tract binding protein 1

NM_001077363

10

1.61

0.000

10471411

Ptges2

prostaglandin E synthase 2

NM_133783

2

-1.28

0.001

10367100

Ptges3

prostaglandin E synthase 3 (cytosolic)

NM_019766

10

1.68

0.000

10567034

Pth

parathyroid hormone

NM_020623

7

-1.20

0.000

10513154

Ptpn3

protein tyrosine phosphatase, non-receptor type 3

NM_011207

4

-1.25

0.000

10409414

Rab24

RAB24, member RAS oncogene family

NM_009000

13

-1.26

0.000

10423068

Rad1

RAD1 checkpoint DNA exonuclease

NM_011232

15

-1.55

0.000

10535312

Radil

Ras association and DIL domains

NM_178702

5

-1.35

0.000

10525983

Ran

RAN, member RAS oncogene family

NM_009391

5

-1.26

0.000

10417713

Rarb

retinoic acid receptor, beta

NM_011243

14

-1.44

0.000

10544573

Rarres2

retinoic acid receptor responder (tazarotene induced) 2

NM_027852

6

-1.54

0.000

10526459

Rasa4

RAS p21 protein activator 4

NM_133914

5

-1.24

0.000

10359235

Rasal2

RAS protein activator like 2

NM_177644

1

-1.25

0.000

10464819

Rbm14

RNA binding motif protein 14

NM_019869

19

-1.41

0.000

10440993

Rcan1

regulator of calcineurin 1

NM_001081549

16

-1.27

0.001
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10373588

Rdh5

retinol dehydrogenase 5

NM_134006

10

-1.32

0.001

10490736

Rgs19

regulator of G-protein signaling 19

NM_026446

2

-1.37

0.000

10428124

Rgs22

regulator of G-protein signalling 22

NM_001195748

15

-1.47

0.000

10566132

Rhog

ras homolog gene family, member G

NM_019566

7

-1.48

0.001

10449071

Rhot2

ras homolog gene family, member T2

NM_145999

17

-1.23

0.000

10423855

Rims2

regulating synaptic membrane exocytosis 2

NM_053271

15

-1.22

0.001

10507731

Rims3

regulating synaptic membrane exocytosis 3

NM_182929

4

-1.23

0.000

10383200

Rnf213

ring finger protein 213

11

-1.37

0.000

10445061

Rnf39

ring finger protein 39

ENSMUST00000
131035
NM_001099632

17

-1.30

0.000

10533106

Rnft2

ring finger protein, transmembrane 2

NM_172998

5

-1.34

0.001

10378768

Rnmtl1

RNA methyltransferase like 1

NM_183263

11

-1.38

0.000

10438564

Rps10

ribosomal protein S10

NM_025963

17

-1.29

0.000

10385034

Rpsa

ribosomal protein SA

NM_011029

9

-1.36

0.000

10383245

Rptor

regulatory associated protein of MTOR, complex 1

NM_028898

11

-1.27

0.001

10444137

Rxrb

retinoid X receptor beta

NM_011306

17

-1.41

0.000

10402428

Serpina12

NM_026535

12

-1.26

0.000

10574404

Setd6

serine (or cysteine) peptidase inhibitor, clade A (alpha-1
antiproteinase, antitrypsin), member 12
SET domain containing 6

NM_001035123

8

-1.51

0.000

10344750

Sgk3

serum/glucocorticoid regulated kinase 3

NM_133220

1

-1.26

0.000

10502224

Sgms2

sphingomyelin synthase 2

NM_028943

3

-1.40

0.000

10400971

Six4

sine oculis-related homeobox 4

NM_011382

12

-1.26

0.000

10360173

Slamf7

SLAM family member 7

NM_144539

1

-1.25

0.000

10531887

Slc10a6

NM_029415

5

-1.21

0.000

10474545

Slc12a6

solute carrier family 10 (sodium/bile acid cotransporter family),
member 6
solute carrier family 12, member 6

NM_133649

2

-1.28

0.000

10377790

Slc16a11

NM_153081

11

-1.50

0.000

10392440

Slc16a6

solute carrier family 16 (monocarboxylic acid transporters), member
11
solute carrier family 16 (monocarboxylic acid transporters), member 6

NM_001029842

11

-1.45

0.000

10481634

Slc25a25

solute carrier family 25 (mitochondrial carrier, phosphate carrier),
member 25

NM_146118

2

-1.35

0.001
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10421172

Slc25a37

solute carrier family 25, member 37

NM_026331

14

-1.29

0.001

10451123

Slc29a1

solute carrier family 29 (nucleoside transporters), member 1

NM_022880

17

-1.28

0.000

10510516

Slc2a5

solute carrier family 2 (facilitated glucose transporter), member 5

NM_019741

4

-1.34

0.001

10352548

Slc30a10

solute carrier family 30, member 10

NM_001033286

1

-1.35

0.000

10496324

Slc39a8

solute carrier family 39 (metal ion transporter), member 8

NM_001135149

3

-1.24

0.000

10435993

Slc9a10

NM_198106

16

-1.31

0.000

10532275

Smndc1

solute carrier family 9, subfamily C (Na+-transporting carboxylic acid
decarboxylase), member 1
survival motor neuron domain containing 1

NM_172429

19

-1.22

0.000

10368806

Smpd2

sphingomyelin phosphodiesterase 2, neutral

NM_009213

10

-1.35

0.001

10508723

Snora61

small nucleolar RNA, H/ACA box 61

NR_034046

4

-1.34

0.000

10564017

Snord115

small nucleolar RNA, C/D Box 115 cluster

AF357427

7

1.71

0.000

10375499

Snord96a

small nucleolar RNA, C/D box 96A

NR_028563

11

-1.26

0.001

10529515

Sorcs2

sortilin-related VPS10 domain containing receptor 2

NM_030889

5

-1.27

0.000

10570189

Sox1

SRY (sex determining region Y)-box 1

NM_009233

8

-1.57

0.001

10491721

Spry1

sprouty homolog 1 (Drosophila)

NM_011896

3

-1.50

0.000

10541721

Spsb2

splA/ryanodine receptor domain and SOCS box containing 2

NM_013539

6

-1.37

0.000

10390430

Srcin1

SRC kinase signaling inhibitor 1

NM_018873

11

-1.29

0.000

10411274

Sv2c

synaptic vesicle glycoprotein 2c

NM_029210

13

-1.34

0.000

10595604

Syncrip

synaptotagmin binding, cytoplasmic RNA interacting protein

NM_019796

9

-1.24

0.000

10361381

Syne1

spectrin repeat containing, nuclear envelope 1

NM_001079686

10

-1.32

0.001

10443080

Syngap1

synaptic Ras GTPase activating protein 1 homolog (rat)

XM_985548

17

-1.25

0.000

10425335

Syngr1

synaptogyrin 1

NM_207708

15

-1.23

0.001

10515708

Szt2

seizure threshold 2

NM_198170

4

-1.24

0.000

10472240

Tanc1

tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1

NM_198294

2

-1.39

0.000

10548677

Tas2r140

taste receptor, type 2, member 140

NM_021562

6

-1.39

0.001

10359701

Tbx19

T-box 19

NM_032005

1

-1.27

0.000

10380887

Tcap

titin-cap

NM_011540

11

-1.22

0.000

10548146

Tead4

TEA domain family member 4

NM_011567

6

-1.34

0.000

10557960

Tgfb1i1

transforming growth factor beta 1 induced transcript 1

NM_009365

7

-1.30

0.000
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10606548

Tgif2lx1

TGFB-induced factor homeobox 2-like, X-linked 1

NM_153109

X

-1.39

0.000

10385518

Tgtp1

T cell specific GTPase 1

NM_011579

11

-1.25

0.000

10516296

Thrap3

thyroid hormone receptor associated protein 3

NM_146153

4

-1.60

0.000

10565081

Timm17a

translocase of inner mitochondrial membrane 17a

NM_011590

1

-1.35

0.000

10512514

Tln1

talin 1

NM_011602

4

-1.25

0.000

10530145

Tlr1

toll-like receptor 1

NM_030682

5

-1.47

0.000

10518714

Tmem201

transmembrane protein 201

NM_001025106

4

-1.38

0.000

10581917

Tmem231

transmembrane protein 231

NM_001033321

8

-1.37

0.000

10491091

Tnfsf10

tumor necrosis factor (ligand) superfamily, member 10

NM_009425

3

-1.37

0.001

10576951

Tnfsf13b

tumor necrosis factor (ligand) superfamily, member 13b

NM_033622

8

-1.23

0.001

10580522

Tox3

TOX high mobility group box family member 3

NM_172913

8

-1.22

0.000

10348600

Traf3ip1

TRAF3 interacting protein 1

NM_028718

1

-1.42

0.000

10437311

Trap1

TNF receptor-associated protein 1

NM_026508

16

-1.35

0.000

10362442

Trdn

triadin

NM_029726

10

-2.21

0.000

10356194

Trip12

thyroid hormone receptor interactor 12

NM_133975

1

-1.22

0.001

10534718

Trip6

thyroid hormone receptor interactor 6

NM_011639

5

-1.52

0.000

10424331

Trmt12

tRNA methyltranferase 12

NM_026642

15

-1.28

0.000

10486722

Trp53bp1

transformation related protein 53 binding protein 1

NM_013735

2

-1.25

0.000

10503520

Ttpa

tocopherol (alpha) transfer protein

NM_015767

4

-1.27

0.000

10548163

Tulp3

tubby-like protein 3

NM_011657

6

-1.66

0.000

10591446

Tyk2

tyrosine kinase 2

NM_018793

9

-1.28

0.000

10528915

Tyms

thymidylate synthase

NM_021288

5

-1.57

0.000

10525885

Ubc

ubiquitin C

BC025894

5

-1.34

0.000

10463185

Ubtd1

ubiquitin domain containing 1

NM_145500

19

-1.30

0.000

10436561

Usp25

ubiquitin specific peptidase 25

NM_013918

16

-1.25

0.000

10367843

Utrn

utrophin

NM_011682

10

-1.26

0.000

10495416

Vav3

vav 3 oncogene

NM_020505

3

-1.63

0.000

10432032

Vdr

vitamin D receptor

NM_009504

15

-1.22

0.000
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10571788

Vegfc

vascular endothelial growth factor C

NM_009506

8

-1.54

0.000

10559970

Vmn1r69

vomeronasal 1 receptor 69

NM_145842

7

-1.33

0.000

10532285

Vmn2r15

vomeronasal 2, receptor 15

NM_001104626

5

-1.44

0.000

10565373

Vmn2r76

vomeronasal 2, receptor 76

NM_001102580

7

-1.34

0.000

10345546

Vwa3b

von Willebrand factor A domain containing 3B

XM_003086154

1

-1.34

0.000

10526193

Wbscr16

Williams-Beuren syndrome chromosome region 16 homolog (human)

NM_033572

5

-1.36

0.000

10419296

Wdhd1

WD repeat and HMG-box DNA binding protein 1

NM_172598

14

-1.37

0.000

10386376

Wnt3a

wingless-type MMTV integration site family, member 3A

NM_009522

11

-1.25

0.000

10562323

Wtip

WT1-interacting protein

NM_207212

7

1.26

0.000

10468489

Xpnpep1

X-prolyl aminopeptidase (aminopeptidase P) 1, soluble

NM_133216

19

-1.26

0.000

10347232

Xrcc5

NM_009533

1

-1.28

0.000

10373000

Xrcc6bp1

X-ray repair complementing defective repair in Chinese hamster cells
5
XRCC6 binding protein 1

NM_026858

10

-1.36

0.000

10434313

Yeats2

YEATS domain containing 2

NM_001145930

16

-1.25

0.001

10458755

Ythdc2

YTH domain containing 2

NM_001163013

18

-1.23

0.001

10490826

Zbtb10

zinc finger and BTB domain containing 10

NM_177660

3

-1.30

0.000

10350377

Zbtb41

zinc finger and BTB domain containing 41 homolog

NM_172643

1

-1.32

0.001

10551426

Zfp59

zinc finger protein 59

NM_011762

7

-1.20

0.000

10547282

Zfp9

zinc finger protein 9

NM_011763

6

-1.29

0.003

Chromosomal location of transcript-encoding gene
p-values < 0.001 are shown as 0.000
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APPENDIX C. microRNAs identified as differentially expressed in the adult (P60) brain of
mice treated with ethanol during synaptogenesis (fold cutoff ≥ ±1.2, FDR-corrected p<0.05).
miRNAs are listed in order of fold change relative to control.
Mature miRNA

Gene ID

Chra

Fold Change

p-value

mmu-miR-704
mmu-miR-1903

Mir704
Mir1903

6
8

-4.169
-2.701

0.003
0.035

mmu-miR-10b
mmu-miR-1196

Mir10b
Mir1196

2
14

-2.276
-2.046

0.036
0.019

mmu-miR-335-3p
mmu-let-7g
mmu-let-7b

Mir335
Mirlet7g
Mirlet7b

6
9
15

-1.930
-1.914
-1.892

0.003
0.016
0.022

mmu-miR-297a
mmu-miR-1947

Mir1947

ml
16

-1.880
-1.755

0.002
0.008

mmu-miR-376b
mmu-miR-1970

Mir376b
Mir1970

mmu-let-7i
mmu-miR-590-5p
mmu-miR-223

Mirlet7i
Mir590
Mir223

12
X
10

-1.702
-1.694
-1.589

0.043
0.034
0.040

unk
X

-1.562
-1.491

0.003
0.001

mmu-miR-503*
mmu-miR-1953

Mir503
Mir1953

mmu-miR-343
mmu-miR-467a-1
mmu-miR-34b-5p

Mir343
Mir467a-1
Mir34b

X
2
7

-1.479
-1.401
-1.317

0.029
0.031
0.037

2
9

-1.313
-1.292

0.037
0.006

mmu-miR-1927
mmu-miR-544

Mir1927
Mir544

mmu-miR-2182
mmu-miR-466i
mmu-miR-696

Mir2182
Mir466i
Mir696

1
12
unk

-1.287
-1.256
-1.256

0.029
0.022
0.048

13
unk

-1.252
-1.231

0.017
0.008

mmu-miR-15b
mmu-miR-665

Mir15b
Mir665

mmu-miR-715
mmu-miR-878-3p
mmu-miR-467b

Mir715
Mir878
Mir467b

3
12
unk

-1.214
-1.207
1.238

0.022
0.032
0.042

X
2

1.242
1.246

0.013
0.038

mmu-miR-1195
mmu-miR-26b

Mir1195
Mir26b

mmu-miR-93
mmu-miR-184
mmu-miR-1941-5p

Mir93
Mir184
Mir1941

17
1
5

1.272
1.284
1.311

0.033
0.036
0.006

9
15

1.485
1.688

0.035
0.037

ml
5

1.876
2.437

0.025
0.004

mmu-miR-669a
mmu-miR-721
a Chromosomal

Mir721

location of miRNA gene; ml: multiple loci; unk: unknown
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APPENDIX D. Animal use protocols approval obtained from the Animal Use Subcommittee at
the University of Western Ontario in compliance with the ethical standards established by
the Canadian Council on Animal Care.
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APPENDIX E. Copyright permission to include data previously published in the journals
Developmental Neuroscience and the Journal of Behavioral and Brain Sciences. Data previously
published within the Journal of Neurodevelopmental Disorders included in this thesis did not
require permission as the journal allows authors to retain ownership of data.

S. Karger AG, M edical and Scientific Publishers, Allschwilerstrasse 10, 4009 Basel, Switzerland
t +41 61 306 11 11, f +41 61 306 12 34, www.karger.com

Dear Ms. Kleiber,
As to your request, I am pleased to inform you that permission is granted herewith to reuse parts
from or your complete article.
Kleiber ML, Laufer BI, Stringer RL, Singh SM.
Third trimester-equivalent ethanol exposure is characterized by an acute cellular stress response
and an ontogenetic disruption of genes critical for synaptic establishment and function in mice.
Dev Neurosci. 2014;36(6):499-519 (DOI: 10.1159/000365549)
Epub 2014 Sep 30. PubMed PMID: 25278313.
in your upcoming doctoral thesis, provided that proper credit will be given to the original source
and that S. Karger AG, Basel will be mentioned.
Please note that this is a non-exclusive permission, hence any further use or distribution, either in
print or electronically, requires written permission again as this permission is valid for the above
mentioned purpose only.
This permission applies only to copyrighted content that S. Karger AG owns, and not to copyrighted
content from other sources. If any material in our work appears with credit to another source, you
must also obtain permission from the original source cited in our work. All content reproduced
from copyrighted material owned by S. Karger AG remains the sole and exclusive property of S.
Karger AG. The right to grant permission to a third party is reserved solely by S. Karger AG.
Thank you for your understanding and cooperation.
Hopefully, I have been of assistance to you with the above.
Best regards,
Silvia Meier
Rights Manager
permission@karger.com
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